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Myocarditis is an inflammatory heart disease that leads to DCM and heart failure. Sex 
hormones play a vital role in the development of myocarditis with testosterone driving 
disease in males. In contrast, estrogen mediates cardioprotection in females. Since 
myocarditis is influenced by sex hormones, it is highly probable that environmental factors 
like vitamin D and endocrine disruptors like bisphenol A (BPA) and BPS, which interfere 
with natural hormone signaling, could play a part in the progression of the disease. To our 
knowledge no one has examined the role of vitamin D receptor or endocrine disruptors like 
BPA on myocarditis. In order to examine the role of vitamin D on viral myocarditis, we 
examined vitamin D receptor knockout mice fed a calcium-supplemented diet to prevent 
rickets. For BPA and BPS experiments, we exposed mice to various doses of endocrine 
disruptors dissolved in their drinking water for two weeks and then examined their effect on 
viral myocarditis. We found that vitamin D receptor signaling protects female mice from 
myocarditis, but increases myocarditis in males. For endocrine disruptor exposure we found 
that BPA and BPS were each able to increase viral myocarditis by increasing mast cell 
numbers/ degranulation and T cells in female BALB/c mice. BPA exposure was also found 
to increase viral myocarditis in male BALB/c mice. In contrast, BPA exposure had no 
significant effect on myocarditis in female C57BL/6 mice. Surprisingly, housing mice in 
plastic cages was able to cause mast cell activation in females and increase myocarditis in 
male BALB/c mice. These data indicate that the traditional cages that investigators use to 
house their mice may be altering the immune response in a sex-specific manner. Our data 
show that exposure to endocrine disruptors significantly alter the immune response according 
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Epidemiology of Autoimmune Diseases 
Myocarditis, defined as an inflammation of the myocardium, is considered to be an 
autoimmune disease. Myocarditis can progress to dilated cardiomyopathy (DCM), a leading 
cause for needing a heart transplant (Cooper 2009A). Autoimmune diseases are acute and 
chronic inflammatory conditions where memory-specific T and B cells and antibodies are 
directed against self-tissues and there has been a breakdown of “tolerance” to self (Rose  
2006). Autoreactive T and B cells occur frequently in individuals but do not necessarily lead 
to autoimmune disease. Epidemiology studies have shown that autoimmune disease usually 
only develops when multiple autoantibodies are directed against a target tissue (Notkins 
2004, Fairweather 2008A). Autoimmune diseases have been estimated as the third most 
common category of chronic disease in the United States (US) after cardiovascular disease 
(CVD) and cancer, if they are considered as a group (Fairweather 2008A). 
Over 80 individual autoimmune diseases or autoimmune syndromes have been 
identified (Hayter 2012). Autoimmune diseases have been estimated to affect around 5-8% of 
the population (Jacobson 1997). The study by Jacobson et al was one of the first to examine 
autoimmune diseases as a group; they included 24 autoimmune diseases in their analysis 
(Jacobson 1997). A study of 31 autoimmune diseases found that the prevalence of 
autoimmune disease in Denmark from 1977 to 2001 was 5.3% (Eaton 2007). The prevalence 
estimates from the Denmark study are considered to significantly underestimate the true 
prevalence of autoimmune diseases because they are based on hospitalization registry data. 
Cooper et al updated the prevalence of 29 autoimmune diseases worldwide from 1989 to 
2008 and estimated a higher incidence ranging from 7.6% to 9.4% (Cooper, 2009B). A more 
recent study examining the prevalence of 81 autoimmune diseases found an overall 
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prevalence of 4.5% (Hayter 2012). Thus, autoimmune diseases are a major cause of 
morbidity and financial burden to the health systems of Western countries. 
 
Sex differences in epidemiology of autoimmune diseases 
One of the earliest epidemiology studies to report sex differences in autoimmune 
diseases was Beeson in 1994 (Beeson 1994). Beeson reported that out of 40 autoimmune 
diseases the highest female bias compared to males were for patients with Sjögren’s 
syndrome (19:1), systemic lupus erythematosus (9:1), and Hashimoto’s thyroiditis (6:1) 
(Beeson 1994). Jacobson et al also reported that autoimmune diseases are more common in 
women. They reported that women were at a 2.7 times greater risk of developing an 
autoimmune disease compared to men, and estimated that 79.8% of 24 autoimmune diseases 
occurred in women (Jacobson 1997). Examples of autoimmune diseases that occur more 
frequently in women than men with more recent prevalence estimates include Hashimoto’s 
thyroiditis (19:1), Sjögren’s syndrome (16:1), scleroderma (also called systemic sclerosis) 
(12:1), systemic lupus erythematosus (7:1), rheumatoid arthritis (3:1), and myositis (2:1) 
(Zandman-Goddard 2007, Hayter 2012). The top 5 most prevalent autoimmune diseases in 
men and women according to the epidemiology study by Hayter and Cook are rheumatoid 
arthritis, Hashimoto’s thyroiditis, celiac disease, Graves’ disease, and type I diabetes (Hayter 
2012). However, the most prevalent autoimmune diseases are not necessarily those with the 
highest sex bias. Hashimoto’s thyroiditis has a high prevalence and sex bias (19:1 women to 
men), but the other 4 most prevalent autoimmune diseases do not have a high sex bias. 
Sjögren’s syndrome and scleroderma have a high sex bias in women, but a relatively low 
prevalence compared to the most prevalent autoimmune diseases. 
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In contrast, with the exception of type I diabetes and Crohn’s disease, most 
autoimmune diseases that are more common in men occur rarely (Hayter 2012). 
Autoimmune diseases that occur more frequently in men have a smaller sex bias of only 
about 2:1 for men compared to women. Inflammatory conditions that occur more frequently 
in men like cardiovascular diseases, many cancers (i.e., lung, liver, stomach), and the leading 
autoimmune disease in men, type I diabetes, are leading causes of death in men (Regitz-
Zagrosek 2010, Dorak 2012, Fairweather 2012A, Soerjomataram 2012, Vos 2012, 
Fairweather 2013). In contrast, inflammatory diseases that occur more often in women like 
autoimmune diseases, allergy and asthma tend to have lower mortality (Fairweather 2008A, 
Lim 2012, Townsend 2012). 
 
Sex differences in the epidemiology of myocarditis and DCM 
Myocarditis and DCM also occur more frequently in men, but they are left out of 
most epidemiology studies of autoimmune diseases. In 1949, Ludden and Edwards from the 
Mayo Clinic reported a 2.5:1 ratio of myocarditis in men to women following a poliomyelitis 
outbreak that occurred in Minnesota in 1946 (Ludden 1949). A study of myocarditis patients 
in 1968 reported that 72% of cases occurred in men compared to women (Sainani 1968). 
Similarly, in 1980 Woodruff conducted a survey of 164 cases of viral myocarditis reported in 
reviews from 1957 to 1973 and found that 67% of patients were male (Woodruff 1980). 
Recent trials and registries of myocarditis report a female to male ratio of around 1:1.7 
(Mason 1995, Magnani 2006, Caforio 2007), while DCM studies report a female to male 
ratio of around 1:1.5 (Bagger 1984, Gillum 1986, Coughlin 1993). In 1989, a population-
based study found the age-adjusted female to male ratio for both incidence and prevalence of 
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idiopathic DCM to be 1:3 (Haddad 2008). There are no recent epidemiology studies of the 
prevalence or incidence of myocarditis. However, McNamara et al found that myocardial 
recovery was significantly better for women than men with myocarditis/ acute DCM in the 
Intervention in Myocarditis and Acute Cardiomyopathy (IMAC)-2 Study (McNamara 2011). 
Transplant-free survival was also significantly better in women than men in that study. The 
increased incidence of men developing idiopathic DCM compared to women was not 
explained by socioeconomic factors, alcohol intake or other variables (Dec 1994, Aguero 
2008). Thus, the incidence of myocarditis appears to be similar to other male-dominant 
autoimmune diseases like type I diabetes, with an approximately 2:1 ratio of men to women. 
 
Pathology of Myocarditis and DCM 
Pathology of Myocarditis 
Myocarditis was listed in a 2012 Lancet report as the 32nd cause of death globally 
(Lozano 2012). Myocarditis can occur at any age in men and women, but most cases in the 
US occur during peak reproductive years so that myocarditis is the leading cause of sudden 
death (aside from accidents) in the US in adults under the age of 40 (Drory 1991, Huber 
1997). From 4-20% of sudden cardiovascular deaths among young adults, the military, and 
athletes are believed to be due to myocarditis (Gupta 2008). In some individuals, myocarditis 
can progress to DCM and heart failure (Cooper 2009A, Wexler 2009, Roger 2011). 
Myocarditis is defined according to “the Dallas criteria” as an inflammatory infiltrate 
of the myocardium with or without necrosis (Aretz 1987). Myocarditis can develop in 
response to infections (i.e., viruses, bacteria, and parasites), toxins, chemicals, allergic 
reactions and/or drugs, and is considered an autoimmune heart disease (Gauntt 2003, Li 
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2006, Cooper 2009A, Guglin 2012, Marchant 2012, Fairweather 2013, Reddy 2013). The 
main cause of myocarditis worldwide is believed to be viral infections, which in the US 
population is believed to be mainly due to coxsackieviruses (CVB). However, the true 
incidence and prevalence of myocarditis are unknown due to the unavailability of safe and 
accurate noninvasive diagnostic tests (Cooper 2009A, Schultheiss 2011A, Schultheiss 
2011B). Myocarditis has been estimated to be the cause of death in less than 1% of autopsy 
cases (Kyto 2007), but a cause of unexpected death in young adults around 17% of the time 
(Doolan 2004). Although most cases of suspected myocarditis are not linked to a specific 
cause (Schultheiss 2011A, Schultheiss 2011B), viral infections like CVB are the most 
commonly identified cause of myocarditis in developed countries (Gupta 2008, Cooper 
2009A). CVB is nearly 100% prevalent in the population worldwide where individuals are 
usually infected as an infant/ child and re-infected each year. CVB is unique in that it has no 
known species barrier, and has no known sex difference in infectivity in humans or mice 
(Frisancho-Kiss 2007, Coronado 2012, Fairweather 2012A, Fairweather 2012B). Antiviral 
treatments with interferon (IFN)-β have been shown to reduce myocarditis and DCM in 
animal models and patients (Kuhl 2003, Wang 2007), further suggesting that viral infections 
are an important cause of myocarditis/ DCM cases in patients. 
Infections are also believed to induce autoimmune disease (Huber 2006, Fairweather 
2007, Ellis 2010, Root-Bernstein 2015). There are a number of theories on how viruses can 
cause autoimmune diseases including molecular mimicry, epitope spread, an adjuvant effect, 
or simply a direct effect of infection (Root-Bernstein 2014). CVB3 induces autoimmune 
myocarditis that progresses to DCM in susceptible strains of mice like A/J and BALB/c that 
closely resembles disease progression in people (Fairweather 2001, Gaunt 2003, Fairweather 
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2012A, Fairweather 2012B, Fairweather 2013, Myers 2013). Black background mice like 
C57BL/6 develop severe acute CVB3 myocarditis, but are resistant against developing DCM 
(Fairweather 2001, Abston 2012A). CVB3 myocarditis in C57BL/6 mice is more severe than 
disease in BALB/c mice during acute myocarditis, and appears to be similar to fulminant 
forms of myocarditis in the patient population. T helper (Th)1 /IFN responses increase acute 
myocarditis in male mice (Fairweather 2004A, Fairweather 2005, Frisancho-Kiss 2006, 
Fairweather 2012B). However, the same elevated Th1 response that increases acute 
myocarditis prevents progression to DCM by preventing remodeling in the heart (Abston 
2012A). A recent study of myocarditis/ acute DCM patients in the US found that more men 
than women developed DCM following myocarditis (McNamara 2011). More male BALB/c 
mice progress to DCM following CVB3 myocarditis compared to females (Fairweather 2001, 
Frisancho-Kiss 2007, Coronado 2012, Fairweather 2013), similar to the sex difference that 
exists for DCM in people. 
Similar to findings in clinical biopsies of myocarditis patients (Cooper 2009A, 
Fairweather 2014), the primary infiltrate in mouse models of myocarditis consists of 
macrophages and neutrophils with lower levels of T cells, B cells, mast cells and dendritic 
cells (DC) (Huber 1983, Frisancho-Kiss 2007, Cihakova 2008). Natural killer cells, CD8 T 
cells and γδT cells, important in antiviral defense, are present in the heart during the early 
cellular response in viral animal models of myocarditis (Fairweather 2001, Huber 2002). 
Acute myocarditis in mice is characterized by a predominantly Th1 and Th17 response 
(Huber 2002, Baldeviano 2010, Yuan 2010, Noutsias 2011, Fairweather 2012B). However, 
only mice that have higher levels of mast cells, such as BALB/c and A/J strains, and respond 
to infection with a Th2 response progress to develop DCM (Afanasyeva 2001, Fairweather 
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2004A, Fairweather 2004B, Frisancho-Kiss 2006, Fairweather 2008B, Abston 2012A, 
Abston 2012B). In many clinical cases, and in the CVB3 animal model, the pericardium as 
well as the myocardium can be affected, which is referred to as perimyocarditis or 
myopericarditis (Abston 2012B, Imazio 2013). Mast cell (MC) degranulation occurs most 
frequently along the pericardium (Fairweather 2004A), and when this occurs mice and 
humans are at an increased risk of progression to DCM and heart failure (Fairweather 2004, 
Fairweather 2008, Abston 2012B, Mina 2013). 
 
Pathology of Dilated Cardiomyopathy 
 DCM is defined as a heterogeneous group of diseases of the myocardium associated 
with mechanical and/or electrical dysfunction that exhibit inappropriate ventricular 
hypertrophy or dilation and are due to a variety of causes (Maron 2006). DCM is considered 
the most common form of cardiomyopathy (Cooper 2009A). Survival of patients with DCM 
is only 50% five years after diagnosis and is a leading cause for needing a heart transplant 
(Maron 2006). The cause of most cases of DCM is unknown, except for familial/genetic 
cases, and so the disease is frequently termed “idiopathic” DCM. Regardless of the cause of 
DCM, the pathogenesis of disease follows a similar progression. For DCM to develop the 
heart most typically must undergo remodeling and fibrosis. 
 
Experimental Mouse Models of Myocarditis and DCM 
Three main mouse models of myocarditis exist: 1) the classic CVB3 model that uses 
tissue culture-derived or purified virus (virus-only), 2) an experimental autoimmune 
myocarditis (EAM) model induced by adjuvant and cardiac myosin or cardiac myosin 
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peptides, and 3) a hybrid-CVB3 model that is induced using heart-passaged CVB3 and 
damaged heart proteins (Cihakova 2004, reviewed in Fairweather 2012B, Myers 2013). Each 
model contributes uniquely to our understanding of the pathogenesis of disease. 
 
CVB3-only model 
Tissue culture-derived CVB3 is the most commonly used method to induce viral 
myocarditis. Mice are infected intraperitoneally (ip) with purified virus or RNA from various 
CVB3 strains (i.e., Woodruff, H3, Nancy) after propagation in HeLa cells. This method was 
originally described in 1974 by Woodruff et al (Woodruff 1974). In this model, viral 
replication peaks in the heart around day 5-7 post infection (pi) (107-109 plaque forming 
units/PFU/g heart) but only causes low levels of inflammation in the heart (5-10% of heart 
tissue inflamed) followed by rapid heart failure (Gaunt 2003). A problem with using this 
model is that only about 30% of the mice survive to day 7 pi (Table 1) (Gaunt 2003). 
Myocarditis using this model is more severe in male compared to female mice (Huber 1981, 
Huber 2005, Li 2009). An innate immune cell type called γδT cells is critical for disease 
induction in this model (Huber 2002, Liu 2011). More severe myocarditis is associated with a 
Th1 response- particularly in male mice (Huber 2002). The presence of autoreactive T and B 




EAM is induced using adjuvants (i.e., inactivated Mycobacterium and/or Pertussis 
toxin) and cardiac myosin peptides, which are typically injected on day 0 and 7 (Cihakova 
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2004). Peak myocarditis occurs at day 21 (Table 1) (Barin 2011, Rose 2011). In EAM, 
myocarditis consists mainly of macrophages and neutrophils with lower amounts of T and B 
cells, mast cells and dendritic cells (Cihakova 2008, Barin 2011). Only Th2 responding 
strains like BALB/c and A/J develop EAM and progress to DCM (Afanasyeva 2001). DCM 
develops around day 42 post inoculation, when fibrosis and necrosis is observed (Afanasyeva 
2001, Afanasyeva 2004). A Th1 immune response has been shown to prevent acute and 
chronic EAM (Afanasyeva 2004, Barin 2010), while a Th17 response increases chronic 
fibrosis and DCM (Baldeviano 2010). 
 
Hybrid-CVB3 model 
The so-called “hybrid” model of CVB3 is the model used in this thesis. Myocarditis 
is induced by propagating the virus in culture in Vero cells (monkey kidney cells) and then 
infecting mice and collecting the heart, homogenizing and then using the homogenate, which 
contains infectious virus and damaged heart tissue, to infect mice (Fairweather 2007). The 
injection of mice with damaged self/ heart tissue as well as infectious virus is why this model 
has been called a “hybrid” or viral-autoimmune model. Mice develop autoantibodies against 
cardiac myosin and immune complexes (ICs) deposit in the heart (Fairweather 2001, 
Fairweather 2006), indicating the importance of the autoimmune component in the 
pathogenesis of disease in this model. All mouse strains that have been tested so far including 
BALB/c, A/J, C57BL/6, and mixed backgrounds develop acute myocarditis that peaks at day 
10 pi. Similar to EAM, acute myocarditis consists mainly of macrophages and neutrophils 
with lower numbers of T and B cells, mast cells, and dendritic cells (Table 1) (Frisancho-
Kiss 2007, Cihakova 2008, Barin 2011). Viral replication peaks around day 7 pi and is 
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cleared from the heart by day 14 pi (Fairweather 2001, Fairweather 2007). In contrast to the 
virus-only model, all wild type (WT) mice survive acute myocarditis (Fairweather 2001). 
Again similar to EAM, only susceptible Th2 responding strains of mice like BALB/c and A/J 
develop chronic myocarditis and DCM (Fairweather 2004A, Fairweather 2004B, Fairweather 
2007, Abston 2012A, Abston 2012B). DCM develops in this model by day 35 pi 
(Fairweather 2004A). Cardiac fibrosis and necrosis are only found in the heart during the 
chronic myocarditis/ DCM stage, but not during acute myocarditis. This hybrid-CVB3 model 
more closely resembles EAM than CVB3-only models (Table 1) (Afanasyeva 2004, 
Fairweather 2004A, Cihakova 2008). Myocarditis and DCM are more severe in male 
BALB/c mice (Frisancho-Kiss 2007, Onyimba 2012, Coronado 2012), similar to myocarditis 
patients (McNamara 2011). Increased myocarditis in male mice is a common feature of all 





Table 1. Summary of animal models of myocarditis/DCMa,b 
 CVB3-only model Hybrid-CVB3 
model 
EAM 
Survival 20-30% by day 7 pi 100% to day 90 pi 100% to day 90 pi 
Viral replication d7 pi 107-109 PFU/g heart 105 PFU/g heart 0 
Acute myocarditis Peak @ day 7 pi Peak @ day 10 pi Peak @ day 21 
Severity of myocarditis 5-10% inflammation 30-60% inflammation 30-60% inflammation 
Key cell mediators γδT & CD8+ T cells Macrophages Macrophages 
DCM Few survive Yes Yes 
Sex differences Males > females Males > females Males > females 
a CVB3, coxsackievirus B3; d, day; EAM, experimental autoimmune myocarditis; pi, post infection; 
PFU, plaque forming units; DCM, dilated cardiomyopathy 






Innate Immune Response in CVB3-induced Myocarditis 
 The innate immune response allows discrimination of self from non-self and launches 
an immune response to pathogens or other agents. Innate immunity determines the type of 
adaptive immune response that will develop based on the type of infectious agent that 
initiates the immune response. The innate immune response is particularly important in the 
pathogenesis of myocarditis. Innate immune mediators like macrophages, mast cells, the 
inflammasome, interleukin (IL)-33, and complement have been found to increase myocarditis 
following CVB3 infection in our hybrid model of myocarditis (Fairweather 2003, 
Fairweather 2004B, Fairweather 2006, Abston 2012B, Coronado 2012). 
 
Complement 
Complement and complement receptors (CRs) are central to the innate immune 
response by promoting phagocytosis, activating the adaptive response, rapidly destroying 
invading microorganisms, and by clearing ICs (Morgan 1999, Kemper 2007, Dunkelberger 
2009, Arbore 2016). Deficiencies in complement and CRs are known to increase 
susceptibility to certain infections like group B Streptococcus and to increase IC-mediated 
autoimmune diseases like systemic lupus erythematosus (Morgan 1999). Activation of the 
complement cascade by infection, for example, generates complement component C3, which 
is cleaved by C3 convertase to produce C3a and C3b. C3a binds C3aR1 on mast cells (Fig 1). 
C3b binds CR1 on mast cells and macrophages, which inhibits C3 convertase to reduce 
inflammation (Fairweather 2006). C3b is further processed to become inactivated C3b 
(iC3b), which binds CR3 (a heterodimer of CD11b and CD18) on mast cells and 
macrophages (Fig 1). CD11b is also called Mac1 or Itgam. Because CR2 (CD21) only binds 
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inactive C3 (i.e., C3d), it does not regulate complement activation. Instead CR2 is mainly a 
part of the B cell receptor (BCR) complex that is needed to activate B cells (Roosendaal 
2007, Jacobson 2008). CD19, which forms part of the BCR complex, is an important 
regulator of B cells (Fujimoto 2007). 
In contrast, CR1 (CD35) binds C4b and C3b, and inhibits C3 and C5 convertase 
activity involved in the classical, alternative, and lectin complement pathways. CR1 is also 
important for clearing ICs, which protects the host from complement-mediated tissue damage 
(Fairweather 2006). While CR1 and CR2 are encoded on separate genes in man, in the mouse 
they are derived from the same gene, Cr2, so that mice deficient in one receptor are also 
deficient in the other (Kurtz 1990). During acute CVB3 myocarditis, CR1/2 is primarily 
expressed on mast cells, GR1+F4/80+ alternatively activated M2 or myeloid-derived 
suppressor-type macrophages (MDSCs), and GR1hi neutrophils (Fig 1) (Fairweather 2006). 
CR1/2 deficient mice have significantly increased CVB3 myocarditis with elevated CD11b+ 
immune cells (i.e., macrophages and mast cells) and IL-1β (Fairweather 2006). Disease is so 
severe in these mice that they rapidly develop myocardial and pericardial fibrosis and 
progress quickly to DCM and heart failure (Fairweather 2006), indicating the critical role for 






Figure 1. Model of CR1 regulation of macrophages, mast cells, fibrosis and DCM in 
males. Following infection with CVB3, C3 is converted to C3b and C3a by C3 convertase. 
C3b binds CR1 and iC3b binds CD11b/CD18 (CR3) on macrophages (M2/MDSC) and mast 
cells (MC) while Toll-like receptor (TLR)4 and caspase-1 (casp-1) generate active 
interleukin (IL)-1β, a potent profibrotic cytokine. C3a binds C3aR on mast cells, which also 
express TLR4, caspase-1 and IL-1β. CR1 expressed on macrophages and mast cells inhibits 
C3 convertase in a negative feedback loop. We observe increased numbers of CD11b+, 
M2/MDSC and mast cells and IL-1β levels in the heart of CR1/2 deficient mice that is 
associated with increased fibrosis and accelerated DCM (Fairweather 2006). Since CR2 does 
not possess complement regulatory functions, we hypothesize that CR1 is responsible for 
protecting against the development of fibrosis and DCM in CR1/2 deficient male mice by 





TLR4 and the inflammasome 
Toll-like receptors (TLRs) are part of a large group of receptors called pattern 
recognition receptor (PRRs) that play an important role in the innate immune system by 
recognizing and binding pathogen-associated molecular patterns (PAMPs) on infectious 
organisms allowing a pathogen (or toxin)-specific immune response (Janeway 2002). In this 
way TLRs allow recognition of self vs. foreign antigens. Thirteen TLRs have been described, 
with only 10 of these expressed in humans. TLR4 is the most highly expressed TLR in the 
heart, followed by TLR2 and TLR3 (Nishimura 2005). TLR4 is expressed on cardiac 
myocytes as well as DCs, mast cells and macrophages (Fig 1). TLR4 is unique because it 
responds to many different agents including lipopolysaccharide from bacteria, respiratory 
syncytial virus, and damaged self- including heat shock proteins and hylauronan. Recently, 
complement C3a has been found to activate the inflammasome leading to increased IL-1β 
expression from macrophages and dendritic cells (Laudisi 2013, Agari 2013, Arbore and 
Kemper 2016). TLR4 is expressed on the cell surface usually in a complex that includes 
CD14, LPS binding protein, and MD2 (Krishnan 2007). TLR4 is also unique among TLRs 
because it can signal via the adaptor protein myeloid differentiation factor 88 (MyD88) or 
TIR-domain-containing adapter-inducing interferon-β (TRIF) (Abston 2012A). 
TLR4 signaling is required to generate pro-IL-1β and pro-IL-18 that is then cleaved 
by caspase-1 (casp-1) to release active IL-1β and IL-18 from cells. TLR4 expression is 
upregulated on innate immune cells like mast cells and macrophages from the spleen and 
peritoneum within hours of infection with heart-passaged CVB3 (Frisancho-Kiss 2006, 
Frisancho-Kiss 2007). However, it is not known if this is due to direct binding or indirect 
activation via complement or damaged heart components, for example. Elevated TLR4 
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expression on mast cells and macrophages is a feature of the male-dominant immune 
response in the spleen and heart following CVB3 infection (Frisancho-Kiss 2006, Frisancho-
Kiss 2007, Coronado 2012). TLR4 deficient male mice develop significantly less acute 
CVB3 myocarditis with decreased levels of IL-1β and IL-18 in the heart after infection 
(Fairweather 2003), indicating an important role for the TLR4 signaling pathway in 
increasing myocarditis in males. Additionally, cardiac myosin has been found to signal via 
TLR2 and TLR8 in myocarditis patients (Zhang 2009), indicating that TLR activation is also 
important in driving autoimmune mechanisms during myocarditis. IL-1β is both strongly 
proinflammatory and profibrotic and has been shown to increase expression of the 
remodeling gene Serpin A3n during acute CVB3 myocarditis (Coronado 2012). Serpin A3n 
is also known as α-chymotrypsin, an enzyme released from mast cells that strongly drives 
tissue remodeling. Testosterone increases both IL-1β and Serpin A3n levels in the heart 
during acute CVB3 myocarditis (Coronado 2012). IL-1β further elevates Serpin A3n levels, 
driving cardiac remodeling and fibrosis by reducing matrix metalloproteinase (Mmp)3 and 
Mmp9 levels in the heart (Coronado 2012). 
 
IL-33 and ST2  
IL-33, a member of the IL-1 receptor (IL1R) family that includes TLR4 and the IL1R, 
is able to increase Th2 responses by signaling through its receptor ST2 located on mast cells, 
macrophages, Th2 cells and other immune cell types (Liew 2010, De la Fuente 2015, Saluja 
2015, Schwartz 2016). Immune cells, most notably mast cells and neutrophils, release 
proteases that cleave active IL-33 into multiple forms that are 10-30 times more potent (De la 
Fuente 2015, Saluja 2015, Schwartz 2016). Innate lymphoid cells (ILCs) are the main cell 
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type that responds to IL-33 and expresses high levels of ST2 ligand (ST2L) leading to 
increases in cytokine production that influence disease progression such as lung eosinophilia 
(Schwartz 2016). Soluble (s)ST2 is a serum biomarker predicting progression to heart failure 
in CVD patients (Shaw 2010). Recombinant (r)IL-33 has been found to reduce inflammation 
and fibrosis in heart failure animal models by inducing a protective, anti-inflammatory Th2-
type immune response (Liew 2010). IL-33 has also been found to reduce left ventricular 
hypertrophy and fibrosis resulting in improved left ventricular function and survival in 
animal models of pressure overload and atherosclerosis (Sanada 2007, Liew 2010). 
IL-33 is localized to the nucleus of fibroblasts, in particular, and has been termed an 
“alarmin” because it is released following tissue damage that occurs with cardiac damage or 
infection (Haraldson 2009, Liew 2010). IL-33 is part of the TLR/IL1R family and binds a 
receptor complex made up of ST2 and the IL-1R accessory protein, which recruits MyD88 
resulting in activation of NF-κB and other transcription factors (Liew 2010). In its soluble 
form sST2 is believed to function as a decoy receptor for IL-33, reducing IL-33 levels. In 
patients with acute myocardial infarction and heart failure, elevated serum sST2 is associated 
with an increased risk of mortality or future heart failure (Shaw 2010). 
Paradoxically, IL-33 has been found to increase inflammation and fibrosis in a 
number of autoimmune diseases in patients and animal models by increasing/ activating mast 
cells (Liew 2010, Oboki 2010, Saluja 2015). sST2 and/or IL-33 were increased in the sera of 
patients with rheumatoid arthritis (Fraser 2006, De la Fuente 2015), Crohn’s disease 
(Pastorelli 2010, De la Fuente 2015, Schwartz 2016), ulcerative colitis (Pastorelli 2010, De la 
Fuente 2015, Schwartz 2016), systemic sclerosis (Manetti 2010), and systemic lupus 
erythematosus (Mok 2010). Similarly, IL-33 was found to increase experimental autoimmune 
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encephalomyelitis, an animal model of multiple sclerosis, and collagen-induced arthritis in 
mice by activating mast cells (Xu 2008, Liew 2010, Oboki 2010). Recombinant IL-33 given 
to BALB/c male mice was found to significantly increase CVB3 myocarditis and heart 
failure by inducing pericarditis and increasing IL-1β, IL-6 and IL-4 levels in the heart 
(Abston 2012B). Thus, a relationship appears to exist between TLR4 and the inflammasome 
and IL-33/ST2 signaling during CVB3 myocarditis. 
 
Adaptive Immune Response in CVB3-induced Myocarditis 
The adaptive immune response is directed by innate immunity to protect the host from 
infections, toxicants, and other agents/ events that result in damaged self. The hallmark of the 
adaptive immune response is to provide long-lasting protection to specific foreign (or 
damaged self) peptides (Doan 2008). Part of the immune strategy to eliminate pathogens and 
heal damaged tissues involves the release of cytokines. There are three main cytokine 
phenotypes that are produced in response to pathogens that are effective at eliminating 
infections, but also characterize diseases like asthma/allergies (i.e., Th2), CVDs (i.e., Th1), 
and autoimmune diseases (i.e., Th1/Th17) (Fairweather 2004C). CD4+ Th cells can become 
Th1, Th2 and/or Th17-type immune cells that characteristically release IFNγ, IL-4, and IL-
17, respectively, as well as other cytokines (Zhu 2010). This skewing of the immune 
response down key pathways affects, to some degree, all of the immune cells involved in the 
adaptive response like macrophages, for example, which can be termed “classically” 
activated M1 macrophages when their phenotype is changed by an IFN/Th1-type 
environment or “alternatively” activated M2 macrophages when they are altered by an IL-
4/Th2-type immune environment (Siracusa 2008, Fairweather 2009). Markers that are often 
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used in mice to identify M1 vs. M2 macrophages by qRT-PCR include arginase-1 (Arg-1) 
and chitinase 313 (Ym1) for M2 macrophages and the Th1-associated chemokines C-X-C 
motif chemokine (Cxcl)9 and Cxcl10 for M1 macrophages (Siracusa 2008, Fairweather 
2009, Abston 2012A). 
 
Role of Th1-type immune responses in CVB3 myocarditis 
Many viral infections including CVB3 require IFNs and a Th1-type immune response 
for effective clearance. In CVB3 models of myocarditis that use tissue-culture derived virus 
without damaged heart tissue (virus-only models), the inflammatory infiltrate usually closely 
correlates to the level of viral replication in the heart (Table 2) (Huber 2002, Gaunt 2003, 
Huber 2005, Li 2009, Riad 2011, Yajima 2011, Fairweather 2012B). In contrast, in the 
hybrid model of CVB3 myocarditis used in this thesis, viral replication levels do not 
correlate with increased myocarditis unless IFN/Th1 pathways have been disrupted (Table 2) 
(Fairweather 2004A, Fairweather 2005 Frisancho-Kiss 2007, Abston 2012A, Abston 2013). 
In 2011 Wiltshire et al compared Th2-responding mouse strains like A/J to Th1-
responding mouse strains like C57BL/6 and found that all mouse strains examined 
upregulated IFN-related genes during myocarditis, and that several of these genes determined 
susceptibility to infection (e.g., Fpgt, H28, Tnni3k) (Wiltshire 2011). Production of innate 
IFNβ is known to protect against viral myocarditis in animal models and myocarditis patients 
(Kuhl 2003, Wang 2007). Protection against viral infection and myocarditis via IFNβ has 
been found to be mediated by the transcription factor TRIF, which is downstream of TLR3 
and TLR4 signaling (Burke 2011, Riad 2011, Xu 2011, Abston 2012A). It has been shown 
that CVB3 itself tries to limit host antiviral defenses (i.e., IFNβ) by inhibiting mRNA 
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translation by activating the translational suppressor eukaryotic initiation factor 4E-binding 
protein-1 (4E-BP1) (Burke 2011). IFNα administration to mice has also been found to 
decrease CVB3 myocarditis by reducing viral replication in the heart (Table 2) (Yue 2011A, 
Yue 2011B). Yue et al found that inhibiting the IFN-induced chemokines Cxcl10 or 
chemokine C-C motif ligand (Ccl)2, also called monocyte chemotactive protein-1 (MCP-1), 
reduced myocarditis by decreasing Th1/ IFNγ responses, but did not alter viral replication in 
the heart (Yue 2011A, Yue 2011B). These studies suggest that IFNs like IFNα/β may be 
more important in preventing viral replication in CVB3 myocarditis mouse models, while 
IFNγ increases inflammation. Although IFNγ increases myocarditis severity, this does not 
necessarily lead to a “bad” outcome for the heart unless it is too severe (as occurs in 
fulminant myocarditis cases). For example, mesenchymal stem cells (MSCs) have been 
found to reduce CVB3-induced myocarditis by increasing IFNγ levels (Miteva 2011, Van 
Linthout 2011). 
Although TLR3 and TRIF deficient mice develop increased myocarditis with elevated 
cardiac viral replication, only TRIF deficient mice progress to chronic myocarditis/ DCM 
(Abston 2012A, Abston 2013). TRIF was found to drive the IFNβ response in the heart 
during CVB3 myocarditis, while TLR3 drove the IFNγ response (Abston 2012A, Abston 
2013). TLR3 deficient mice had a significant increase in a IL-4-associated Th2-response 
while TRIF deficient mice had an increased IL-33-associated Th2-driven response (Abston 
2012A, Abston 2013). The IL-4 type immune response in TLR3 deficient mice had only a 
mild effect on increasing cardiac dysfunction leading to chronic myocarditis and DCM, while 
the increased IL-33 response in TRIF deficient mice caused severe eosinophilic 
perimyocarditis, DCM, and early heart failure. Thus, Th2 cytokines can drive the 
22 
 
development of DCM following CVB3 myocarditis by promoting cardiac remodeling and 
fibrosis. 
 
Role of Th2-type immune responses in CVB3 myocarditis 
Although Th1-type immune responses are known to decrease viral replication and 
prevent progression to chronic myocarditis/ DCM by reducing remodeling, they also increase 
acute inflammation in the heart (Huber 2002, Fairweather 2004A, Huber 2005, Fairweather 
2005, Li 2009). Th2-associated IL-10 and T regulatory cells (Treg) have been found to 
reduce CVB3-induced myocarditis (Table 2) (Frisancho-Kiss 2007, Liu 2011). 
Administration of cardiac myosin peptide to mice with CVB3 myocarditis reduced cardiac 
inflammation by increasing IL-10 levels and Treg numbers (Fousteri 2011). Administration 
of recombinant galectin-9 to mice was found to inhibit acute CVB3 myocarditis by 
increasing IL-4/ Th2 cells, GR1+CD11b+ macrophages and IL-10 in the heart (Lu 2011). γδT 
cells that produce IFNγ were found to significantly increase myocarditis in “CVB3-only” 
models of myocarditis by decreasing Treg numbers (Liu 2011). Mast cells are frequently 
associated with Th2-type immune responses. Histamine receptor-1, which is one of many 
receptors that induce mast cell activation, was shown to significantly reduce CVB3 
myocarditis by decreasing γδT cells and Th1 responses in the heart (Case 2012). Thus, 
regulatory cells associated with Th2-type immune responses, like IL-10 and Treg, decrease 
acute CVB3 myocarditis. In contrast, Th2-associated immune responses that activate mast 
cells, TLR4-TRIF-inflammasome, and M2 macrophages that express TLR4 and release IL-
1β are able to increase remodeling in the heart (i.e., Mmps, Serpin A3n) and promote 
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progression from myocarditis to DCM and heart failure (Table 2) (Abston 2012A, Abston 
2012B, Coronado 2012). 
 
Role of Th17-type immune responses in CVB3 myocarditis 
Elevated IL-17 (i.e., IL-17A) during the acute phase of myocarditis in the EAM 
model has been shown to increase chronic fibrosis and DCM (Table 2) (Baldeviano 2010). 
Yuan et al showed that IL-17 levels increase in the circulation and heart during the peak of 
CVB3 myocarditis (day 7-10 pi) (Yuan 2010A, Yuan 2010B). IL-23 and STAT3, which are 
both important in IL-17 /Th17 immune responses, as well as IL-17 were increased in the 
heart during acute and chronic CVB3 myocarditis (Yang 2011). Researchers found that 
Th17-producing cells were increased in the spleen during CVB3 myocarditis compared to 
controls (Qing 2011, Xie 2011). Blocking IL-17 using neutralizing antibodies in the CVB3-
only model was found to improve survival, reduce acute myocarditis, reduce viral replication 
in the heart, and to increase Treg cells (Fan 2011, Xie 2011A, Xie 2011B). However, CVB3 
myocarditis in the hybrid model was not significantly altered in IL-12p40 (IL-23) deficient 
mice (Fairweather 2012B). IL-23 is a cytokine that is important in promoting IL-17/ Th17-
mediated immune responses. Yet co-exposure of mice for 2 weeks with low-dose inorganic 
mercury prior to infection with CVB3 in the hybrid CVB3 myocarditis model did not 
significantly increase acute myocarditis, but was found to increase IL-17 levels in the heart 
which was associated with increased fibrosis and DCM (Nyland 2012). This finding is 






Table 2. Role of Th immune responses in animal models of myocarditisa,b 
Cytokine CVB3-only model Hybrid-CVB3 model EAM 
IFN-α (Th1) Inhibits viral 
replication 
ND ND 
IFN-β (Th1) Inhibits viral 
replication 
Inhibits viral replication 
Prevents DCM 
ND 
IFN-γ (Th1) Inhibits viral 
replication 
Inhibits viral replication 
Prevents DCM 
Prevents DCM 
IL-4 (Th2) Prevents myocarditis Increases DCM Increases DCM 
IL-33 (Th2) ND Increases DCM ND 
IL-23 (p40) (Th17) Increases myocarditis No effect on 
myocarditis 
Increases EAM 
IL-17 (Th17) Increases myocarditis ND No effect on EAM 
Increases DCM 
a Th, T helper; CVB3, coxsackievirus B3; EAM, experimental autoimmune myocarditis; IFN, 
interferon; IL, interleukin; DCM, dilated cardiomyopathy; ND, no data 




Sex Differences in the Immune Response During Myocarditis/ DCM 
Sex hormone effects on the immune system 
Estrogens, testosterone, progesterone, and vitamin D are the major sex hormones that 
have been studied for their effects on the immune response (Wilder 1995, Lahita 2010). Sex 
hormones bind to hormone receptors within the cytoplasm of the cell, but can also bind to 
receptors on the surface of immune cells to mediate rapid responses (Buskiewicz 2016). Sex 
hormone receptors alter gene expression in cells via androgen and estrogen response 
elements, which can turn on or off 100’s to 1000’s of genes at a time (Hammes 2011). These 
genomic effects are the reason why sex hormones are able to have such large effects on 
immune function. 
Most immune cells express multiple sex hormone receptors that are involved in 
driving immune responses in sex-specific directions following antigen stimulation. Sex 
steroid hormone receptors like estrogen receptor (ER)α, ERβ, estrogen-related receptor 
(ERR)γ and the androgen receptor (AR) are expressed on and within many immune cell 
populations including mast cells, macrophages, dendritic cells, natural killer cells, T cells and 
B cells (Gilliver 2010, Buskiewicz 2016). Human and mouse monocyte/ macrophages 
express ERα, ERβ and the AR (Gilliver 2010, Villablanca 2010). ARs have been found to be 
expressed more on/in circulating macrophages in men than women (McCrohon 2010). Thus, 
it is possible that the ratio of sex hormone receptors on any given cell is the key to 
understanding their effect on immune cell function. 
Women respond to infection, vaccination, and trauma with increased antibody 
production (Styrt 1991, Lang 2004, Cook 2008, Flanagan 2011). Although increased 
antibody levels protect women from infections, they also increase the risk of developing 
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autoimmune diseases, particularly female-dominant rheumatic diseases (Beeson 1994, 
Whitacre 2001, Gharee-Kermani 2005, Gleicher 2007, Zandman-Goddard 2007, Fairweather 
2008A, Dube 2009, Pennell 2012). Women may be at an increased risk of developing an 
autoimmune disease because estrogen activates B cells resulting in increased levels of 
antibodies and autoantibodies (Straub 2007, Cook 2008, Fairweather 2008A, Lahita 2010, 
Rubtsov 2010, Fairweather 2012A). In contrast, testosterone decreases B cell maturation, 
reduces B cell synthesis of antibody, and suppresses autoantibody production in humans. 
Sex hormones are able to skew immune responses into characteristic Th1, Th2 and/or 
Th17 directions because of their ability to influence antigen presenting cells like dendritic 
cells, mast cells, and monocytes. Sex hormone receptors on T and B cells further drive sex 
differences in the immune response. Importantly, depending on the context estrogen can 
either increase Th1/ Th17 responses or increase Th2 responses with very different outcomes 
on pathology (Fairweather 2012, Papenfuss 2011, Rubtsov 2010, Straub 2007). In cell culture 
and animal models estrogen has been shown to induce differentiation of dendritic cells, 
stimulate T cell proliferation, and drive T cells to a Th1 and/or Th17 type immune response 
by activating the transcription factor NFκB (Straub 2007, Carrers 2010, Khan 2010, Wang 
2010, Wahren-Herlenius 2013). However, in other studies estrogen was found to increase 
Th2 responses, Treg, IL-4-driven alternatively activated M2 macrophages, and the regulatory 
cytokines IL-4, IL-10, and TGFβ (Polanczyk 2004, Polanczyk 2005, Frisancho-Kiss 2007, 
Straub 2007, Fairweather 2008A, Xia 2009, Finesh 2010, Pulendran 2010, Rubtsov 2010, 
Papenfuss 2011, Sellner 2011). Estrogen has been found to be able to inhibit components of 
the innate immune response including TLR4-induced IL-1β, IL-6, tumor necrosis factor-α 
and NFκB activation from macrophages (Deshpande 1997, Evans 2001, Frisancho-Kiss 
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2007, Lahita 2010, Temple 2008). Estrogen can also inhibit transcriptionally Th1-type 
immune responses resulting in an increased Th2-type immune response (Frisancho-Kiss 
2007, Fairweather 2008, Lahita 2010, Pulendran 2010, Fairweather 2012A). Far less research 
has been conducted on the role of testosterone/ androgens on the immune response. In 
general, androgens have been found to increase Th1 responses although more research into 
their function is needed (Giltay 2000, Giron-Gonzalez 2000, Loria 2002, Desai 
2004, Frisancho-Kiss 2007, Fairweather 2008A, Lahita 2010, Giron-Gonzalez 2011). 
One of the difficulties in studying the effect of estrogens and androgens on immune 
function is that most researchers do not report whether the cells used in culture or animals 
used in experiments are male or female (Hammes 2011, Saha Roy 2012, Miller 2014). 
Equally important is that many researchers have not considered how sex could influence the 
interpretation of their data (Miller 2012). Experiments involving the immune response that 
do not report the sex of the cell or animal become essentially uninterpretable. Dose is another 
very important consideration when assessing the influence of sex hormones on immune 
function. Low doses of estrogen have been found to increase Th1 responses while higher 
doses increase Th2 responses (Fairweather 2008, Cutolo 2010). Other important 
considerations include how testosterone is metabolized to estrogen in different organs/tissues 
(i.e., aromatase levels), and differences in cytochrome P450 (Cyp) enzyme expression in 
various target organs which also effect sex hormone metabolism (Straub 2007). 
Contradictory findings in the literature have in part led to the recent requirement by NIH to 
include both sexes in government funded studies and to interpret the findings according to 




Sex hormone effects on the cardiovascular system 
ERα, ERβ, and the AR is expressed on cardiac fibroblasts, cardiomyocytes, vascular 
smooth muscle cells, and vascular endothelial cells in humans and rodents (Regitz-Zagrosek 
2008, Vitale 2009). Aromatase, the enzyme that converts androgens to estrogens, is also 
expressed in the heart cells. Platelets also express ERβ and the AR and respond to sex 
steroids (Gilliver 2010). Women have been reported to have higher ER expression in their 
arteries than men (Vitale 2009). ERα has been shown to protect against vascular injury and 
atherosclerosis (Hammes 2011, Hodgin 2001). 17β-estradiol has been found to prevent 
cardiac hypertrophy and fibrosis (Regitz-Zagrosek 2008). Estradiol also inhibits reactive 
oxygen species-induced cardiac damage and apoptosis in cardiac myocytes (Regitz-Zagrosek 
2008). These cardioprotective effects of estrogen are believed to be mediated mainly by 
signaling through cell membrane ERs rather than traditional genomic receptors (Regitz-
Zagrosek 2008). In contrast, ERβ signaling regulates arterial tone and blood pressure. 
Testosterone levels in cardiac tissues have been reported to be higher in men than 
women (Deslypere 1985, Melchert 2001). Male rats that underwent gonadectomy had lower 
heart weights compared to sham operated rats, suggesting that testosterone promotes 
hypertrophy (Melchert 2001, Scheuer 1987). Additionally, it is known that men develop 
atherosclerotic plaques earlier and more extensively than women (Vitale 2009, Regitz-
Zagrosek 2008, Fairweather 2012A). The fact that CVDs in women rise after menopause 
further suggests that sex hormones influence heart disease (Fairweather 2012A). Part of the 
difficulty in assessing the role of testosterone is that aromatase is able to convert testosterone 
to estradiol, so that it is difficult to distinguish which hormone is mediating the effect. 
Additionally, testosterone has many beneficial effects, including metabolism of body fat. Fat 
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deposits have high aromatase activity, which metabolizes testosterone to estradiol (Jones 
2010). Several studies have reported an association between low serum testosterone levels 
and higher CVD and mortality in older men (Jones 2010, Malkin 2010, Yeap 2010). 
Testosterone supplementation has also been reported to reduce CVD in older men (Jones 
2010, Ohlsson 2011, Yeap 2010). However, a trial of testosterone administration to older 
men was discontinued because of a higher rate of adverse cardiovascular events in the 
testosterone group compared to the placebo group (Basaria 2010). There are several possible 
explanations for the contradictory findings. Lower testosterone levels could indicate that the 
hormone is being consumed (Onyimba 2011). Testosterone is also known to gradually 
decrease with age. Also proinflammatory cytokines like tumor necrosis factor-α, IL-1β and 
IL-6 regulate the hypothalamic-pituitary axis resulting in reduced circulating levels of 
testosterone (Jones 2010, Hales 1992), and so the CVD itself could be driving down 
testosterone levels. 
 
Sex differences in myocarditis 
CVDs like atherosclerosis and myocarditis occur more frequently in men than 
women, and men are at an increased risk of developing DCM and heart failure (Cocker 2009, 
McNamara 2011, Fairweather 2012A, Kyto 2013). Huber and colleagues were the first to 
describe that male BALB/c mice have increased CVB3-induced myocarditis compared to 
females (Lyden 1987). Myocarditis is also increased in male BALB/c mice in the hybrid 
CVB3 model (Frisancho-Kiss 2006B, Frisancho-Kiss 2007, Fairweather 2012A). Elevated 
myocarditis in males is not due to increased viral replication in the heart, which is not 
significantly different between the sexes (Frisancho-Kiss 2006B, Frisancho-Kiss 2007). Male 
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BALB/c mice with CVB3 myocarditis develop a predominantly Th1-type adaptive immune 
response with more Th1-induced IgG2a anti-CVB3 antibodies compared to female mice, 
who develop a dominant Th2 response and more Foxp3+ Treg cells (Huber 1994, Huber 
1999, Frisancho-Kiss 2006A, Frisancho-Kiss 2007, Huber 2008, Frisancho-Kiss 2009). 
Huber et al have found that Vγ4+ γδT cells are increased in the heart of male mice drive a 
Th1-type immune response (Huber 1994, Huber 2005, Huber 2008). Using the hybrid CVB3 
model, the dominant Th1-type immune response in male BALB/c mice was found not to be 
due to classical IL-12/ STAT4-induced interferon IFNγ production, but instead to be due to 
TLR4-induced IL-18- a cytokine that strongly induces IFNγ (Frisancho-Kiss 2006B). 
Patients with clinically suspected myocarditis or DCM were found to have higher levels of 
IFNγ and these patients were mainly men (Warraich 2011). 
CD11b/CR3+ immune cells are the dominant infiltrating cells in the heart of male 
BALB/c mice with CVB3 myocarditis and in male myocarditis patients (Frisancho-Kiss 
2007 Frisancho-Kiss 2009, Fairweather 2014). CD11b is expressed on macrophages, mast 
cells, neutrophils and some dendritic cell populations, for example. Male BALB/c mice also 
have more classically activated M1 macrophages in the heart during acute CVB3 
myocarditis, while females have more inhibitory alternatively activated M2 macrophages 
(Fairweather 2009, Abston 2012A). In the hybrid CVB3 model TLR4 is expressed on 
macrophages that resemble a M2- or MDSC-phenotype more than a M1 phenotype 
(Frisancho-Kiss 2006A, Frisancho-Kiss 2007, Frisancho-Kiss 2009). Elevated CD11b and 
TLR4 expression on macrophages and mast cells from male BALB/c mice with CVB3 
myocarditis are thought to play a key role in increasing IL-1β levels in the heart and driving 
cardiac remodeling and fibrosis in males (Fairweather 2003, Frisancho-Kiss 2007, 
31 
 
Fairweather 2008B, Levick 2011, Coronado 2012, Abston 2012A, Abston 2012B). CD11b 
and TLR4 mRNA expression has been found to be higher in male myocarditis and DCM 
patients (Satoh 2003, Satoh 2004, Fairweather 2014). During the innate immune response to 
heart-passaged CVB3 in the spleen, male BALB/c mice were found to upregulate genes 
associated with promoting CVD (Onyimba 2011). Compared to female BALB/c mice, males 
have increased TLR4 expression on macrophages and mast cells in the spleen at 12 hours 
post infection (pi) (Frisancho-Kiss 2006A). A recent study in mice showed that although sex 
chromosomes influence CVB3 myocarditis, sex hormones mediate the dominant sex effect 
(Robinson 2011). Limited studies in myocarditis patients exist and so most of our 
understanding on the role of sex hormones comes from studies using myocarditis models in 
mice. 
 
Sex differences in cardiac remodeling, DCM and heart failure 
Heart failure occurs with advancing age in both sexes (Regitz-Zagrosek 2011). Even 
so, men are at an increased risk for developing heart failure (Cleland 2003, Robinson 2011). 
Heart failure can be the consequence of atherosclerosis, myocarditis, and DCM, which are all 
male dominant CVDs (Sliwa 2000, Sliwa 2006, Fairweather 2012A). Sheppard et al found 
that men with myocarditis or acute DCM had higher cardiac expression of genes associated 
with apoptosis that correlated to increased risk of heart failure compared to women 
(Sheppard 2005). In contrast, heart failure with preserved ejection fraction is more common 
in women than men (Bursi 2006). However, age is an important factor in heart failure cases 
in women (Regitz-Zagrosek 2011). Women develop heart failure at an older age than men. 
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Regardless of age, women with heart failure have better heart function than men (Lenzen 
2008, Barsheshet 2012). 
Cardiac remodeling is a critical step in the progression from myocarditis to DCM and 
heart failure (Asakura 2009, Kania 2009). Cardiac remodeling involves the break down and 
synthesis of extracellular matrix component. This process is regulated by enzymes and 
cytokines released from immune cells, and mast cells and macrophages in particular 
(Fairweather 2008A, Fairweather 2008B, Levick 2011, Coronado 2012). Serpin A 3n, also 
known as α1-anti-chymotrypsin, is released from mast cells and has been found to be 
upregulated in 11 separate microarray studies of acute DCM patients (Asakura 2009). This 
gene was also one of the most highly expressed genes by microarray in male BALB/c mice 
with acute CVB3 myocarditis (Coronado 2012). Profibrotic cytokines that promote 
remodeling and fibrosis during myocarditis/ DCM include IL-4, IL-1β, IL-33, IL-17, and 
TGFβ1 (Fairweather 2004A, Fairweather 2006, Baldeviano 2010, Coronado 2012). Only 
male mice that have higher numbers of mast cells and respond to CVB3 infection with a 
“mixed Th1/Th2”-type immune response go on to develop DCM and heart failure 
(Fairweather 2004A, Fairweather 2006, Coronado 2012, Abston 2012A, Abston 2012B, 
Abston 2013). This includes BALB/c and A/J mice. CVB3 myocarditis in male mice is far 
more severe if driven by the Th2 cytokine IL-33 compared to the Th2 cytokine IL-4 (Abston 
2012A, Abston 2012B). Female BALB/c mice develop only very mild DCM after 
myocarditis (2/10 BALB/c females have mild DCM compared to 10/10 males that have 
severe DCM) (Coronado 2012). Similarly, men with myocarditis were 2x more likely to 
present with myocardial fibrosis by cardiac magnetic resonance imaging then women 
(Cocker 2009). Several studies report that men with myocarditis or DCM have a greater 
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induction of extracellular matrix proteins and/or fibrosis in the heart compared to women 
(Haddad 2008, Cocker 2009, Regitz-Zagrosek 2011). Studies in animal models suggest that 
testosterone is responsible for increasing cardiac remodeling in males (Cavasin 2006). 
Estrogen signaling via ERβ has been found to prevent cardiac fibrosis in females by blocking 
TGFβ1 and collagen synthesis (Hammes 2011). Overall, these studies suggest that elevated 
testosterone in men increases remodeling and fibrosis, leading to DCM and heart failure. 
 
Vitamin D 
Vitamin D (VitD) regulates serum calcium levels and bone homeostasis, but also 
functions as a sex steroid. VitD is obtained from cholesterol in the skin and exposure to 
ultraviolet B (UVB) from the sun or from dietary sources forms pre-vitamin D, which is 
hydroxylated in the liver by vitamin D 25-hydroxylase (Cyp2R1) and carried in the 
bloodstream by VitD binding protein (DBP) to the kidney where it is converted by 25- 
dihydroxyvitamin D3-1α-hydroxylase (Cyp27B1) to the active form of VitD (i.e., 1a,25-
dihydroxyvitamin D3), which binds the VitD receptor (VDR) (Lavie 2011, Plum 2010, 
Zittermann 2010, Zhu 2013, Christakos 2016). VitD bound to the VDR forms a complex 
with the retinoid X receptor and this complex activates VitD response elements (VDREs) 
that influence a large number of genes at a time in a manner similar to estrogen and androgen 
response elements (Lisse 2011, Trochoutsou 2015). Additionally, many genes that regulate 
immune function have a VDRE in their promoter, like tumor necrosis factor for example 
(Bikle 2011). VitD is regulated in part by 1,25-dihydroxyvitamin D3 24-hydroxylase 
(Cyp24A1), which actively down-regulates VitD levels (Zittermann 2010). Many tissues are 
able to produce VitD and express the VDR including cardiomyocytes, fibroblasts, vascular 
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endothelial cells, and immune cells (Norman 2006, Mason 2013). Macrophages possess all of 
the components necessary to import/ synthesize cholesterol and convert it to active VitD 
including Cyp2R1 and Cyp27B1 (Bikle 2011, Onyimba 2011). Although VitD is mainly 
known for its role in promoting bone health it has been shown to influence innate immune 
signaling (Liu 2009, Lee 2011, Gambhir 2011, Verway 2013), suggesting that it could exert 
sex-specific effects on inflammation. 
VitD/ VDR is known to mediate protection against infections where it is able to 
activate mast cells, macrophages, and dendritic cells (Bikle 2011). In response to infection, 
VitD upregulates TLR2, TLR4, CD14 (part of TLR4 signaling complex), the inflammasome, 
IL-1β, TNF and IFNγ, for example (Rook 1986, Wang 2004, Liu 2006, Baroni 2007, Liu 
2007). In tissue culture studies and animal models, VitD has been shown to increase Th2 
immune responses, IL-10, Treg, alternatively activate M2 macrophages, and TGFβ (Gregori 
2001, Topiliski 2004, Daniel 2008, Bikle 2011, Litwack 2011). These results appear 
contradictory, but investigators in these studies did not describe the sex of animals or cells 
used in their experiments. Because VitD is a sex steroid, sex differences in its effect on 
immune cells are likely to exist. Although few studies examine the issue of sex differences in 
VitD, one study did report that VitD administration was only protective in female mice in an 
animal model of multiple sclerosis, an autoimmune disease that occurs more frequently in 
women than men (Spach 2005, Fairweather 2008A). 
 
Vitamin D deficiency and autoimmune disease 
Deficiency in the active form of VitD (i.e., 1α,25-dihydroxyvitamin D3) is highly 
prevalent worldwide with around 25% of the population in the US found to have inadequate 
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VitD levels and 8% at risk for deficiency (Plum 2010, Lavie 2011, Looker 2011, Litwack 
2011, Hilger 2014, Welles 2014, Alkerwi 2015). VitD deficiency is defined by the Institute 
of Medicine as <10 ng/mL based on the role of VitD in bone health (Lavie 2011). Many 
published studies consider VitD levels <20 ng/mL to be deficient and levels <30 ng/mL as 
inadequate because they have found an association with disease with VitD levels <20 ng/mL 
(Lavie 2011, Looker 2011, Ross 2011, Welles 2014). A number of epidemiologic studies 
have found an association between low levels of VitD and all-cause mortality (Melamed 
2008) and an increased risk of developing an autoimmune disease (Cutolo 2009, Ascherio 
2010). However, whether low VitD levels cause disease or occur as a result of the disease 
process is not yet clear. 
One autoimmune disease where low serum VitD levels have been associated with 
increased risk of disease is systemic lupus erythematosus (SLE) (Muller 1995, Cutolo 2011). 
One factor that could complicate interpreting this data is that SLE patients are recommended 
to avoid sunlight and use sunscreen to prevent rashes associated with the disease. Also, SLE 
occurs more frequently in dark-skinned women, and dark skin is known to lower circulating 
VitD levels (Clemens 1982, Cutolo 2011, Tang 2012). Also, kidney dysfunction is a primary 
component of SLE (Kronbichler 2013), and this is a key organ that metabolizes VitD to its 
active form which could also result in lower circulating VitD levels. Evidence that VitD may 
protect against SLE comes from animal studies where lupus-prone MRL/lpr mice given VitD 
had improved disease (Lemire 1992, Schoenfeld 2009). 
VitD deficiency or insufficiency has also been found to occur more often in 
rheumatoid arthritis (RA) patients. In RA lower VitD levels have been found to correlate to 
higher disease activity (Oelzner 1998, Cutolo 2006). Additionally, RA patients treated with 
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VitD have improved disease (Andhelkovic 1999, Cutolo 2011, Zold 2011). Animal models 
of RA report that VitD administration reduces disease progression and severity (Cantoma 
1998, Larsson 1998). VitD supplementation has been used to treat psoriatic arthritis (Huckins 
1990, Gaal 2009, Cutolo 2011). Interestingly, a VDR polymorphism in psoriasis and 
psoriatic arthritis patients has been found to reduce success with VitD therapy (Datangac-
Erden 2007). Overall, these data suggest that VitD reduces RA and psoriatic arthritis. 
Scleroderma, also called systemic sclerosis, is a chronic autoimmune disease 
characterized by diffuse skin fibrosis and vasculopathy. Low circulating VitD levels are 
frequently observed in scleroderma patients. A number of studies report VitD insufficiency 
in 63-86% and deficiency in 35-95% of these patients (Calzolari 2009, Vacca 2009, 
Caramaschi 2010). Additionally, patients with VitD deficiency have worse disease than those 
that were VitD insufficient. Dermatologists use the topical form of VitD to treat scleroderma, 
demonstrating that VitD can decrease disease. TGFβ is believed to be responsible for 
increasing fibrosis in scleroderma patients. VitD administered to murine cells has been found 
to inhibit TGF production (Zold 2008, Zold 2011, Artaza 2009). Again, sex of the cells, 
animals or patients was not addressed in these studies. 
Another autoimmune disease that has been linked to low VitD levels is Sjögren’s 
syndrome, which is an inflammation of the salivary and lacrimal glands that results in dry 
mouth and eyes (Kronbichler 2013, Brandt 2015). Several studies have found that low VitD 
levels in Sjögren’s syndrome patients correlate with increased disease severity (Muller 1990, 
Bang 1999). Additionally, low VitD levels correlated with higher levels of rheumatoid factor, 
which are antibodies made against antibody that often lead to IC formation. It is possible that 
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low VitD levels in Sjögren’s syndrome patients may be due to kidney damage caused by the 
disease potentially affecting the body’s ability to synthesize VitD (Kronbichler 2013). 
 
Vitamin D deficiency and cardiovascular disease 
 Epidemiologic studies have found that VitD deficiency is associated with an 
increased risk of CVD (Agarwal 2011, Lavie 2011, Welles 2014). CVDs with this 
association include hypertension (Forman 2007, Forman 2008), myocardial infarction 
(Marniemi 2005, Giovannucci 2008, Brøndum-Jacobsen 2012), peripheral artery disease 
(Melamed 2008), stroke (Marniemi 2005, Poole 2006), congestive heart failure (Schleithoff 
2006), heart failure and all-cause mortality (Dobnig 2008, Wang 2008, Ginde 2009, 
Kilkkinen 2009, Agarwal 2011, Tomson 2013, Belen 2015, Lutsey 2015). Two recent studies 
reported that women with low VitD levels were at an increased risk for myocardial infarction 
compared to men (Karakas 2013, Verdoia 2015). Whether the association of low VitD levels 
with increased risk of CVD is due to low exposure to sunlight or poor nutrition, for example, 
or directly related to the pathology of CVD remains unclear. There are no reports on the role 
of VitD on myocarditis or DCM. 
 
Endocrine Disruptors 
 The term endocrine disruptor (ED) was first described in 1991 by a group of scientists 
who gathered in order to discuss what could be causing adverse effects in the offspring of 
wild animals. Then in 1995 the Environmental Protection Agency (EPA) defined endocrine 
disruptors as “exogenous agents that interfere with the synthesis, secretion, transport, 
binding, action, and elimination of natural hormones (like estrogen) in the body that are 
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responsible for the maintenance of homeostasis, reproduction, development, and/or behavior” 
(Kavlock 1997, Crisp 1998, Vandenberg 2009). There are a variety of agents that have been 
classified as EDs including metals, pesticides, estrogens from plants, fungi, and synthetically 
made chemicals like bisphenol A (BPA) (Ahmed 2000, Darbre 2006, Rahman Kabir 2015, 
Jochmanova 2015). Estrogen has been found to increase transport of TLRs from the 
endoplasmic reticulum and to increase T cell and B cell activation (Panchanathan 
2008, Cunningham 2011, Panchanathan 2013, Kharrazian 2014), suggesting that EDs may 
also influence the immune system. Using a gene expression assay, bisphenol S (BPS), the 
replacement for BPA in many products, was found to effect 1,980 genes of which 900 were 
upregulated compared to BPA which only altered 48 genes (Fic 2015). Interestingly, the 
genes that were altered by BPA were mostly immunological in nature (Fic 2015). 
 
Bisphenol A 
BPA or 2,2-bis(4-hydroxyphenyl)propane (CAS No. 80-05-7) was first synthesized in 
1891 by a Russian scientist Aleksander Dianin (Michalowicz 2014, Acconcia 2015). BPA is 
made by using a catalyst to condense acetone and phenol. Importantly it is moderately water 
soluble, which is considered to be a primary exposure route in the population (US EPA 
2014). The half-life of BPA in humans is t1/2 5.3 hours and it is metabolized mainly by 
glucuronidation, but can also to be metabolized by sulfation (Corrales 2015). In 1930, BPA 
began to be used as a synthetic estrogen to increase estrogen levels in women that did not 
produce estrogen naturally to prevent miscarriages. After that it was found that BPA also has 
properties that allow its use in plastics, which began in the 1950s and continues to this day 
(Michalowicz 2014, Acconcia 2015). In 2004, 1 million tons of BPA was produced in the US 
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(US National Toxicology Program 2008). In 2009 it was estimated that 6 billion pounds of 
BPA was produced worldwide (Vandenberg 2009). BPA or its metabolites have been found 
in the urine of 90% of the US population and in the blood of 97% of pregnant mothers 
(Calafat 2005, Wolff 2007, Calafat 2008, Jenkins 2011, Bauer 2012, Koch 2012, Gerona 
2016, Han 2016). Some studies have reported that higher levels of BPA (4.61 ng/mL) have 
been found in pregnant women from low income households (Gerona 2016). BPA can be 
transferred to the fetus through the placenta and the milk of the mother (Mead 2008, 
Balakrishnan 2010). The BPA level in babies is also a public health concern as babies have 
low expression of the enzymes needed for BPA metabolism. 
BPA was initially used in plastics in order to allow plastic to be used multiple times 
(i.e., to allow recycling) (Mirmina 2014). BPA is used in a number of different types of 
plastic such as polycarbonate, polysulfone, and polyphthalate carbonate. Importantly from a 
toxicological perspective, BPA is released into solution from polycarbonate after heating of 
plastic (water) bottles or food containers and/or through direct UV exposure by sunlight 
(Rowell 2016). Plastic items labeled with recycling codes 3 and 7 contain BPA (Mirmina 
2014). BPA is found in a number of widely used products including plastic water bottles, 
epoxy resins that line food and beverage cans, plastic food containers, receipts, dental 
amalgams, water pipes, paper products like photocopy paper, medical devices, cigarettes, 
toys, baby teethers, and residual industrial and waste found in the environment (Olea 1996, 
Snyder 2000, Matthews 2001, Howdeshell 2003, Hunt 2003, Jenkins 2011, Belcher 2012, 
Teeguarden 2013, Mirmina 2014, Oldring 2014, Berger 2015, Corrales 2015, Lorber 2015, 
Rahman Kabir 2015, Yama 2015, Gerona 2016, Hehn 2016, Liao 2016, Ndaw 2016). BPA 
and the BPA replacements BPS and bisphenol F (BPF) have been detected in 75% of foods 
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in the US such as fruits, dairy products, and “preserved” foods (Liao 2013). BPA and BPS 
were detected in 98% of thermal paper receipts tested in Brazil (Rocha 2015). BPA has also 
been detected in water, soil, air, landfills, sewage sludge, electronic waste, and wildlife 
(Corrales 2015, Rahman Kabir 2015). 
There has been a lot of controversy about what is defined as a “low dose” of BPA. 
Toxicology studies define low doses as the dose that causes the lowest adverse effect level 
(LOAEL) (50,000 µg/kg/day) (US National Toxicology Program). A low dose exposure can 
be defined in two separate ways: 1) as any dose below the LOAEL (50,000 µg/kg/day) and 2) 
the “environmental relevant dose” which is the level of chemical that is present in the blood 
in a population (Vandenberg 2012, Acconcia 2015, Vandenberg 2014). BPA has been 
discovered to have a dose response curve that is an inverted “U”, which indicates a non-
monotonic dose response curve. This means that low doses of BPA are associated with 
increasing disease while higher doses protect against disease up to a certain very high dose 
(Nagel 1997, von Saal 2005, Vandenberg 2012, Acconcia 2015, Zoeller 2015). If BPA 
follows a non-monotonic dose response curve, then extrapolations from the high doses used 
in toxicity testing to very low doses experienced by humans would not be an accurate 
measure of exposure risk (Zoeller 2015). 
BPA has been found to have estrogenic effects in multiple estrogen assays (Andersen 
1999). BPA can induce effects by both genomic means (i.e., ERs binding to the ERE) and 
non-genomic means (e.i., signaling pathways like the MAP kinase pathway) (Goodson 2004, 
Marino 2012, Acconcia 2015). BPA influences ERs by binding to the receptor and causing it 
to be in its active formation even when estrogen is not present (Li 2015). Studies have shown 
that although BPA binds to ERα, that the molecular bonds (i.e., hydrogen bonds and van der 
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Waals forces) are much weaker than when estrogen binds ERβ (Li 2015). Although BPA 
binds to ERs with a lower affinity than estrogen, one way in which BPA could cause 
transcriptional changes through the ERs and activation of ERE is by inducing conformational 
changes of the ERs that lead to either agonist or antagonist functions or by altering its 
binding to other transcription factors or acting as a co-activator (Ascenzi 2006, Acconcia 
2015). 17β-estradiol (E2) binds to both ERα and ERβ, but it has been found that it does not 
bind to ERRγ. No endogenous ligand is yet known for ERRγ, but BPA does appear to target 
the receptor. E2 is known to bind with a higher affinity to ERα than to ERβ (Kuiper 1997, 
Zaid 2015). BPA binds to both ERα and ERβ, but at a 10,000 times lower potency than E2. 
Additionally, BPA has been found to have a higher affinity for ERβ than ERα, the opposite 
of E2 (Kuiper 1997, Hiroi 1999, Molina-Molina 2013, Li 2015, Zaid 2015). 
The first studies on the effect of BPA in animal models discovered that BPA 
significantly affected reproductive tissues (Cabaton 2011, Markey 2011, Vandenberg 2013, 
McGuinn 2015). Since then BPA has been associated in epidemiology and animal studies 
with increasing a number of diseases including cancers (Jenkins 2011 Costas 2015), diabetes 
in both prenatal and adult exposures (Melzer 2010, Bodin 2014, Aekplakorn 2015), obesity 
in both children and adults (Carwille 2011, Trasande 2012, Ranciere 2015, Yang 2016), and 
asthma/ wheezing (Nakajima 2012, Spanier 2012, Peters 2013). Epidemiology studies have 
also found associations between BPA and cardiovascular conditions including coronary 
artery disease, peripheral artery disease, high blood pressure, and hypertension (Melzer 2012, 
Ranciere 2015, Shankar 2012, Gao 2014, Han 2016). Rodent models have found that BPA 
has an effect on the heart including atherosclerosis, arrhythmias, blood pressure, vascular 
inflammation, ventricular contraction, and cardiac remodeling (Yan 2011, Patel 2013, Gao 
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2013, Gao 2014, Kim 2014, Belcher 2015). BPA was found to alter electrical signals in the 
heart in a rat model, and at very high doses could cause complete heart block (Posnack 
2014). No studies have assessed the effect of BPA on myocarditis or DCM. 
Epidemiology and animal models have also found an association between BPA and 
pyometra (infection of the uterus), asthma, and type II diabetes (Kendziorski 2012, O’Brien 
2014). BPA was able to induce eosinophilia in the alveoli of the lung and increase IL-1β 
expression in the ovalbumin model of asthma in mice (He 2016). In another study BPA 
exposure led to increased reactive oxygen species and IL-1β in the lung (Yang 2015). BPA 
has been found to be associated with an increased prevalence of multiple sclerosis in humans 
(Orton 2004, Weinstock-Guttman 2003, Jochmanova 2015) and to increase disease in animal 
models (Brinkmeyer-Langford 2014, Jochmanova 2015). Prenatal exposure to BPA was 
found to alter cytokine levels in cord blood immune cells stimulated with a TLR agonist 
(Liao 2016), indicating that BPA can have an effect on the immune response. In an animal 
model of SLE, BPA exposure led to increased IgM and anti-DNA autoantibody release from 
B1 cells (Yurino 2004) as well as IgA and IgG2 release from B cells (Goto 2007, Rogers 
2013). Adult exposure to BPA caused histamine release from bone marrow-derived mast 
cells (O’Brien 2014). BPA was also found to decrease Treg cells in mice exposed either 
prenatally or as adults (Yan 2008, Rogers 2013). 
 
Bisphenol S 
Concerns over BPA exposure in the public led to the replacement of BPA in baby 
bottles and many plastic water/ drink bottles with another component of plastic called BPS 
(Dieter 2012). Fewer than 100 papers have been reported in PubMed that mention BPS. The 
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first paper mentioning BPS was published in 2000 and titled, “Estrogenic activity of dental 
materials and bisphenol-A related chemicals in vitro” by Hashimoto and Nakamura in the 
journal Dental Materials (Hashimoto 2000). Of the 99 papers reported in PubMed, over 50% 
have been published in the last two years and only 15 examine in vivo or in vitro effects of 
BPS. 
 Several studies assessing the estrogenic effect of BPS found that BPS can bind to 
ERs, but its estrogenic potency depends on the location of the ER (Rochester 2015). When 
BPS binds to the nuclear ER it was less estrogenic than BPA, but if it bound to membrane 
ERs it was more estrogenic than BPA (Rochester 2015). When E2 is bound to ERα, a high 
concentration of BPA (10µM) can displace E2 from its binding site. In contrast, BPS only 
inhibited about 70% of the binding of E2 compared to BPA (Molina-Molina 2013). BPA can 
activate both ERα and ERβ, whereas BPS more potently activates ERβ compared to ERα 
(Molina-Molina 2013). BPA and BPS are also thought to bind to the AR receptor as an 
agonist but at only 20% of the binding of testosterone (Molina-Molina 2013). However, BPS, 
but not BPA, can also act as an ER antagonist (Molina-Molina 2013). One study assessed the 
effect of BPS on CVD and found that BPS increases heart rate, arrhythmias, and induced 
Ca2+ handling changes via ERβ in females, but not in males (Gao 2015) similar to what was 
seen with BPA. No studies have assessed the effect of BPS on myocarditis or DCM. 
 
Hypothesis and Specific Aims 
Based on the literature we hypothesize that environmentally-derived sex steroids (i.e., 




Aim 1: Examine the effect of the VDR on CVB3 myocarditis in male and female mice 
 Deficiency in the active form of VitD is highly prevalent worldwide with around 25% 
of the population in the US found to have inadequate VitD levels and 8% at risk for 
deficiency. VitD is well known for its role in regulating serum calcium levels and bone 
homeostasis, but few realize that it also functions as a sex steroid. The VDR is expressed on 
cardiomyocytes, fibroblasts, vascular endothelial cells, and immune cells. Importantly, 
macrophages express the VDR and possess all of the components necessary to import/ 
synthesize cholesterol and convert it to active VitD including Cyp2R1 and Cyp27B1. The 
critical role that macrophages play in driving sex differences in CVB3 myocarditis in males, 
suggests that VitD via the VDR could influence myocardial inflammation in a sex specific 
manner. Recently low VitD levels have been associated with an increased risk of a number of 
CVDs, but no one has examined the role of VitD/VDR in myocarditis. This led us to examine 
the role of VDR signaling using male and female mice deficient in the VDR to examine its 
role in relation to sex differences in acute CVB3 myocarditis. Mice were fed a high calcium 
diet to prevent the development of rickets. We did not directly examine the role of VitD in 
these experiments. 
 
Aim 2: Examine the effect of the endocrine disruptor BPA on CVB3 myocarditis in male 
and female mice 
 There are a number of agents that have been classified as EDs including metals, 
pesticides, estrogens from plants, fungi, and synthetically made chemicals like BPA. 
Myocarditis in patients and in animal models displays profound sex differences in the acute 
inflammation and the chronic stage that involves DCM. Testosterone has been shown to 
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increase CVB3 myocarditis in male BALB/c mice, but the role of estrogen is less well 
defined in this model. The first step in this thesis was to examine the role of estradiol on 
CVB3 myocarditis in BALB/c female mice. We show in this thesis that ovariectiomy of 
female mice significantly increases acute CVB3 myocarditis, while estradiol supplementation 
reverses this. These findings indicate that estrogen does indeed protect female mice from 
CVB3 myocarditis. This led us to hypothesize that endocrine disruptors that are known to 
alter ER function like BPA could alter acute myocarditis in a sex-specific manner. 
In this aim we exposed male and female BALB/c (a mouse strain that develops acute 
and chronic myocarditis/ DCM) and C57BL/6 (a mouse strain that develops acute 
myocarditis but not DCM) mice to BPA in their drinking water for 2 weeks before infecting 
with CVB3. BPA exposure continued from day 0 until harvest at day 10 pi, and we used soy-
free food and bedding in all of these experiments to prevent that estrogenic influence on the 
experiments. We began the experiments in the traditional plastic cages and water bottles that 
almost all investigators are using for their experiments. Then we repeated experiments using 
glass cages and water bottles to eliminate that route of additional exposure. We were 
surprised to find how significant the effect of the plastic cages was on our experiments and 
this led to many experiments that we had not originally anticipated. That meant that the 
chronic stage of the disease has not yet been examined and will need to be examined in the 
future. 
 




 BPS is the primary ED that has replaced BPA in many plastic products like water 
bottles and baby bottles. For this reason it was thought when we started this project that BPS 
exposure may be a more environmentally relevant human exposure than BPA. The large 
published literature on BPA that has come out in the past 2 or so years, indicates that BPA is 
still found in many products that the population is exposed to (i.e., receipts, photocopy 
paper), and so BPA remains an important contaminant. Because of the critical role of sex 
hormones in driving myocarditis and DCM in humans and animal models, we hypothesized 
that BPS would alter CVB3 myocarditis in a sex specific manner. For these experiments, we 
exposed female BALB/c mice to BPS in their drinking water for 2 weeks before infecting 
mice with CVB3. BPS exposure continued from day 0 until harvest at day 10 pi, and we used 
soy-free food and bedding in all of these experiments to prevent that estrogenic influence on 
the experiments. In order to prevent ED exposure from the caging we used glass cages and 





















Animal Care Ethics Statement 
Mice were maintained and used in strict accordance with the recommendations in the 
Guide for the Care and Use the Laboratory Animals of the National Institutes of Health. Mice 
were maintained under pathogen-free conditions in the animal facility at the Johns Hopkins 
School of Medicine and at Mayo Clinic Florida, and approval obtained from the Animal Care 
and Use Committee of Johns Hopkins University and Mayo Clinic Florida for all procedures. 
Mice were sacrificed according to the Guide for the Care and Use the Laboratory Animals of 
the National Institutes of Health to minimize suffering. 
 
CVB3-induced Myocarditis Model 
Male and female BALB/c (stock #651) or C57BL/6 (stock #664) 6-8 week old adult 
mice were obtained from the Jackson Laboratory (Bar Harbor, ME). Mice were maintained 
under pathogen-free conditions in the animal facility at the Johns Hopkins School of 
Medicine or the Mayo Clinic Florida animal facility. Approval was obtained from the Animal 
Care and Use Committee for all experiments at both institutions. Generally, 10 mice per 
group/ sex were used for experiments. Mice were inoculated ip with sterile phosphate 
buffered saline (PBS) or 103 PFU of heart-passaged stock of CVB3 on day 0 and acute 
myocarditis examined at day 10 pi, as previously described (Fairweather 2007, Myers 2013). 
CVB3 (i.e., Nancy strain) was originally obtained from the American Type Culture 






Gonadectomy and Hormone Replacement Studies 
Sexually immature 4-6 week old WT BALB/c male or female mice (Jackson 
Laboratory, Bar Harbor, ME) received a bilateral [males- gonadectomy (Gdx), females- 
ovariectomy (Ovx)] or sham operation as previously described (Frisancho-Kiss 2009, 
Coronado 2012, Fairweather 2014). Mice were given 2 weeks to recover from surgery before 
being infected ip with CVB3, which is considered “day 0”. Immediately after the operation a 
control (Con), testosterone (Te) or estradiol (E2) 90-day slow-release pellet was implanted 
subcutaneously (sc) in the midscapula region (Klein 2000, Siracusa 2008, Coronado 2012, 
Fairweather 2014). Circulating testosterone levels generated from the pellet are around 10-15 
ng/mL, similar to physiologic levels of 10 ng/mL for normal male mice (Klein 2000, 
Coronado 2012). The estradiol pellet maintains physiological circulating estrogen 
concentrations of 100-200 pg/mL in female mice following gonadectomy (Siracusa 2008). 
Successful gonadectomy in males was confirmed by examining serum testosterone 
concentrations using an ELISA kit (Cayman Chemicals, Ann Arbor, MI), according to 
(Easterbrook 2007). Successful gonadectomy in females was confirmed immediately after 
harvest using uterine horn weights because epithelial cells of the uterine horn require 
estrogen for cell survival (O’Brien 2006). After a 2 week recovery period from surgery the 
mice were inoculated ip with 103 PFU of heart-passaged stock of CVB3 on day 0 and acute 
myocarditis examined at day 10 pi, as previously described (Coronado 2012, Myers 2013). 
 
VDR-/- Studies 
Male and female (6-8 week old) heterozygous VDR deficient (VDR+/-) (B6.129S4-
Vdrtm1Mbd/J, stock #6133) mice were obtained from the Jackson Laboratory (Bar Harbor, 
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ME). VDR+/- mice were mated to produce homozygous VDR deficient (VDR-/-) and wild 
type (WT) (VDR+/+) mice and genotyped according to the PCR protocol provided by the 
Jackson Laboratory. VDR +/+ and -/- mice were fed a Ca2+-supplemented diet (TD.96348, 
20% lactose, 2% calcium, 1.25% phosphorus; Harlan Laboratories, Madison, WI) to prevent 
the development of rickets (Li 1997). WT VDR+/+ littermates were used for comparison to 
VDR-/- mice. Mice were inoculated ip with 103 PFU of heart-passaged stock of CVB3 on 
day 0 and acute myocarditis examined at day 10 or day 35 pi, as previously described 
(Coronado 2012, Myers 2013). 
 
Endocrine Disruptor Studies 
6-8 week old WT male and female BALB/c (stock #651) or C57BL/6 (BL/6) (stock 
#664) mice were obtained from the Jackson Laboratory (Bar Harbor, ME). Plastic cages and 
water bottles (i.e., traditional housing) or glass cages and water bottles were used to house 
the mice as determined by the experiment. The bedding (Envigo-Tekland, 7990.BG) and 
food (Envigo-Tekland, 2020X) used in the endocrine disruptor studies were soy and 
phytoestrogen-free in order to prevent inclusion of other naturally occurring endocrine 
disruptors in the experiments and were purchased from Envigo (Minneapolis, MN). In 
separate experiments, MilliQ water containing varying doses of endocrine disruptors (BPA or 
BPS) or control MilliQ water were given to mice dissolved in drinking water for two weeks 
prior to inoculation ip with 103 PFU of heart-passaged stock of CVB3 on day 0 and acute 
myocarditis was examined at day 10 pi, as previously described (Coronado 2012, Myers 




Figure 1. Timeline for BPA exposure experiments. BPA was dissolved in MilliQ water overnight 
at room temperature on a stir plate and serial dilutions were performed in order to obtain determined 
doses. BPA or control water was then placed in water bottles in mouse cages and mice were exposed 
for two weeks prior to infection with CVB3 at day 0 pi. BPA exposure in drinking water was 
continued until mice were harvested at day 10 pi for analysis. This same timeline was used for BPS 
experiments. 
 
The BPA doses used in our studies, seen in Table 1 below, were obtained from 
Jenkins et al and based on predicted daily exposure levels in the human population (Jenkins 
2011). At the time of the development of this project Jenkins et al was the only study 
available that assessed the effect of BPA in a mouse model using oral exposure in drinking 
water. Estimated daily BPA intakes were determined previously by Jenkins et al (their 
unpublished data) by looking at how much water mice drink daily (Jenkins 2011). The EPA 
reference dose used in our experiments and reported by Jenkens et al was derived from EPA 
calculations. The EPA reference dose was calculated by using a safety factor of 1000x the 
LOAEL (lowest observable adverse effect level) (Vandenberg 2009). The EPA reference 
dose is defined as an estimate of the daily exposure to a susceptible individual without an 
appreciable risk of deleterious effects during a lifetime (EPA). The doses that were chosen 
are described in Table 1 for BPA and Table 2 for BPS, along with the estimated intake per 
mouse, and predicted human exposure level (Jenkins 2011). BPS dosing was determined by 
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analytical calculations using molecular weights of BPA and BPS to determine a BPA-
equivalent dose for BPS. 




(µg BPA/kg BW) 
Human exposure level 
0 0 Control 
2.5 0.5 Human relevant exposure 
25 5 High human relevant exposure 
250 50 EPA reference dose 
a from Jenkins 2011 
 




(µg BPS/kg BW) 
Human exposure level 
0 0 Control 
2.75 0.55 Human relevant exposure 
27.5 5.5 High human relevant exposure 
275 55 EPA reference dose 
a Doses converted from BPA doses in Table 1 to their molar equivalent for BPS 
b from Jenkins 2011 
 
Myocarditis Patients 
 A diagnosis of myocarditis was confirmed by echocardiogram (Cooper 2009), and 
serum vitamin D3 levels were determined by liquid chromatography-mass spectrometry/ 
mass spectrometry (LC-MS/MS) at Mayo Clinic in Rochester, MN. Approval for use of the 
data was obtained from the Institutional Review Board (IRB) at both Mayo Clinic and Johns 
Hopkins University. Consent forms used under Mayo Clinic IRB approved protocols gave 
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permission for samples collected from patients at Mayo Clinic to be used for future research 
studies. Vitamin D levels were compared to patient ejection fraction (%EF) as a marker of 
cardiac function at baseline (time of patient diagnosis) and after treatment for disease (1 
month, 2 months, 6 months, and 1 year). Vitamin D levels were defined by Institute of 
Medicine standards and common levels used in research studies (LaVie 2011, Ross 2011). 
The vitamin D status levels were defined as: deficient (<12 ng/mL), inadequate (Inadeq, 12-
19 ng/mL), mildly deficient (Mild Def, 20-30 ng/mL), sufficient (30-50 ng/mL) or 
potentially harmful (50+ ng/mL). VitD levels were analyzed in the sera of lymphocytic 
myocarditis (LM) patients (n=16) and giant cell myocarditis (GCM) patients (n=28). 
 
Histology 
Mouse hearts were cut longitudinally and fixed in 10% phosphate-buffered formalin 
and embedded in paraffin for histological analysis. 5 μm sections were stained with 
hematoxylin and eosin (H&E) to detect inflammation, trichrome blue to detect collagen 
deposition (fibrosis), or toluidine blue to detect mast cell granules. Myocarditis was assessed 
as the percentage of the heart with inflammation compared to the overall size of the heart 
section using a microscope eyepiece grid, as previously (Fairweather 2003, Frisancho-Kiss 
2009, Coronado 2012, Fairweather 2014). Sections were scored by at least two individuals 








The heart was homogenized at 10% weight/ volume in 2% minimal essential media and 
individual supernatants from hearts were used to preform plaque assays to determine the 
level of infectious virus, as previously described (Fairweather 2003, Frisancho-Kiss 2009, 
Coronado 2012, Fairweather 2014). Viral replication was expressed as the mean PFU/g of 
heart. 
 
Quantitative Real-time PCR 
RNA isolation of heart tissue 
 At harvest half of the heart was collected and stored at -80C for RNA isolation. 
Hearts were cut so that all chambers were present in both sections. Prior to RNA isolation 
frozen hearts were weighed. If individual hearts weighed more than 30 mg the heart was cut 
in half a second time prior to homogenization. Hearts were homogenized and lysed using 
Tissuelyser (Qiagen) with 7 mm stainless steel beads in RTL buffer with 0.5% DX buffer to 
reduce foam (Hilden, Germany). The homogenate was then placed in an automated RNA 
isolation and purification instrument, QIAcube, with reagents for RNase Easy Fibrous Mini 
Kit including a DNase and Proteinase K step (Qiagen). RNA was eluted into 30 µL. If the 
heart had been divided in the earlier step, the eluted RNA was pooled prior to being 
aliquoted. RNA quantification was determined in µg/µL using NanoDrop (Thermo 





Total RNA from mouse hearts was assessed by quantitative real time (qRT)-
polymerase chain reaction (PCR) using Assay-on-Demand primers and probe sets and the 
ABI 7000 Taqman System from Applied Biosystems Biosystems (Foster City, CA) after 
RNA was converted to cDNA using High Capacity cDNA Reverse Transcriptase Kit 
(Applied Biosystems), as previously described (Onyimba 2011, Abston 2012A). Data are 
shown as relative gene expression (RGE) normalized to the housekeeping gene hypoxanthine 
phosphoribosyltransferase 1 (Hprt). Hprt was selected because GAPDH and actin, common 
housekeeping genes, were both found to be increased in expression during CVB3 
myocarditis. Gene expression was analysed by assessing comparative quantification, which 
utilizes cycle threshold (Ct) for each primer to calculate the delta Ct (∆Ct), which is the 
threshold cycle comparison between the gene of interest and the housekeeping gene. This is 
then used to calculate the relative gene expression using the formula RGE= 2 –(∆Ct-∆Ct(max)). 
 
Measurement of CVB3 genome levels by qRT-PCR 
Probe sets to detect CVB3 were developed by Antoniak et al and obtained from 
Integrated DNA Technologies (Coralville, IA) (Antoniak 2013). Probe sets: CVB3 forward, 
5′-CCCTGAATGCGGCTAATCC-3′; CVB3 reverse, 5′-ATTGTCACCATAAGCAGCCA-
3′; CVB3 probe, 5′-FAM-TGCAGCGGAACCG-TAMRA-3′. 
 
ELISA 
The heart was homogenized at 10% weight/ volume in 2% minimal essential media 
and individual supernatants from hearts were used in enzyme linked immunosorbent assay 
(ELISA) to measure cytokine levels and in plaque assays to determine the level of infectious 
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virus, as previously described (Fairweather 2003, Frisancho-Kiss 2009, Coronado 2012, 
Fairweather 2014). Cytokines were determined using R&D Systems ELISA kits 
(Minneapolis, MN), according to the manufacturer's instructions and expressed as pg/g of 
heart. Hormone levels were determined using Cayman Chemical ELISA kits (Ann Arbor, 
MI, item #582701) and expressed as pg/mL of sera. Bisphenol A levels in the water were 




Heart tissues were dissected and snap frozen on dry ice and stored at -80 C until ready 
to be analyzed. Tissues were then lysed by homogenizing using a mechanical cell disperser 
with RIPA buffer (Abcam) and protease/phosphate inhibitor cocktail (BioRad) to obtain 
proteins from membrane, cytoplasm and nucleus. RIPA buffer contains 0.22% beta 
glycerophosphate, 10% tergitol-NP40, 0.18% sodium orthovanadate, 5% sodium 
deoxycholate, 0.38% EGTA, 1% SDS, 6.1% Tris, 0.29% EDTA, 8.8% sodium chloride, 
1.12% sodium pyrophosphate decahydrate (Abcam). Extracted proteins were separated on a 
Criterion XT precast bis-tris 4-12% gel (BioRad) then transferred onto nitrocellulose 
membrane (BioRad). Samples were probed with primary antibodies specific for ERα (mouse 
IgG1 monoclonal, H226, 1:200), phospho-ERα (rat polyclonal IgG, Serine 118, 1:200), ERβ 
(mouse monoclonal IgG2a, 1531 1:200), phospho-ERβ (rat polyclonal IgG, Serine 87, 1:200), 
VDR (mouse poylclonal IgG2a, D-6, 1:200) and normalized to Hprt (goat polyclonal IgG, N-
15, 1:200). Species-specific secondary antibodies were conjugated to horseradish peroxidase 
(HRP) for densitometric analyses performed using Image J 1.50i.  
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BPA Analysis by Collaborators at University of Kentucky 
In order to assess free BPA and BPA-glucuronide levels in the water and urine in our 
animal experiments we established a collaboration with Dr. Changcheng Zhou, Associate 
Professor in the Department of Pharmacology & Nutritional Sciences at the Saha 
Cardiovascular Research Center at the University of Kentucky. His laboratory found that 
BPA exposure to mice in a model of atherosclerosis increased disease and has developed a 
method to assess BPA levels in urine using modified chemical derivatization liquid 
chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) 
instrumentation (Sui 2014). We sent Dr. Zhou urine samples collected from individual ear-
tagged mice using the “free drop” method. Samples were collected on day 0, 3, 7, and 10 pi. 
After Dr. Zhou’s laboratory performed the analysis, they sent us the free BPA and BPA-
glucuronide levels expressed as ng/20µL. 
 
Microarray Analysis 
 Processing and GeneChip analysis for microarray were performed on three heart 
samples for each treatment group (4 treatment groups/ timepoint: PBS inoculated uninfected 
male vs. female BALB/c mice and CVB3-myocarditis males vs. females at day 10 pi). Heart 
RNA (100 ng) was processed for hybridization to Affymetrix Mouse Gene ST 1.0 
microarrays using the Affymetrix GeneChip Whole Transcript Sense Target Labeling Assay, 
according to manufacturer’s protocol and a previously published method (Affymetrix, Santa 
Clara, CA) (Onyimba 2011, Coronado 2012). The Affymetrix Mouse GeneChip Gene 1.0 ST 
Array interrogates 28,853 well-annotated genes with 764,885 distinct probes. The expertise, 
facilities and instrumentation for Affymetrix GeneChip experimentation and analyses were 
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provided and supported by the Johns Hopkins Malaria Research Institute. Genes altered by 
CVB3 myocarditis and by sex were compared to known VDRE genes (Wang 2005). 
Candidate VDRE genes from the microarray analysis were verified by qRT-PCR. 
Microarray data accession number. The Affymetrix gene expression data were deposited to 
the GEO (www.ncbi.nlm.nih.gov/geo) with accession number GSE35182. 
 
Echocardiography 
 In vivo cardiac function was performed by transthoracic echocardiogram using an 
Acuson Siemens Sequonia C256 and 13 megahertz (MHz) transducer on conscious mice. 
Nair was used to remove fur from mice prior to echocardiography in order to allow the 
transducer to have appropriate contact with the ultrasound gel on the mouse. The transducer 
was aligned in parasternal short axis view of the heart. A two-dimensional M-mode tracing 
was used to obtain left ventricular (LV) dimensions to determine fractional shortening (%FS) 
(measurement of the capacity of the LV) and relative wall thickness (RWT). A LV trace was 
preformed to assess chamber size (LVmass). These values were calculated by the Acuson 




Normally distributed data comparing two groups were analysed using a 2-tailed, 
Student’s t test. The Mann-Whitney rank sum test was used to evaluate nonparametric data. 




When comparing more than 2 groups multiple comparison analysis was performed by 
ANOVA with each group compared to the corresponding control group. Data are expressed 
as mean ±SEM. A value of p<0.05 was considered significant. 
Survival curves were analyzed using the Mantel-Cox test to determine if there was a 
significant difference in survival during chronic myocarditis. A value of p<0.05 was 
considered significant. 
Correlation between x and y values was calculated by liner regression and shown as R 
squared (R2) values. R is defined as the correlation coefficient (R2 values closer to 1 indicate 
high correlation between values).  
Analysis of microarray data was performed with Partek Genomics Suite (GS) Version 
6.4 (Partek, MO, USA). Gene expression patterns for each gene were normalized to the 
median array intensity for all chips and data from infected animals were normalized to 
uninfected PBS controls (Onyimba 2011, Coronado 2012). Microarray data were analyzed 
with Partek GS software by 2-way ANOVA in order to look for significant differences 
between conditions (with sex and infection as factors) and then P values and fold changes 
were generated using Fisher’s least significant difference (LSD) post hoc analysis for 
comparisons of diseased to undiseased or sex. False discovery rate (FDR) corrections for 
multiple comparisons (Benjamini-Hochberg) were applied to reduce the total number of 
























Studies estimate that 1 billion people worldwide have deficient or insufficient levels 
of VitD, while roughly 25% of individuals in the US have inadequate VitD levels. 
Epidemiology studies show that VitD deficiency is associated with an increased risk of 
cardiovascular disease, yet the mechanism remains unclear. Aside from its role in bone 
health, VitD functions as a sex steroid where it influences innate and adaptive immune cell 
function. In this study we examined the role of the VDR on viral-induced myocarditis using 
male and female knockout mice. Prior to infection the heart of female mice expressed 
significantly more VDR than males, and OVX with estradiol replacement revealed that 
elevated VDR in females was due at least in part to estrogen. In contrast, males expressed 
higher VDR levels during myocarditis, which was not due to testosterone. By microarray, 97 
genes associated with the Vitamin D Response Element (VDRE) were upregulated in the 
heart of males during myocarditis compared to controls, while only 27 VDRE-related genes 
were upregulated in females, suggesting increased VDR signaling in males. VDR deficiency 
significantly increased myocarditis in female mice that typically have low cardiac 
inflammation. In contrast, VDR deficiency significantly reduced myocarditis in males. VDR 
deficient females developed a characteristically “male-type” immune response with increased 
TLR2, TLR4, caspase-1, IL-1β, IL-17, IFNγ, and classically activated M1 macrophage 
markers. These data suggest that women with low VitD levels may be at an increased risk for 
developing viral myocarditis similar to other autoimmune diseases, while activation of the 
VDR by viral infection may exacerbate disease in men by promoting innate inflammation. 
The data shown in this Chapter has been submitted for publication and that is why some 




Deficiency in the active form of VitD (i.e., 1,25-dihydroxyvitamin D3) is highly 
prevalent worldwide with around 25% of the population in the US found to have inadequate 
VitD levels and 8% at risk for deficiency (Plum 2010, Lavie 2011, Looker 2011, Litwack 
2011, Hilger 2014, Welles 2014, Alkerwi 2015). VitD deficiency is most widely defined as 
less than 20 ng/mL, and inadequate VitD reported as less than 30 ng/mL (Lavie 2011, Looker 
2011, Welles 2014). Epidemiologic studies report that VitD deficiency is associated with an 
increased risk of CVD (Agarwal 2011, Lavie 2011, Welles 2014), hypertension (Forman 
2007, Forman 2008), myocardial infarction (Marniemi 2005, Giovannucci 2008, Brøndum-
Jacobsen 2012), peripheral artery disease (Melamed 2008), stroke (Marniemi 2005, Poole 
2006), congestive heart failure (Schleithoff 2006), and an increased risk of heart failure and 
all-cause mortality (Wang 2008, Dobnig 2008, Ginde 2009, Kilkkinen 2009, Agarwal 2011, 
Tomson 2013, Belen 2015, Lutsey 2015). Two recent studies reported that women with low 
VitD levels were at an increased risk for myocardial infarction compared to men (Karakas 
2013, Verdoia 2015). Whether the association of low VitD levels with increased risk of CVD 
is due to low exposure to sunlight or poor nutrition, for example, or directly related to the 
pathology of CVD remains unclear. The role of VitD in myocarditis has not been previously 
investigated. 
VitD obtained from exposure to the sun or from dietary sources is hydroxylated in the 
liver (and other organs) by 25-hydroxylase (Cyp2R1) and carried in the bloodstream by VitD 
binding protein (DBP) to the kidney where it is converted by 25-OH-D-1-hydroxylase 
(Cyp27B1) to the active form of VitD (i.e., 1,25-dihydroxyvitamin D3), which binds the 
VDR (Rowling 2007, Plum 2010, Zittermann 2010, Zhu 2013). VitD is regulated in part by 
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Cyp24A1, which actively down-regulates VitD levels (Zittermann 2010). VitD can also be 
produced locally in many different tissues and cell types including cardiomyocytes and 
vascular endothelial cells. Macrophages express VDRs and possess all of the components 
necessary to import/ synthesize cholesterol and convert it to active VitD including Cyp2R1 
and 27B1 (Bikle 2011). VitD bound to the VDR forms a complex with the retinoid X 
receptor and this complex activates the VDRE, which influences a large number of genes at a 
time in a manner similar to estrogen and androgen response elements (Lisse 2011, 
Trochoutsou 2015). Although VitD is known for its role in promoting bone health, it is also a 
sex steroid that has been shown to influence innate immune signaling (Liu 2009, Lee 2011, 
Gambhir 2011, Verway 2013) suggesting that it could exert sex-specific effects on 
inflammation. 
Myocarditis is an inflammation of the myocardium that can cause sudden death due 
to heart failure and may be responsible for up to half of all DCM cases in the US (Sagar 
2012, Cooper 2014). DCM is a leading cause of chronic heart failure leading to the need for 
transplantation. Common viruses like influenza and CVB3 cause myocarditis in people and 
animal models (Cooper 2009, Fairweather 2012A, Fairweather 2012B, Myers 2013). 
Myocardial inflammation is far more severe in male BALB/c mice following CVB3 infection 
compared to females; and similar to patients, male mice progress from myocarditis to DCM 
and chronic heart failure while females recover (Huber 2005, Frisancho 2007, Cocker 2009, 
McNamara 2011, Coronado 2012, Fairweather 2013, Fairweather 2014). Previously we and 
others showed that genes related to the inflammasome including TLR4, caspase-1, IL-1β, IL-
18 and IFNγ are elevated in the heart of male mice with CVB3 myocarditis leading to a 
dominant adaptive Th1-type immune response (Huber 1994, Fairweather 2003, Frisancho-
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Kiss 2007, Coronado 2012, Roberts 2013). Gdx of male mice significantly reduces cardiac 
inflammation and converts males to a “female-type” immune response with increased Th2 
cytokines (i.e., IL-4), Treg, inhibitory cytokines (i.e., IL-10), and more alternatively activated 
anti-inflammatory M2 macrophages (Frisancho-Kiss 2007, Frisancho-Kiss 2009, Li 2009). In 
this study we show that estrogen increases VDR expression in the heart of females, which 
reduces CVB3-induced myocarditis in females. In contrast, VDR activation in males after 
infection increases cardiac inflammation. These data suggest that women with VitD 
deficiency could be at an increased risk of developing viral myocarditis, while activation of 















Females express more VDR before infection, males during myocarditis 
VDRs are expressed on a wide variety of cells including immune cells, vascular 
endothelial cells, cardiomyocytes and cardiac fibroblasts (Chen 2008, Plum 2010, Lavie 
2011). Additionally, Cyp27B1 and Cyp24A1 have been reported to be expressed in the heart 
of rodents (Chen 2008). To determine whether components needed for VitD metabolism 
were present in the heart during murine CVB3 myocarditis, we compared mRNA levels of 
VDR, DBP, Cyp2R1, Cyp27B1 and Cyp24A1 in the heart of PBS-treated control male and 
female BALB/c mice vs. males and females with CVB3 myocarditis by qRT-PCR at day 10 
pi (Fig 1, Table 1). We found that Cyp2R1 was significantly increased during acute 
myocarditis in both female (p=0.002) and male (p=0.002) mice compared to controls, but 
was significantly higher in males compared to females with myocarditis (p=0.03, Table 1). 
Cyp27B1, which is needed to convert VitD to its active form, did not increase during 
myocarditis, but was expressed at 2-fold higher levels in the heart than the housekeeping 
gene Hprt in both sexes (Table 1). Prior to infection, hearts from female mice had 
significantly higher expression of the VDR (p=0.008, Fig 1A) and DBP (p=0.04) compared 
to uninfected males (Table 1). In contrast, males with CVB3 myocarditis had increased 
expression of VDR (p=0.006, Fig 1D) and DBP (p=0.04, Table 1) compared to control 
males. VDR expression was not significantly different in females vs. males with CVB3 
myocarditis (Fig 1B) or in females with myocarditis compared to control females (Fig 1C). 
However, the enzyme that breaks down VitD, Cyp24A1, was significantly higher in females 
vs. males with myocarditis (p=0.03, Table 1). Thus, the components needed to process VitD 
are present in the murine heart during myocarditis and differ between males and females. 
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Table 1. Expression of VDR-related genes in the heart of WT and mice with CVB3 
myocarditis at day 10 pi 
 PBS Female vs. CVB3 Female* PBS Male vs. CVB3 Male 
 PBS CVB3 P value PBS CVB3 P value 
VDR 3.60±0.32 3.82±0.19 0.57 1.82±0.42 3.66±0.14 0.006 
DBP 6.82±1.05 3.82±0.19 0.04 2.61±0.82 6.46±1.37 0.04 
Cyp2R1 1.36±0.04 2.07±0.14 0.002 1.36±0.10 2.58±0.24 0.002 
Cyp27B1 1.58±0.18 1.59±0.06 0.93 1.91±0.08 1.89±0.21 0.92 
Cyp24A1 8.74±2.11 7.58±1.05 0.38 5.89±1.14 4.56±0.54 0.33 
 PBS Female vs. Male CVB3 Myocarditis Female vs. Male 
 Female Male P value Female Male P value 
VDR 3.60±0.32 1.82±0.42 0.008 3.82±0.19 3.66±0.14 0.54 
DBP 6.82±1.05 2.61±0.82 0.01 3.82±0.19 6.46±1.37 0.07 
Cyp2R1 1.36±0.04 1.36±0.10 0.96 2.07±0.14 2.58±0.24 0.03 
Cyp27B1 1.58±0.18 1.91±0.08 0.13 1.59±0.06 1.89±0.21 0.22 
Cyp24A1 8.74±2.11 5.89±1.14 0.26 7.58±1.05 4.56±0.54 0.03 
* Data show relative gene expression normalized to the housekeeping gene hypoxanthine 
phosphoribosyltransferase 1 (Hprt) using qRT-PCR. Data show the mean +/-SEM of relative 
gene expression (RGE) compared to Hprt by qRT-PCR using a 2-tailed Mann-Whitney rank 





Figure 1. Greater VDR expression in female hearts prior to infection and male hearts during 
CVB3 myocarditis. Female (F) and male (M) BALB/c mice were injected with PBS or CVB3 ip on 
day 0 and the whole heart analyzed for VDR mRNA expression on day 10 pi, during acute 
myocarditis. Sex differences were examined in males and females A) without myocarditis, B) with 
CVB3-induced myocarditis, C) in females before and after disease, and D) in males before and after 
disease. Data show the mean +/-SEM of relative gene expression (RGE) compared to Hprt by qRT-
PCR using a 2-tailed Mann-Whitney rank sum test, n=10/ group. 
 
VDRE genes upregulated during CVB3 myocarditis 
 To gain a better understanding of genes related to VDR signaling that may be 
involved in CVB3 myocarditis, we conducted microarray analysis of undiseased (PBS-
treated) male vs. female BALB/c mice compared to males and females with myocarditis. We 
picked genes to analyze based on published reports of genes found to be downstream of the 
VDRE (Wang 2005, Bosse 2009). Genes that are regulated by the VDRE that were increased 
in males with CVB3 myocarditis compared to control males include IFN-induced genes 
(Ifit1-3, 6.2-fold increase, p=0.0002), caspase-1 (2.2-fold increase, p=0.006), TGFβ2 (2.1-
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fold increase, p=0.03), Cxcl11 (an M1 marker, 1.7-fold increase, p=0.04), and IL-1R 
antagonist (1.5-fold increase, p=0.02), for example (Supplemental Table 1 and 
Supplemental Fig 1). The full list of up- and down-regulated VDRE genes in diseased and 
undiseased male and female mice are found in Supplemental Table 1-4. We found that 97 
genes associated with the VDRE were significantly upregulated in the heart of male mice 
with myocarditis compared to control males (Supplemental Table 1), while only 27 VDRE 
genes were upregulated in females compared to undiseased females (Supplemental Table 
2), suggesting that VDR signaling is greater in males with CVB3 myocarditis than females 
(Fig 1D). 
 
Estrogen increases VDR expression in the heart of females 
We showed previously that testosterone is responsible for increasing acute CVB3 
myocarditis in male BALB/c mice (Frisancho-Kiss 2009, Coronado 2012). In this study we 
wanted to determine the role of estrogen (17β-estradiol) and testosterone on VDR expression 
in whole hearts during CVB3 myocarditis by qRT-PCR. Female and male sexually immature 
4-6 week old WT BALB/c mice received a Sham operation or bilateral ovariectomy (Ovx) 
for females or gonadectomy (Gdx) for males and mice were allowed to recover from the 
surgery for 2 weeks before infection with CVB3 ip on day 0. At the time of surgery mice 
received either an empty control pellet (Con) or a slow-release estradiol (E2) or testosterone 
(Te) pellet subcutaneously (sc). The release of hormones has been found to last for at least 90 
days (Klein 2000). 
We found that female mice with an ovariectomy develop significantly increased 
CVB3 myocarditis as represented by the percent inflammation (p=0.001) (Fig 2), with a 
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severity similar to WT males (i.e., 30-40% inflammation) (Frisancho-Kiss 2007, Coronado 
2012). Male mice with a gonadectomy have significantly reduced inflammation (p=0.0003) 
(Fig 2), similar to the severity of WT females (i.e., 10-15% inflammation) (Frisancho-Kiss 
2007, Frisancho-Kiss 2009). Estradiol treatment of ovariectomized females (Ovx+E2) 
significantly decreased myocardial inflammation (p=0.02) and increased VDR expression in 
whole hearts (p=0.005) compared to females with an operation but no hormone 
supplementation (Ovx+Con) (Fig 2A). Success of the operation and estrogen replacement 
was verified by a significant increase in wet uterine horn weight (p=4x10-7) (Fig 2A). In 
contrast, testosterone treatment of gonadectomized males (Gdx+Te) did not significantly 
alter VDR expression in the whole heart (p=0.18) in spite of its ability to increase 
myocarditis (p=0.04) and circulating testosterone levels (p=3x10-5) compared to males with 
an operation but no hormone treatment (Gdx+Con) (Fig 2B). Thus, estrogen (i.e., estradiol) 
increases VDR expression in the heart of females with CVB3 myocarditis, but testosterone is 
not responsible for increasing VDR expression in males when examining expression levels in 
the whole heart. However, we showed previously that testosterone replacement only 
increased the CD11b-associated gene TSPO if immune cells were isolated from whole hearts 
and then gene expression examined (Fairweather 2014). In future experiments we will need 
to evaluate the effect of testosterone on VDR expression levels from isolated cardiac immune 
cells during myocarditis. It is possible that estrogen is increasing VDR expression primarily 




Figure 2. Estrogen increases cardiac VDR expression and decreases CVB3 myocarditis. A) 
Female and B) male sexually immature 4-6 week old WT BALB/c mice received a Sham operation or 
bilateral ovariectomy (Ovx) for females or gonadectomy (Gdx) for males and mice recovered from 
surgery for 2 weeks before infection with CVB3 ip on day 0. During surgery mice received either 
slow-release control pellets (Con), estradiol (E2) or testosterone (Te) sc. At day 10 pi, myocarditis 
(left), uterine horn weight or circulating Te levels (center), and cardiac VDR expression was assessed 
(right). Relative gene expression (RGE) of VDR by was compared to Hprt in hearts by qRT-PCR as 
Data show the mean +/-SEM using a 2-tailed Mann-Whitney Rank Sum test, n=7-10/group. 
 
VDR reduces CVB3 myocarditis in females, but increases disease in males 
Two recent studies found that low VitD levels increased the risk for myocardial 
infarction in women, but not in men (Karakas 2013, Verdoia 2015) suggesting a sex 
difference in the effect of VitD on CVD. However, no studies have been conducted 
examining the effect of VitD deficiency in human or mouse models of myocarditis. To assess 
the effect of VDR deficiency (-/-) on murine CVB3 myocarditis, VDR+/+ and VDR-/- 
littermates were provided a calcium supplemented diet from birth to prevent the development 
of cardiac dysfunction associated with rickets that would occur in knockout mice (Li 1997, 
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Chen 2011). Calcium supplementation continued throughout the experiment. 8-10 week old 
mice received CVB3 ip on day 0 and myocarditis was assessed histologically at day 10 pi, 
during acute myocarditis, as depicted in representative photos in Figure 3A. We found that 
VDR-/- females had significantly increased (p=2x10-8) while VDR-/- males had significantly 
reduced (p=0.03) myocarditis at day 10 pi compared to WT VDR+/+ mice (Fig 3B). These 
results demonstrate that VDR signaling decreases myocarditis in female mice but increases 
inflammation in males. 
 
 
Figure 3. VDR deficiency increases myocarditis in females but decreases disease in males. 
Female (F) and male (M) WT+/+ and VDR-/- mice supplemented with calcium feed to prevent 
rickets from birth and injected with CVB3 ip on day 0 and myocarditis assessed at day 10 pi. A) 
Representative H&E photos of myocarditis, magnification x100. B) Average inflammation (i.e., 
myocarditis) assessed histologically showing the mean +/-SEM using a 2-tailed Mann-Whitney rank 
sum test, n=10-35/ group. 
 
VDR deficiency does not alter viral replication in the heart 
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Because VitD/ VDR signaling is known to promote antimicrobial innate immune 
responses (Wang 2004, Wang 2010, Bikle 2011, Hewison 2011, Verway 2013, Tulk 2015) 
and to decrease certain viral infections like hepatitis C virus and HIV (Yano 2007, Campbell 
2011), we examined whether VDR deficiency altered CVB3 replication in the heart during 
acute myocarditis. We found that VDR deficiency had no significant effect on viral 
replication in the heart during CVB3 myocarditis at day 10 pi (females: WT 2.5x10-4±1.4x10-
4, VDR-/- 2.7x10-3±1.5x10-3 PFU/g heart, p=0.13; males: WT 7.3x10-2, VDR-/- 4.9x10-
2 PFU/g heart, p=0.64; n=7-12/group). Thus, increased myocarditis in VDR-/- females was 
not due to increased viral replication. 
 
VDR deficiency increases T cells in females 
The VDR is known to be expressed on T and B cells, macrophages, mast cells, 
natural killer (NK) cells and Treg (Fairweather 2015, Toniato 2015). During CVB3 
myocarditis male BALB/c mice have significantly higher cardiac inflammation consisting of 
CD11b+ immune cells including neutrophils, macrophages, and mast cells and mount a 
dominant Th1-type immune response, whereas females have higher B cells, T cells, Treg and 
mount a Th2-type immune response (Huber 2005, Frisancho-Kiss 2007, Frisancho-Kiss 
2009, Roberts 2013, Fairweather 2014). In this study, the expression of markers for immune 
cells from whole hearts were assessed in WT+/+ and VDR-/- mice by qRT-PCR during acute 
myocarditis. VDR-/- females had significantly increased CD45 (p=0.02), CD3 (p=0.04), CD4 
(p=0.04), and CD8 (p=0.04) compared to control females (Fig 4A), suggesting increased 
levels of T cells. VDR-/- males had increased Foxp3 (Treg) (p=0.04) and decreased cKit 
(market for mast cells and/or stem cells) (p=0.04) compared to control males (Fig 4B). We 
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also tested CD11b, CD14, GR1 and F4/80 expression levels and found no significant 
differences between VDR-/- and WT mice for either sex (data not shown). Both the increase 
in CD45 and T cell markers in VDR-/- females and the increase in the Treg marker FoxP3 
and decrease in mast cell marker cKit in males are consistent with the histology findings (Fig 
3). 
 
Figure 4. T cell markers increase in VDR deficient female hearts during myocarditis, Treg 
markers increase in males. A) Female (F) and B) male (M) WT (+/+) or VDR-/- mice were infected 
ip with CVB3 on day 0 and mRNA expression of immune cells examined in whole hearts at day 10 pi 
by qRT-PCR. Data show the mean +/-SEM relative gene expression (RGE) compared to Hprt by a 2-
tailed Mann-Whitney rank sum test, n=7-10/group. 
 
VDR deficiency increases IFNγ and IL-17 in females and IL-4 in males 
VitD/ VDR signaling has been shown to increase Th2-type immune responses and 
Treg while decreasing Th1 and Th17 responses (Adorini 2008, Bruce 2010, Bikle 2011, 
Hewison 2011, Toniato 2015, Fairweather 2015). For this reason we examined IL-4, IFNγ, 
and IL-17 (IL-17A) levels in the heart of VDR +/+ and -/- mice with CVB3 myocarditis by 
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ELISA as an indicator of Th responses. We found that VDR-/- females had significantly 
increased IFN-γ (p=0.005) and IL-17 (p= 0.03) compared to control females (Fig 5A). In 
males, VDR-/- significantly decreased IFNγ (p=0.03) but increased IL-4 and IL-17 (p=0.04 
and p=0.0002, respectively) compared to control males (Fig 5B). These results are consistent 
with the reported effects of VitD/ VDR for females but not for males because VitD is 
assumed to be protective for both women and men. These data demonstrate that sex 
differences exist in the effect of VDR on the immune response during viral myocarditis. 
 
Figure 5. VDR deficiency increases cardiac IFNγ and IL-17 in female, but IL-4 and IL-17 in 
male hearts during CVB3 myocarditis. A) Female (F) and B) male (M) WT (+/+) or VDR-/- mice 
were infected ip with CVB3 at day 0 and cytokine levels representative of Th1 (IFNγ), Th2 (IL-4) and 
Th17 (IL-17) immune responses assessed in homogenized heart supernatants by ELISA at day 10 pi. 
Data show the mean +/-SEM pg/g of heart using a 2-tailed Mann-Whitney rank sum test, n=22-
45/group. 
 
VDR deficiency increases M1 macrophages in females and M2 in males 
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Classically activated M1 macrophages are driven by IFNs/Th1 responses and are 
increased in males during CVB3 myocarditis, while alternatively activated M2 macrophages 
are anti-inflammatory and are elevated in females with myocarditis (Li 2009, Fairweather 
2009, Abston 2012A, Abston 2013). Markers of M2 macrophages include arginase-1 and 
Ym1 (eosinophilic protein from chitinase family) and M1 markers include the IFN-
associated chemokines Cxcl9 and Cxcl10 (Fairweather 2009). Here we found that VDR-/- 
females had higher levels of M1 macrophage markers Cxcl9 (p=0.04) and Cxcl10 (p=0.04) 
compared to WT females (Fig 6A), whereas VDR-/- males had higher anti-inflammatory M2 
macrophage markers arginase-1 (p=0.03) and Ym1 (p=0.03) compared to WT males (Fig 
6B). Thus, VDR signaling increases M2 macrophages in females and M1 macrophages in 
males, which is consistent with the sex differences we observed in the shift of Th1/Th2-type 
cytokines mediated by VDR during myocarditis (Fig 5). 
 
Figure 6. VDR deficiency increases cardiac M1 macrophages in females and alternatively 
activated M2 macrophages in males during myocarditis. A) Female (F) and B) male (M) WT 
(+/+) or VDR-/- mice were infected with CVB3 on day 0 and markers of M1 (Cxcl9, Cxcl10) vs. M2 
(Arg1, Ym1) macrophages examined in whole hearts at day 10 pi by qRT-PCR. Data show the mean 
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+/-SEM of relative gene expression (RGE) compared to HPRT using a 2-tailed Mann-Whitney rank 
sum test, n=6-10/ group. 
 
VDR deficiency activates TLR4/IL1R/capase-1/IL-1β pathway in females 
We showed previously that components of IL-1R signaling including TLR4, caspase-
1 and the inflammasome (i.e., TLR4, IL-1R, caspase-1, IL-1β and IL-18) are upregulated by 
testosterone during CVB3 myocarditis in male mice leading to more severe inflammation and 
DCM in males (Huber 2005, Frisancho-Kiss 2007, Frisancho-Kiss 2009, Coronado 2012, 
Roberts 2013, Fairweather 2015). In this study we found that VDR-/- females had 
significantly increased expression of TLR2 (p=0.02), TLR4 (p=0.03), caspase-1 (p=0.03) and 
IL-1R2 (p=0.03) by qRT-PCR, and increased active IL-1β (p=0.02) by ELISA compared to 
WT females (Fig 7A). In contrast, VDR-/- males had significantly decreased levels of IL-1β 
(p=0.02) compared to WT males (Fig 7B). These data indicate that VDR deficiency is 
driving females to a more “male-like” innate inflammatory profile during myocarditis. The 
decrease in IL-1β in males suggests that VDR increases this proinflammatory and profibrotic 
cytokine in males. Although we did not observe a change in TLR4 or caspase-1 in VDR-/- 
males compared to WT males, these components are required to produce active IL-1β and so 
must have been decreased earlier in the disease process. In future studies, earlier timepoints 




Figure 7. VDR deficiency increases cardiac TLR2/TLR4/IL-1R2/caspase/IL-1β pathway 
expression in females. A) Female (F) and B) male (M) WT (+/+) or VDR-/- mice were infected ip 
with CVB3 on day 0 and TLR2, TLR4, caspase-1 (casp1), IL-1R2 assessed by qRT-PCR and IL-1β 
by ELISA at day 10 pi. Data show the mean +/-SEM of relative gene expression (RGE) compared to 
Hprt for qRT-PCR (n=7-10/ group) or pg/g for ELISA using a 2-tailed Mann-Whitney rank sum test 
(n=22-45/ group). 
 
VDR deficiency leads to hypertrophy and cardiac dysfunction during chronic myocarditis 
in males 
 VDR deficiency significantly decreased myocarditis in male mice (Fig 3), suggesting 
that VitD/ VDR increases myocarditis in males. In order to determine whether VDR altered 
the chronic phase of CVB3 myocarditis and DCM, we infected WT, VDR+/-, and VDR-/- 
male mice with CVB3 at day 0 and assessed myocarditis and DCM at day 35 pi. We were 
surprised to find that all of the VDR-/- mice died by day 32 pi, prior to assessment of heart 
function by echocardiography (Fig 8). We were not expecting this outcome because VDR-/- 
male mice had less acute CVB3 myocarditis, otherwise we would have performed 
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echocardiography at an earlier timepoint on these mice, as it is a non-invasive procedure. 
This will be done in future experiments. 
In contrast, only one WT (VDR+/+) male mouse died during this time course (Fig 8). 
The surviving mice (VDR+/+ and VDR+/-) were then assessed at day 35 pi, during chronic 
myocarditis, by echocardiography to determine cardiac function (Fig 9A). VDR+/- mice had 
significantly increased hypertrophy as determined by increased left ventricular mass and 
relative wall thickness (RWT) (Fig 9B&D). Cardiac function was determined by the %FS 
and we found that the VDR+/- males had significantly lower %FS and decreased cardiac 
function (Fig 9C). It is possible that the deaths in the VDR-/- group were due to DCM and/or 
heart failure, but that will need to be assessed in future experiments. If VDR-/- mice 
developed DCM, the result would likely be due to the shift in VDR-/- male mice to a 
Th2/M2-type immune response which the Fairweather lab has shown leads to DCM and 
heart failure following myocarditis (Abston 2012A, Abston 2012B, Abston 2013). 
 
Figure 8. VDR deficiency leads to death in males during chronic myocarditis. Male WT 
(VDR+/+), heterozygote (VDR+/-) or VDR-/- mice were infected ip with CVB3 on day 0 and 
survival was tracked until day 35 pi when echocardiography was performed on surviving mice. 




Figure 9. VDR+/- leads to hypertrophy and cardiac dysfunction in male mice with chronic 
CVB3 myocarditis. Male WT (VDR+/+), heterozygote (VDR+/-), and VDR -/- were infected ip with 
CVB3 on day 0 and echocardiography performed on day 35 pi on surviving mice. A) Short axis M-
mode of LV in VDR+/+ and VDR+/- mice. Measurements taken from the echocardiogram included 
B) LV mass to assess hypertrophy, C) fractional shortening (%FS) to assess cardiac function, and D) 
relative wall thickness (RWT) to assess hypertrophy. Data show the mean +/-SEM comparing WT 
and VDR+/- groups using a 2-tailed Mann-Whitney rank sum test, n=5/ group. 
 
VDR levels correlate to ejection fraction in sex specific manner in myocarditis patients 
McNamara et al showed in 2011 that mainly men with myocarditis progress to DCM 
and heart failure (McNamara 2011). Based on our finding that VDR signaling appeared to 
increase myocarditis in males (Fig 3), we decided to examine whether a relationship existed 
between serum VitD levels in myocarditis patients and their %EF, as a marker of heart 
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McNamara 2011). The most common type of myocarditis found in the US is termed 
lymphocytic myocarditis (LM) (Cooper 2009A). Giant cell myocarditis (GCM) is a rare type 
of myocarditis that involves eosinophilic infiltration and the formation of macrophage 
accumulations called giant cells and typically rapidly progresses to dilation and heart failure 
(Cooper 2008, Cooper 2012). In this small pilot study, we were able to examine both of these 
myocarditis populations in collaboration with Dr. Leslie Cooper at Mayo Clinic. 
In this pilot study, we examined serum VitD levels in a small number of lymphocytic 
myocarditis patients (n=16). We found that most patients had sufficient VitD levels (>20 
ng/mL) (Fig 10A), and there was no relationship between sera VitD levels and poor cardiac 
function assessed as %EF when data from men and women were combined (Fig 10B). 
However, similar to the animal model, analysis by sex revealed that low VitD levels 
correlated with low/worse %EF in women with myocarditis, while higher VitD levels 
correlated with lower/worse %EF in men (Fig 11). This data, in a small sample of patients, 
suggest that few myocarditis patients have deficient levels of VitD and that there is no 
relationship to VitD and %EF. However, analysis by sex, shown in Fig11, below, reveals a 
different relationship between men and women. 
  
Figure 10. VitD levels in men and women with lymphocytic myocarditis in relation to cardiac 
function, in a small preliminary study. A) Percentage of men and women lymphocytic myocarditis 
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(LM) patients (same type of myocarditis as CVB3 mouse model) with deficient (<12 ng/mL), 
inadequate (Inadeq, 12-19 ng/mL), mildly deficient (Mild Def, 20-30 ng/mL), sufficient (30-50 
ng/mL) or potentially harmful (50+ ng/mL) VitD levels in their sera assessed using LC-MS/MS 
(n=16). VitD category definitions based on the Institute of Medicine recommendations and the 
literature of commonly used categories (LaVie 2011, Ross 2011). B) Comparison of cardiac function 
based on %EF vs. serum VitD levels in myocarditis patients (R2, 0.0266, n=16). Correlation between 
x and y values was calculated by liner regression and shown as R squared (R2) values. R is defined as 
the correlation coefficient (R2 values closer to 1 indicate high correlation between values)  
 
Figure 11. Correlation of VitD levels with cardiac function in LM patients according to sex. 
Because VitD is a sex steroid, VitD relationships should be analyzed according to sex. This type of 
analysis of the data in Fig 10 reveals that worse cardiac function assessed as % ejection fraction 
(%EF) is associated with A) higher VitD levels in males (r2=0.81, n=6) and B&C) lower VitD levels 
in women (r2=0.54, n=10) with myocarditis. C) The correlation still exists in women if the lowest 
VitD level is removed (r2=0.43) or the top value in removed (i.e., %EF 62, r2=0.55, data not shown). 
Correlation between x and y values was calculated by liner regression and shown as R squared (R2) 
values. R is defined as the correlation coefficient (R2 values closer to 1 indicate high correlation 
between values). 
When we examined a small number of GCM patients, we found that the majority of 
patients (75%) with GCM had low sera VitD levels (<20 ng/mL) when examining both sexes 
combined (Fig 12A). When the patient originally presented to the physician (when they were 
diagnosed and entered the study) we have termed “baseline”, and sera from later dates (from 
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one month to two years after intial diagnosis) with the same patient after they received 
treatment for myocarditis/ heart failure is termed “treatment”. We found no significant 
difference in sera VitD levels between men and women with myocarditis at Baseline (Fig 
12B). However, we did find a significant difference in VitD levels in men and women with 
GCM after treatment (p=0.04) (Fig 12B). Since GCM has been found to be responsive to 
immunosuppressive treatments, these data suggest that VitD is playing a role in the 
inflammatory process in GCM in a sex-specific manner. These data, in a small sample of 
patients, suggest that low VitD is associated with GCM regardless of sex, and that women 
respond better than men to immunosuppressive treatment. The limitations of this study 
include the small numbers per group, all women in the study are post menopausal, and there 
is a wide range of follow-up dates for the patients in the “treatment” group. 
 
Figure 12. VitD levels in men and women with giant cell myocarditis before and after treatment 
in a small preliminary study. A) Percentage of men (M) and women (W) giant cell myocarditis 
(GCM) patients with deficient (<12ng/mL), inadequate (Inadeq, 12-19ng/mL), mildly deficient (Mild 
Def, 20-30ng/mL), sufficient (30-50ng/mL) or potentially harmful (50+ng/mL) VitD levels in their 
sera (n=16). Definitions based on (LaVie 2011, Ross 2011). B) Comparison of serum VitD levels in 
GCM (n=24) at time of diagnosis (Baseline) and after receiving treatment. Data show the mean +/-





In this study we demonstrate that VDR signaling is important in driving sex 
differences in inflammation during CVB3 myocarditis in mice, with VDR protecting females 
and exacerbating disease in males. Using ovariectomy and hormone replacement we show 
that estrogen increases VDR expression in the heart of females, which may explain why WT 
females have more VDR expression in the heart than males prior to infection. This suggests 
that estrogen may be increasing VDR expression on cardiac resident cells rather than 
inflammatory cells. In contrast, increased expression of VDR in males with myocarditis 
suggests that VDR expression may be increased primarily in/on immune cells. Another 
possible explanation for the sex difference in VDR expression in the heart could be that male 
and female mice with myocarditis have different cell infiltrates with differing VDR 
expression. Males are likely to express VDR more on macropahges and mast cells, which are 
a greater proportion of the infiltrate in males with myocarditis (Frisancho-Kiss 2007). We did 
not find that testosterone increased VDR expression in the heart, but the analysis included the 
whole heart and we have found previously that testosterone only increased gene expression 
in CD11b+ immune cells rather than the whole heart (Fairweather 2014). Future studies will 
need to examine the effect of testosterone on gene expression by qRT-PCR using cells 
isolated from the heart or by flow cytometric analysis. 
Interestingly, ERα, which is known to increase VDR expression, was significantly 
elevated in males with CVB3 myocarditis compared to control males (p=0.02, Supplemental 
Table 1), but not in females during myocarditis (Supplemental Table 2). Thus, ERα-
mediated signaling may increase VDR expression during myocarditis in males, where 
estrogen acts as a growth/ survival factor for cardiac tissues (Buskiewicz 2015). Additionally, 
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the decrease in IL-1β in VDR-/- males indicates that VDR signaling increases this 
proinflammatory and profibrotic cytokine in males with myocarditis. Although we did not 
see a change in TLR4 and caspase-1 pathway expression in VDR-/- males with myocarditis 
compared to controls, these components are required for active IL-1β production and so must 
have been altered at an earlier timepoint. This will need to be confirmed in future 
experiments. These data suggest that VDR signaling contributes to elevated TLR4, caspase-1 
and IL-1β in males with myocarditis. 
Males may use VDR signaling in mast cells and macrophages as a strategy to 
eliminate CVB3 infection. Many studies have shown that VDR signaling activates innate 
immune pathways including the inflammasome to prevent viral and bacterial infections 
(Wang 2004, Liu 2009, Bikle 2011, Gambhir 2011, Hewison 2011, Lee 2011, Verway 2013, 
Wang 2010, Tulk 2015). Although in this context VDR signaling would be effective at 
eliminating CVB3 infection, it could also have the negative side effect of activating TLR2 
and/or TLR4 and the inflammasome on/in mast cells, macrophages and cardiomyocytes. We 
showed previously that male BALB/c mice with CVB3 myocarditis have more mast cells and 
macrophages in the spleen and heart during the innate immune response and during acute 
myocarditis, respectively, as well as higher expression of TLR4 and other inflammasome-
related genes (i.e., caspase-1, IL-1β, IL-18, IFNγ) than females (Fairweather 2003, 
Frisancho-Kiss 2007, Onyimba 2011, Coronado 2012, Fairweather 2014). We also 
previously demonstrated that testosterone increases an TLR4-mediated Th1-type immune 
response and this immunophenotype predisposes males to progress to DCM later (Frisancho-
Kiss 2006B, Frisancho-Kiss 2009, Onyimba 2011, Coronado 2012, Fairweather 2014). 
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In contrast, females may use cytotoxic CD8 T cells, NK and/or natural killer T cells 
(NKT) cells instead of VDR signaling to eliminate CVB3, possibly via ERα signaling which 
is known to induce T, NK and NKT cell proliferation. Estrogen/ERα and VDR signaling are 
known to work together to increase T cell number and activation and to drive IL-4/Th2 and 
Treg responses- an immune environment that would not be effective at clearing virus 
(Buskiewicz 2015, Cantorna 2015, Hayes 2015, Piantoni 2015, Spanier 2015). Thus, 
activation of CD8+ T cells and/or NKT cells could be an effective viral control mechanism 
for females. Interestingly, VDR deficient females with myocarditis had significantly 
increased expression of T cell markers as well as the classic “male-type” immune profile 
with activation of TLR2/TLR4/IL-1R, caspase-1, and IL-1β, indicating that VDR signaling 
in females inhibits this pathway. Anti-viral strategies used by males and females appear to be 
sufficient, because there was no significant difference in cardiac viral replication according 
to sex during myocarditis. 
Many studies report that VitD and/or VDR signialing increase IL-4/Th2 and Treg 
responses while inhibiting IFNγ/Th1 and IL-17/Th17 responses (Bikle 2011, Lisse 2011, 
Buskiewicz 2015, Cantorna 2015, Hayes 2015, Piantoni 2015, Spanier 2015, Toniato 2015, 
Trochoutsou 2015). However, most manuscripts and reviews of VitD/VDR effects on the 
immune response do not analyze or describe data by sex. Our data show that VDR signaling 
inhibits IFNγ/Th1/M1 and IL-17/Th17 responses only in female mice with CVB3 
myocarditis. Based on the published literature and our findings here, VDR signaling could be 
responsible with testosterone for increasing TLR2, TLR4/IL-1R/caspase-1/IL-1β, 
IFNγ/Th1/M1, and IL-17A/Th17 proinflammatory responses in males. Our data suggest that 
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activation of [TLR4/caspase-1/]IL-1β, IFNγ/M1 macropahges, and mast cells (cKit) by VDR 
signaling in response to CVB3 infection elevates myocarditis in males. 
There are a few scattered reports in the literature that suggest that sex differences in 
the inflammatory response to VitD and/or VDR exist. A small study compared healthy 
volunteer men and women and found that after two oral fat-loading tests VitD treatment 
reduced CD11b+ cells only in women (Klop 2014). In a separate study, women with low 
VitD levels were found to have more colorectal adenomas and women on VitD 
supplementation had lower numbers of adenomas, but this inverse association of VitD with 
adenoma number was not observed for men (Aigner 2014). A study in mice found that UVB 
radiation increased VitD levels in the skin of female, but not male mice (Xue 2015). This was 
found to be due to androgen receptor signaling, which lowered 7-dehydrocholesterol levels in 
the skin of males (Xue 2015). Two recent studies reported that women with low VitD levels 
were at an increased risk for myocardial infarction and this relationship was not observed for 
men (Karakas 2013, Verdoia 2015). Unfortunately, most animal and human studies of 
VitD/VDR do not study whether a sex difference in VitD levels and effects exist. 
Considering that all major CVDs are known to manifest sex differences in incidence, 
diagnosis, disease severity and/or progression combined with the epidemiologic data 
showing an increased risk for CVD based on VitD status, it is critically important to 
reanalyze past data and all future studies should specifically determine male and female 
responses. Adjusting for sex often prevents sex differences that exist in the data from being 
apparent. Our data in mice and the small study in patients suggest that women with low VitD 
levels may be at an increased risk of developing viral myocarditis, and that VDR activation 
in men could make disease more severe. Further studies with higher numbers are needed to 
87 
 
determine whether sex differences in VitD/VDR levels exist in myocarditis patients. 
Analyzing animal and human studies by sex will be critical to determine whether VitD 
supplementation or the use of VDR ligands (Crescioli 2014, Takada 2015) may benefit 





Supplementary Table 1. Vitamin D receptor response element (VDRE) gene changes 
during CVB3 myocarditis in the heart of males compared to undiseased males 





VDRE genes upregulated during myocarditis in males 
NM_008331 Ifit1 Interferon-induced protein with 
tetratricopeptide repeats 1 
6.20 0.0002 
NM_010501 Ifit3 Interferon-induced protein with 
tetratricopeptide repeats 3 
5.99 0.0004 
NM_021893 Cd274 CD274/ PD-L1 4.24 0.003 
NM_008332 Ifit2 Interferon-induced protein with 
tetratricopeptide repeats 2 
3.57 0.002 
NM_010728 Lox Lysyl oxidase 3.38 0.003 
NM_009019 Rag1 Recombination activating gene 1 3.03 0.04 
NM_172435 P2ry10 Purinergic receptor P2Y,G-protein 
coupled10 
2.94 0.002 
NM_021384 Rsad2 Radical S-adenosyl methionine domain 
containing 2 
2.52 0.0008 
NM_007609 Casp4 Caspase 4 2.48 0.0007 
NM_007498 Atf3 Activating transcription factor 3 2.37 0.05 
NM_001081211 Ptafr Platelet-activating factor receptor 2.29 0.002 
NM_009807 Casp1 Caspase 1 (interleukin 1beta convertase) 2.17 0.006 
NM_0111898 Ptgs2 Prostaglandin-endoperoxide synthase 2 2.16 0.02 
89 
 
NM_009367 Tgfb2 Transforming growth factor, beta 2 2.11 0.03 
NM_001127348 Snx10 Sorting nexin 10 2.10 0.002 
NM_009256 Serpinb9 Serine (or cysteine) proteinase inhibitor, 
clade B (ovalbumin), member 9 
1.90 0.009 
NM_001111021 Runx1 Runt-related transcription factor 1 1.90 0.01 
NM_001033135 Rnf149 Ring finger protein 149 1.86 0.005 
NM_00117646 Sirpa Signal-regulatory protein alpha/ SHP-1 1.85 0.006 
NM_001159394 Nfkbiz Nuclear factor of kappa light polypeptide 
gene enhancer in B-cells inhibitor, zeta 
1.85 0.01 
NM_010496 Id2 Inhibitor of DNA binding 2, dominant 
negative helix-loop-helix protein 
1.81 0.001 
NM_029023 Scpep1 Serine carboxypeptidase 1 1.80 0.002 
NM_133662 Ier3 Immediate early response 3 1.78 0.01 
NM_011932 Dapp1 Dual adaptor of phosphotyrosine and 3-
phosphoinositides 
1.77 0.008 
NM_013589 Ltbp2 Latent transforming growth factor beta 
binding protein 2 
1.76 0.03 
NM_010720 Lipg Lipase 1.74 0.006 
NM_015759 Fgd3 FGD1 family, member 3 1.73 0.01 
NM_030710 Slamf6 Kallmann syndrome 1 sequence 1.72 0.004 
NM_008062 G6pdx Glucose-6-phosphate dehydrogenase x-
linked 
1.71 0.004 
NM_022019 Dusp10 Dual specificity phosphatase 10 1.70 0.006 
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NM_019388 Cd86 CD86 antigen (B7-2 antigen) 1.68 0.04 
NM_009655 Alcam Activated leukocyte cell adhesion 
molecule 
1.68 0.0007 
NM_008390 Irf1 Interferon regulatory factor 1 1.67 0.009 
NM_011201 Ptpn1 Protein tyrosine phosphatase, non-
receptor 1 
1.66 0.008 
NM_019494 Cxcl11 Chemokine (C-X-C motif) ligand 11 1.66 0.04 
NM_007742 Col1a1 Collagen, type I, alpha 1 1.66 0.02 
NM_001136079 Ptger4 Prostaglandin E receptor 4 (subtype EP4) 1.65 0.002 
NM_134164 Syt12 Synaptotagmin XII 1.64 0.009 
NM_001163540 Plec1 Plectin 1 1.64 0.002 
NM_007730 Col12a1 Collagen, type XII, alpha 1 1.63 0.02 
NM_001111096 Lyn V-yes-1 Yamaguchi sarcoma viral related 
oncogene homolog 
1.62 0.02 
NM_009264 Sprr1a Small proline-rich protein 1A 1.60 0.0009 
NM_027677 Gpr39 G protein-coupled receptor 39 1.59 0.008 
NM_001009947 Dock11 Dedicator of cytokinesis 11 1.58 0.01 
NM_001145960 Slc37a2 Solute carrier family 37 (glycerol-3-
phosphate transporter), member 2 
1.57 0.02 
NM_009841 Cd14 CD14 antigen 1.55 0.04 
NM_016911 Srpx Sushi-repeat-containing protein, X-linked 1.53 0.009 
NM_008494 Lfng Lunatic fringe homolog 1.53 0.003 
NM_181402 Parp11 Poly (ADP-ribose) polymerase family 11 1.51 0.02 
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NM_001037717 Slc38a6 Solute carrier family 38, member 6 1.49 0.001 
NM_031167 Il1rn Interleukin 1 receptor antagonist 1.47 0.02 
NM_010658 Mafb V-maf musculoaponeurotic fibrosarcoma 
oncogene homolog B 
1.47 0.02 
NM_001198914 Myb V-myb myeloblastosis viral oncogene 
homolog 
1.46 0.03 
NM_175188 March Membrane-associated RING-CH protein 
I 
1.42 0.02 





Serine (or cysteine) proteinase inhibitor, 
clade B (ovalbumin), member 1 
1.42 0.02 
NM_053109 Clec2d C-type lectin superfamily 2, member D 1.41 0.002 
NM_008047 Fstl1 Follistatin-like 1 1.41 0.03 
NM_028421 Zc3hav1 Zinc finger CCCH type, antiviral 1 1.39 0.02 
NM_007464 Birc3 Baculoviral IAP repeat-containing 3 1.39 0.02 
NM_001135727 Sh3kbp1 SH3-domain kinase binding protein 1 1.37 0.002 
NM_013650 S100a8 S100 calcium binding protein A8 1.37 0.04 
NM_009255 Serpine2 Serine (or cysteine) proteinase inhibitor, 
clade E (nexin, plasminogen activator 
inhibitor type 1), member 2 
1.36 0.03 
NM_009302 Swap70 SWAP-70 protein 1.36 0.004 
NM_013673 Sp100 Nuclear antigen Sp100 1.36 0.03 
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NM_153139 Slc36a1 Solute carrier family 36 (proton/amino 
acid symporter), member 1 
1.33 0.01 
NM_011479 Sptlc2 Serine palmitoyltransferase, subunit 2 1.33 0.02 
NM_001080813 Rab11fi
p1 
RAB11 family interacting protein 1 (class 
I) 
1.33 0.03 
NM_173370 Cds1 CDP-diacylglycerol synthase 1 1.33 0.01 
NM_007746 Map3k8 Mitogen-activated protein 3x-kinase 8 1.32 0.04 
NM_010941 Nsdhl NAD(P)-dep steroid dehydrogenase-like 1.31 0.001 
NM_001008700 Il4ra Interleukin 4 receptor alpha 1.30 0.09 
NM_138952 Ripk2 receptor-interacting serine-threonine 
kinase 2 
1.30 0.002 
NM_172779 Ddx26b DEAD/H box polypeptide 26B 1.29 0.004 
NM_026678 Blvra Biliverdin reductase A 1.28 0.02 
NM_001037177 Nfatc2 Nuclear factor of activated T-cells 2 1.27 0.01 
NM_009114 S100a9 S100 calcium binding protein A9 1.26 0.04 
NM_001081011 Srgap2 SLIT-ROBO Rho GTPase activating 
protein 2 
1.26 0.01 
NM_001080548 Usp6nl USP6 N-terminal like 1.25 0.04 
NM_013454 Abca1 ATP-binding cassette, sub-family A 
(ABC1) 
1.24 0.02 
NM_010809 Mmp3 Matrix metalloproteinase 3 1.24 0.01 
NM_007956 Esr1 Estrogen receptor 1 1.24 0.02 
NM_024239 Stambp STAM binding protein 1.24 0.005 
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NM_011200 Ptp4a1 Protein tyrosine phosphatase type IVA, 1 1.24 0.006 
NM_007658 Cdc25a Cell division cycle 25A 1.24 0.004 
NM_172702 Serinc2 Tumor differentially expressed 2-like 1.22 0.03 
NM_026281 Tm7sf3 Transmembrane 7 superfamily member 3 1.21 0.003 
NM_028523 Dcbld2 Discoidin, CUB and LCCL domain 
containing 
1.21 0.04 
NM_008179 Gspt2 G1 to S phase transition 2 1.19 0.03 
NM_018886 Lgals8 Galectin 8 1.18 0.03 
NM_001042513 Txnrd1 Thioredoxin reductase 1 1.18 0.02 
NM_001164604 Nsmce2 Breast cancer membrane protein 101 1.17 0.04 
NM_009504 Vdr Vitamin D receptor 1.16 0.04 
NM_177586 Eif5a2 Eukaryotic translation initiation factor 
5A2 
1.16 0.02 
NM_172288 Nup133 Nucleoporin 133kDa 1.15 0.03 
NM_011897 Spry2 Sprouty homolog 2 1.15 0.03 
NM_133838 Ehd4 EH-domain containing 4 1.13 0.04 
NM_024195 Cyb5r4 NADPH cytochrome B5 oxidoreductase 1.12 0.01 
 
VDRE genes downregulated during myocarditis in males 
NM_001081276 Clasp1 Cytoplasmic linker associated protein 1 -1.59 1.7E-5 
NM_022982 Rtn4r Reticulon 4 receptor -1.56 0.04 
NM_14926 Sez6l2 Seizure related 6 homolog-like 2 -1.52 0.002 
NM_026346 Fbxo32 F-box protein 32 -1.49 0.03 
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NM_008882 Plxna2 Plexin A2 -1.49 0.0009 
NM_133754 Fblim1 Filamin-binding LIM protein-1 -1.46 0.004 
NM_017391 Slc5a3 Solute carrier family 5, member 3 -1.44 0.009 
NM_026880 Pink1 PTEN-induced putative kinase 1 -1.42 0.002 
NM_007382 Acadm Acyl-coenzyme A dehydrogenase -1.42 0.004 
NM_007425 Ager Renal tumor antigen/ RAGE -1.41 0.004 
NM_001170978 Abat 4-aminobutyrate aminotransferase -1.41 0.01 
NM_008650 Mut Methylmalonyl coenzyme A mutase -1.40 0.01 
NM_021715 Chst7 Carbohydrate sulfotransferase 7 -1.40 0.004 
NM_001122759 Pde7a Phosphodiesterase 7A -1.39 0.01 
NM_007416 Adra1b Adrenergic receptor alpha-1b -1.38 0.02 
NM_001013777 Zfp488 Zinc finger protein 488 -1.37 0.03 
NM_007445 Amh Anti-Mullerian hormone -1.36 4.0E-5 
NM_007731 Col13a1 Collagen, type XIII, alpha 1 -1.36 0.009 
NM_001040682 Clmn Calmin (calponin-like, transmembrane) -1.35 0.04 
NM_010637 Klf4 Kruppel-like factor 4 (gut) -1.35 0.0002 
NM_031185 Akap12 A kinase (PRKA) anchor protein 12 -1.35 0.007 
NM_001243132 Tspan2 Tetraspan 2 -1.34 0.01 
NM_172532 Aldh5a1 Aldehyde dehydrogenase 5 family, A1 -1.34 0.004 
NM_175443 Etnk2 Ethanolamine kinase 2 -1.33 0.001 
NM_010097 Sparcl1 SPARC-like 1 (mast9, hevin) -1.32 0.0001 
NM_172420 Ppp1r1c Protein phosphatase 1, regulatory 1C -1.32 0.005 
NM_001025250 Vegfa Vascular endothelial growth factor -1.31 0.04 
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NM_001103177 Ablim1 Actin binding LIM protein 1 -1.31 4.9E-5 
NM_138956 Rassf3 Ras association domain family 3 -1.30 0.0006 
NM_001164572 Snrk SNF-1 related kinase -1.30 0.02 
NM_025862 Acad8 Acyl-coenzyme A dehydrogenase 8 -1.30 0.003 
NM_019739 Foxo1 Forkhead box O1A -1.29 0.04 
NM_001081977 Rnf144a Ring finger protein 144 -1.29 0.01 
NM_008984 Ptprm Protein tyrosine phosphatase, M -1.29 0.02 
NM_010111 Efnb2 Ephrin-B2 -1.28 0.02 
NM_001039509 Pnkd Myofibrillogenesis regulator 1 -1.28 0.02 
NM_009662 Alox5 Arachidonate 5-lipoxygenase -1.28 0.04 
NM_026385 Pllp Plasmolipin -1.27 0.007 
NM_008090 Gata2 GATA binding protein 2 -1.27 0.01 
NM_029653 Dapk1 Death-associated protein kinase 1 -1.27 0.04 
NM_178357 Klf11 Kruppel-like factor 11 -1.26 0.04 
NM_001166506 Sec14l1 SEC14-like 1 -1.26 0.009 
NM_001252341 Syt1 Synaptotagmin I -1.26 0.01 
NM_010340  Gpr50 G protein-coupled receptor 50 -1.26 0.03 
NM_001164717 Sh3pxd2a SH3 multiple domains 1 -1.25 0.008 
NM_010778 Cd46 Membrane cofactor protein (CD46) -1.24 0.04 
NM_172671 Lgr4 Leucine-rich repeat-containing G 
protein-coupled receptor 4 
-1.24 0.04 
NM_001177849 Asph Aspartate beta-hydroxylase -1.24 8.9E-5 




NM_010570 Irs1 Insulin receptor substrate 1 -1.23 0.02 
NM_021883 Tmod1 Tropomodulin 1 -1.23 0.02 
NM_001077403 Nrp2 Neuropilin 2 -1.23 0.04 
NM_010588 Jag2 Jagged 2 -1.22 0.0004 
NM_012026 Rgnef Rho-guanine nucleotide exchange 
factor 
-1.22 0.02 
NM_010119 Ehd1 EH-domain containing 1 -1.22 0.04 
NM_019563 Cited4 Cbp/p300-interacting transactivator 4 -1.21 0.02 
NM_177839 Tnn Tenascin N -1.20 0.02 
NM_001163512 Rgs12 Regulator of G-protein signalling 12 -1.20 0.009 
NM_001008548 Pde2a Phosphodiesterase 2A, cGMP-
stimulated 
-1.20 0.04 
NM_011177 Klk6 Kallikrein 6 (neurosin, zyme) -1.20 0.008 
NM_053207 Egln1 Egl nine homolog 1 -1.19 0.003 
MN_001005863 Mtus1 Mitochondrial tumor suppressor 1 -1.19 0.04 
NM_207666 Dlk2 EGF-like-domain/ delta-like 2 homolog -1.19 0.04 
NM 030067 Gpr115 G protein-coupled receptor 115 -1.18 0.003 
NM_001111272 Stau2 Staufen, RNA binding protein, 
homolog 2 
-1.18 5.4E-5 
NM_027174 Col22a1 Collagen, type XXII, alpha 1 -1.17 0.04 





NM_001199151 Sncaip Synuclein, alpha interacting protein 
(synphilin) 
-1.17 0.03 
NM_001172424 Dhrs3 Dehydrogenase/reductase member 3 -1.17 0.04 
NM_152915 Dner Delta-notch-like EGF repeat-containing -1.17 0.04 
NM_008290 Hsd17b2 Hydroxysteroid (17-beta) 
dehydrogenase 2 
-1.16 0.03 
NM_008861 Pkd2 Polycystic kidney disease 2 -1.15 0.02 
NM_011170 Prnp Prion protein/ Creutzfeld-Jakob disease -1.14 0.01 
NM_172266 Lpgat1 Lysophosphatidylglycerol 
acyltransferase 1 
-1.14 0.002 
NM_001081960 Clasp2 Cytoplasmic linker associated protein 2 -1.13 0.04 
NM_001130109 Ptk2 PTK2 protein tyrosine kinase 2 -1.13 0.04 
NM_001029850 Magi1 Membrane associated guanylate kinase 
interacting protein-like 1 
-1.13 0.04 
NM_001001602 Dab2ip DAB2 interacting protein -1.12 0.04 
NM_029466 Arl5b ADP-ribosylation factor-like 8 -1.12 0.03 
NM_010434 Hipk3 Homeodomain interacting protein 
kinase 3 
-1.11 0.04 
NM_001146059 Als2cl ALS2 C-terminal like -1.11 0.04 
NM_001135559 Sos2 Son of sevenless homolog 2 -1.09 0.02 
NM_212433 Fbxo3 F-box protein 3 -1.08 0.04 
NM_009579 Slc30a1 Solute carrier family 30 (zinc 




NM_009303 Syngr1 Synaptogyrin 1 -1.07 0.01 
NM_010629 Kifap3 Kinesin-associated protein 3 -1.07 0.03 









Supplementary Table 2. Vitamin D receptor response element (VDRE) gene changes 
during CVB3 myocarditis in the heart of females compared to undiseased females 





VDRE genes upregulated during myocarditis in females 
NM_021893 Cd274 CD274/ programmed cell death 1 ligand 
1 (PD-L1) 
4.03 0.003 
NM_007609 Casp4 caspase 4, apoptosis-related cysteine 
protease 
2.16 0.002 
NM_021384 Rsad2 radical S-adenosyl methionine domain 
containing 2 
2.12 0.003 
NM_019494 Cxcl11 chemokine (C-X-C motif) ligand 11 2.03 0.01 
NM_001111021 Runx1 runt-related transcription factor 1 (acute 
myeloid leukemia 1; aml1 oncogene) 
1.91 0.01 
NM_172435 P2ry10 purinergic receptor P2Y, G-protein 
coupled10 
1.91 0.02 
NM_001081211 Ptafr platelet-activating factor receptor 1.82 0.01 
NM_001159394 Nfkbiz nuclear factor of kappa light polypeptide 
gene enhancer in B-cells inhibitor, zeta 
1.80 0.02 
NM_019388 Cd86 CD86 antigen (CD28 antigen ligand 2, 
B7-2 antigen) 
1.77 0.03 
NM_009807 Casp1 caspase 1, apoptosis-related cysteine 




NM_00117646 Sirpa signal-regulatory protein alpha/ SHP-1 1.64 0.02 
NM_009256 Serpinb9 serine (or cysteine) proteinase inhibitor, 
clade B (ovalbumin), member 9 
1.63 0.03 
NM_181402 Parp11 poly (ADP-ribose) polymerase family, 
member 11 
1.52 0.02 
NM_001033135 Rnf149 ring finger protein 149 1.50 0.03 
NM_001163540 Plec1 plectin 1, intermediate filament binding 
protein 500kDa 
1.50 0.006 
NM_001127348 Snx10 sorting nexin 10 1.49 0.04 
NM_029023 Scpep1 serine carboxypeptidase 1 1.43 0.02 
NM_013673 Sp100 Nuclear antigen Sp100 1.38 0.02 
NM_028421 Zc3hav1 zinc finger CCCH type, antiviral 1 1.35 0.03 
NM_001037717 Slc38a6 solute carrier family 38, member 6 1.26 0.03 
NM_001145920 Runx2 Runt-related transcription factor 2 1.21 0.01 
NM_001135727 Sh3kbp1 SH3-domain kinase binding protein 1 1.21 0.03 
NM_053109 Clec2d C-type lectin superfamily 2, member D 1.20 0.04 
NM_001079883 Bcl11b B-cell CLL/lymphoma 11B (zinc finger 
protein) 
1.21 0.04 
NM_011188 Psmc2 Proteasome (prosome, macropain) 26S 
subunit, ATPase, 2 
1.19 0.02 
NM_011374 St8sia1 ST8 alpha-N-acetyl-neuraminide alpha-
2,8-sialyltransferase 1 
1.19 0.0004 
NM_019689 Arid3b AT rich interactive domain 3B 1.12 0.02 
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VDRE genes downregulated during myocarditis in females 
NM_183216 Scd4 stearoyl-CoA desaturase 4 -2.16 0.009 
NM_001024955 Pik3r1 phosphoinositide-3-kinase, regulatory 
subunit  
-1.45 0.03 
NM_001170978 Abat 4-Aminobutyrate aminotransferase -1.41 0.01 
NM_026880 Pink1 PTEN induced putative kinase 1 -1.39 0.003 
 Dgat2 diacylglycerol O-acyltransferase homolog 
2 (mouse) 
-1.39 0.05 
NM_153587 Rps6ka5 ribosomal protein S6 kinase, 90kDa, 
polypeptide 5 
-1.39 0.02 
 Wnt5a wingless-type MMTV integration site 
family, member 5A 
-1.36 0.03 
NM_172532 Aldh5a1 aldehyde dehydrogenase 5 family, 
member A1 (succinate-semialdehyde 
dehydrogenase) 
-1.36 0.003 
NM_008650 Mut methylmalonyl Coenzyme A mutase -1.33 0.02 
NM_001008548 Pde2a phosphodiesterase 2A, cGMP-stimulated -1.30 0.01 
NM_001252341 Syt1 synaptotagmin I -1.28 0.006 
NM_008882 Plxna2 plexin A2 -1.28 0.01 
NM_017391 Slc5a3 solute carrier family 5 (inositol 
transporters), member 3 
-1.28 0.04 
NM_007382 Acadm acyl-Coenzyme A dehydrogenase, C-4 to 




NM_001122758 Pcdh7 BH-protocadherin (brain-heart) -1.28 0.002 
NM_007556 Bmp6 bone morphogenetic protein 6 -1.27 0.04 
 Tceal1 transcription elongation factor A (SII)-
like 1 
-1.27 0.01 
NM_023270 Rnf128 ring finger protein 128 -1.26 0.008 
NM_001146059 Als2cl ALS2 C-terminal like -1.26 0.001 
NM_009662 Alox5 arachidonate 5-lipoxygenase -1.25 0.05 
NM_001164034 Ntf3 neurotrophin 3 -1.24 0.04 
NM_001081146 Prickle2 prickle-like 2 (Drosophila) -1.22 0.01 
NM_021883 Tmod1 tropomodulin 1 -1.21 0.02 
NM_010119 Ehd1 EH-domain containing 1 -1.21 0.05 
 Ulk1 unc-51-like kinase 1 (C. elegans) -1.20 0.02 
NM_021439 Chst11 carbohydrate (chondroitin 4) 
sulfotransferase 1 
-1.20 0.02 
NM_025862 Acad8 acyl-Coenzyme A dehydrogenase family, 
member 8 
-1.20 0.02 
NM_013723 Podxl podocalyxin-like -1.19 0.02 
NM_018784 St3gal6 ST3 beta-galactoside alpha-2,3-
sialyltransferase 6 
-1.19 0.0001 
NM_008984 Ptprm protein tyrosine phosphatase, receptor 
type, M 
-1.18 0.08 
NM_011897 Spry2 sprouty homolog 2 (Drosophila) -1.18 0.01 
NM_001038621 Rabgap1l RAB GTPase activating protein 1-like -1.17 0.04 
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NM_138956 Rassf3 Ras association (RalGDS/AF-6) domain 
family 3 
-1.17 0.01 
NM_053207 Egln1 egl nine homolog 1 (C. elegans) -1.167 0.005 
NM_194344 Sh3tc1 SH3 domain and tetratricopeptide repeats 
1 
-1.17 0.006 
NM_001103177 Ablim1 actin binding LIM protein 1 -1.17 0.002 
NM_001001602 Dab2ip DAB2 interacting protein -1.15 0.02 
NM_011804 Creg1 cellular repressor of E1A-stimulated 
genes 1 (females) 
-1.15 0.02 
NM_001177849 Asph aspartate beta-hydroxylase (cardiac 
remodeling) 
-1.14 0.003 
NM_0.0179 Clip4 restin-like 2 -1.13 0.002 
NM_008783 Pbx1 Pre-B-cell leukemia transcription factor 1 
(females) 
-1.12 0.02 
NM_008970 Pthlh Parathyroid hormone-like hormone -1.12 0.04 
NM_010097 Sparcl1 SPARC-like 1 (mast9, hevin) -1.12 0.02 
NM_153178 Eif2c2 Eukaryotic translation initiation factor 
2C, 2 
-1.11 0.04 
NM_001111272 Stau2 staufen, RNA binding protein, homolog 2 
(Drosophila) 
-1.11 0.001 
 Slc25a4 solute carrier family 25 (mitochondrial 





 Trip11 thyroid hormone receptor interactor 11 -1.10 0.03 
 Pcnx pecanex homolog (Drosophila) -1.09 0.05 
NM_009579 Slc30a1 Solute carrier family 30 (zinc 
transporter), member 1 
-1.09 0.01 
NM_025446 Aig1 Androgen-induced 1 -1.09 0.04 
 Capn7 calpain 7 (?females) -1.08 0.05 
NM_009303 Syngr1 synaptogyrin 1 -1.07 0.008 
 Ppp3ca Protein phosphatase 3 (formerly 2B), 
catalytic subunit, alpha isoform 
(calcineurin A alpha) 
-1.07 0.01 
NM_001025250 Vegfa vascular endothelial growth factor -1.03 8.3E-1 














Supplementary Table 3. Vitamin D receptor response element (VDRE) gene changes in the 
heart of undiseased males compared to undiseased females 





VDRE genes upregulated in undiseased males compared to undiseased females 
NM_019568 Cxcl14 chemokine (C-X-C motif) ligand 14 1.81 0.007 
NM_009616 Adam19 A disintegrin and metalloproteinase 
domain 19 (meltrin beta) 
1.43 0.04 
NM_007425 Ager renal tumor antigen 1.36 0.008 
NM_009255 Serpine2 Serine (or cysteine) proteinase inhibitor, 
clade E (nexin, plasminogen activator 
inhibitor type 1), member 2 
1.33 0.04 
NM_001112698 Ngf nerve growth factor, beta polypeptide 1.27 0.06 
NM_009446 Tuba3a tubulin, alpha 3 1.26 0.04 
NM_007731 Col13a1 collagen, type XIII, alpha 1 1.25 0.04 
NM_026385 Pllp transmembrane 4 superfamily member 11 
(plasmolipin) 
1.24 0.01 
NM_001079883 Bcl11b B-cell CLL/lymphoma 11B (zinc finger 
protein) 
1.22 0.03 
NM_011170 Prnp prion protein (p27-30) (Creutzfeld-Jakob 
disease, Gerstmann-Strausler-Scheinker 
syndrome, fatal familial insomnia) 
1.22 0.0009 
NM_011349 Sema3f sema domain, immunoglobulin domain 1.21 0.01 
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(Ig), short basic domain, secreted, 
(semaphorin) 3F 
NM_029961 Abcb5 ATP-binding cassette, sub-family B 
(MDR/TAP), member 5 
1.17 0.06 
NM_009199 Slc1a1 solute carrier family 1 
(neuronal/epithelial high affinity 
glutamate transporter, system Xag), 
member 1 
1.17 0.03 
NM_001195083 Phc2 Polyhomeotic-like 2 (Drosophila) 1.16 0.04 
NM_001013616 Trim6 tripartite motif-containing 6 1.14 0.07 
NM_025821 Carhsp1 calcium regulated heat stable protein 1, 
24kDa 
1.13 0.07 
NM_199465 Nexn nexilin (F actin binding protein) 1.07 0.03 
 
VDRE genes downregulated in undiseased males compared to undiseased females 
NM_022019 Dusp10 dual specificity phosphatase 10 -1.47 0.03 





NM_001177713 Cyp26b1 cytochrome P450, family 26, subfamily 





NM_027629 Pgm2l1 phosphoglucomutase 2-like 1 -1.30 0.009 
NM_007499 Atm ataxia telangiectasia mutated (includes 







NM_146236 Tceal1 transcription elongation factor A (SII)-
like 1 
-1.25 0.02 
NM_010049 Dhfr dihydrofolate reductase -1.25 0.02 
NM_001122758 Pcdh7 BH-protocadherin (brain-heart) -1.24 0.004 
NM_001113351 Synj2 synaptojanin 2 -1.24 0.04 
NM_031402 Crispld1 LCCL domain containing cysteine-rich 





NM_007440 Alox12 arachidonate 12-lipoxygenase -1.21 0.06 
NM_172288 Nup133 Nucleoporin 133kDa -1.20 0.009 












NM_001164604 Nsmce2 breast cancer membrane protein 101 -1.18 0.03 
NM_138952 Ripk2 receptor-interacting serine-threonine 
kinase 2 
-1.17 0.03 
NM_001038621 Rabgap1l RAB GTPase activating protein 1-like -1.16 0.05 
NM_007658 Cdc25a cell division cycle 25A -1.16 0.03 
NM_025347 Ypel3 yippee-like 3 (Drosophila) -1.15 0.05 
NM_011594 Timp2 tissue inhibitor of metalloproteinase 2 -1.15 0.009 
NM_026281 Tm7sf3 Transmembrane 7 superfamily member 3 -1.14 0.02 
NM_212446 Psmf1 Proteasome (prosome, macropain) 







NM_009796 Capn7 calpain 7 -1.07 0.05 

















Supplementary Table 4. Vitamin D receptor response element (VDRE) gene changes in the 
heart of males vs. females with acute CVB3 myocarditis 





VDRE genes upregulated in males during myocarditis  
NM_009019 Rag1 recombination activating gene 1 3.32 0.03 
NM_019568 Cxcl14 chemokine (C-X-C motif) ligand 14 1.86 0.005 
NM_0111898 Ptgs2 prostaglandin-endoperoxide synthase 2 
(prostaglandin G/H synthase and 
cyclooxygenase) 
1.80 0.06 
NM_016911 Srpx sushi-repeat-containing protein, X-linked 1.67 0.003 
NM_134164 Syt12 synaptotagmin XII 1.60 0.01 
NM_019662 Serpine2 Serine (or cysteine) proteinase inhibitor, 
clade E (nexin), plasminogen activator 
inhibitor type 1), member 2 
1.57 0.006 
NM_001198914 Rrad Ras-related associated with diabetes 1.57 0.02 
NM_009264 Myb v-myb myeloblastosis viral oncogene 
homolog (avian) 
1.42 0.05 
NM_021361 Col12a1 Collagen, type XII, alpha 1 1.41 0.07 
NM_008542 S100a8 S100 calcium binding protein A8 
(calgranulin A) 
1.40 0.03 





NM_029961 Ptger4 prostaglandin E receptor 4 (subtype EP4) 1.39 0.02 
NM_009423 Sprr1a small proline-rich protein 1A 1.39 0.007 
NM_001130476 Nova1 neuro-oncological ventral antigen 1 1.30 0.002 
NM_011200 Smad6 SMAD, mothers against DPP homolog 6 
(Drosophila) 
1.29 0.04 
NM_133252 S100a9 S100 calcium binding protein A9 1.26 0.05 
NM_025821 Carhsp1 calcium regulated heat stable protein 1, 
24kDa 
1.19 0.02 
NM_001042513 Txnrd1 thioredoxin reductase 1 1.16 0.02 
NM_153178 Eif2c2 Eukaryotic translation initiation factor 
2C, 2 
1.16 0.008 
NM_029582 Txndc11 thioredoxin domain containing 11 1.16 0.02 
NM_013659 Sema4b sema domain, immunoglobulin domain 
(Ig), transmembrane domain (TM) and 
short cytoplasmic domain, (semaphorin) 
4B 
1.16 0.02 
NM_011897 Spry2 sprouty homolog 2 (Drosophila) 1.14 0.03 
NM_194344 Sh3tc1 SH3 domain and tetratricopeptide repeats 
1 
1.14 0.01 
NM_011170 Prnp prion protein (p27-30) (Creutzfeld-Jakob 
disease, Gerstmann-Strausler-Scheinker 
syndrome, fatal familial insomnia) 
1.13 0.01 




NM_026281 Tm7sf3 Transmembrane 7 superfamily member 3 1.11 0.05 
     
VDRE genes downregulated in males during myocarditis 
NM_14926 Sez6I2 seizure related 6 homolog (mouse)-like 2 -1.47 0.003 
NM_001122759 Pde7a Phosphodiesterase 7A -1.42 0.009 
NM_028711 Slc25a27 solute carrier family 25, member 27 -1.32 0.02 
NM_001081276 Clasp1 cytoplasmic linker associated protein 1 -1.31 0.0007 
NM_009200 Slc1a6 solute carrier family 1 (high affinity 
aspartate/glutamate transporter), member 6 
-1.27 0.02 
NM_007445 Amh anti-Mullerian hormone  -1.25 0.0003 
NM_031185 Akap12 A kinase (PRKA) anchor protein 12 -1.24 0.03  
NM_010097 Sparcl1 SPARC-like 1 (mast9, hevin) -1.24 0.0007 
NM_021715 Chst7 carbohydrate (N-acetylglucosamine 6-O) 
sulfotransferase 7 
-1.21 0.06 
NM_007440 Alox12 arachidonate 12-lipoxygenase -1.20 0.05 
NM_172420 Ppp1r1c protein phosphatase 1, regulatory 
(inhibitor) subunit 1C 
-1.20 0.04 
NM_028307 Tdrkh tudor and KH domain containing -1.20 0.01 
NM_011374 St8sia1 ST8 alpha-N-acetyl-neuraminide alpha-
2,8-sialyltransferase 1 
-1.19 0.0005 
NM_001081977 Rnf144a ring finger protein 144 -1.18 0.08 
NM_207666 Dlk2 EGF-like-domain/ delta-like 2 homolog -1.18 0.06 
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NM_177580 Baiap2l2 BAI1-associated protein 2-like 2 -1.17 0.04 
NM_177839 Tnn tenascin N -1.16 0.05 
NM_020626 Tmem27 transmembrane protein 27 -1.10 0.03 
NM_001177849 Asph aspartate beta-hydroxylase (cardiac 
remodeling) 
-1.10 0.01 





Supplementary Figure 1. Verification of microarray results of VDRE genes upregulated during 
myocarditis in males. WT mice were infected ip with CVB3 on day 0 and mRNA expression was 
examined in whole hearts at day 10 pi by qRT-PCR and compared to uninfected male mice to confirm 
VDRE pro-inflammatory (COX, Caspase-1, CXCL11), regulatory (IL-4Rα and TGFβ2) and 
profibrotic (TGFβ2 and Mmp3) genes found by microarray data. Data show the mean +/-SEM 








BPA increases myocarditis in female mice in plastic cages 
by increasing mast cell/inflammasome/Th1 responses and 














Myocarditis is an inflammatory heart disease that leads to DCM and heart failure. Sex 
hormones play a vital role in development of myocarditis with testosterone driving disease in 
males. Whereas, estrogen, via ERα, mediates cardioprotection in females. Since myocarditis 
is influenced by sex hormones, it is highly probable that endocrine disruptors, which interfere 
with natural hormones, will play a part in the progression of the disease. The human 
population is widely exposed to the endocrine disruptor BPA from plastics, such as water 
bottles, plastic food containers, copy paper, and receipts. BPA has been found to act through 
ERβ in cardiomyocytes to increase cardiac arrhythmias. Thus, BPA could increase 
myocarditis through deleterious actions of the ERβ rather than beneficial effects via ERα. We 
also found that VDR signaling is protective in females during myocarditis. To our knowledge 
no one has examined the role of endocrine disruptors like BPA on myocarditis. We found 
that a human relevant dose of BPA (25 µg/L), which has an estimated intake exposure of 5 
µg BPA/kg BW, increased acute CVB3 myocarditis in female BALB/c mice compared to 
control water. We also found that all doses of BPA increased pericarditis. We found BPA 
significantly decreased ERα and VDR expression, while ERβ was significantly increased in 
the heart at day 10 pi. At 24 hours pi, BPA increased both ERα and ERβ expression in the 
spleen. We also assessed protein levels and found that BPA increased phosphorylated active 
forms of both ERα and ERβ. We found that BPA increased mast cell (cKit) numbers and 
degranulation, especially along the pericardium. The main inflammatory cells increased in 
the heart were mast cells and CD4+ T cells according to qRT-PCR. IFN-γ, IL-17, C5aR1, 
TLR4, caspase-1, IL-1β, and Mmp9 were all significantly increased in the heart during 
myocarditis with BPA exposure, all immune components known to increase myocarditis and 
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remodeling. Thus, BPA exposure at a clinically relevant dose is able to increase CVB3-







Myocarditis is an inflammatory heart disease that leads to DCM and heart failure 
(Cooper 2009A). Myocarditis has been found to be influenced by the sex hormones 
testosterone and estrogen, which likely accounts for the increased prevalence and severity of 
disease in men over women (Lyden 1987, Frisancho-Kiss 2006B, Frisancho-Kiss 2007, 
Cocker 2009, McNamara 2011, Coronado 2012, Fairweather 2012A, Kyto 2013). It has also 
been found that estrogen, via ERα but not ERβ, mediates cardioprotection in females 
(Regitz-Zagrosek 2008). Since myocarditis is influenced by sex hormones, EDs could play a 
part in the development and progression of disease. Endocrine disruptors are compounds that 
interfere with the function of natural hormones like estrogen (Kavlock 1997, Crisp 1998, 
Vandenberg 2009). Estrogen is known to regulate the function of the cardiovascular and 
immune system. The human population is exposed to BPA, a known estrogen disruptor, from 
plastics, such as water bottles and plastic food containers (Olea 1996, Snyder 2000, Matthews 
2001, Howdeshell 2003, Hunt 2003, Jenkins 2011, Belcher 2012, Teeguarden 2013, Mirmina 
2014, Oldring 2014, Berger 2015, Corrales 2015, Lorber 2015, Rahman Kabir 2015, Yama 
2015, Gerona 2016, Hehn 2016, Liao 2016, Ndaw 2016). BPA is an estrogen disruptor that 
mimics estrogen, acting as an agonist that binds to the ER (Kuiper 1997, Anderson 1999, 
Hiroi 1999, Molina-Molina 2013, Li 2015, Zaid 2015). BPA has been found to act through 
ERβ in cardiomyocytes to increase cardiac arrhythmias (Liang 2014, Belcher 2015). Thus, 
BPA could increase myocarditis through deleterious actions of the ERβ signaling rather than 
beneficial effects via ERα signaling. To our knowledge no one has examined the role of EDs 
like BPA on myocarditis or DCM. Previous studies by us and others have established that 
CVB3-induced myocarditis is increased by testosterone (Huber 1994, Gauntt 2003, 
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Frisancho-Kiss 2006A, Frisancho-Kiss 2006, Frisancho-Kiss 2007, Frisancho-Kiss 2009, 
Coronado 2012, Fairweather 2012A, Fairweather 2013, Reddy 2013), while BPA down-
regulates the protective effects of estrogen (Matthews 2001). This raises the possibility that 
myocarditis could be influenced by BPA exposure, which is an estrogenic endocrine 
disruptor (Belcher 2012). 
To test this idea, we exposed adult female BALB/c mice to different doses of BPA 
dissolved in MilliQ water or control drinking water (0 µg/L water) for 2 weeks using 
traditional plastic cages and water bottles (Chapter 2, Table 3), prior to ip injection with 
CVB3 to induce myocarditis and tissues were harvested at day 10 pi during peak myocarditis 
(Meyers 2013). BPA exposure was continued from day 0 of infection until harvest at day 10 
pi. Soy-free food and bedding were used to prevent that estrogenic influence on the 
experiments. The BPA doses used in our studies were obtained from Jenkins et al and based 
on predicted daily exposure levels in the human population (Jenkins 2011). The doses that 
were chosen are described in Chapter 2, Table 3. The EPA reference dose is defined as an 
estimate of the daily exposure to a susceptible individual without an appreciable risk of 
deleterious effects during a lifetime and is equivalent to the highest dose used in our 
experiments (50 µg/kg/day). The EPA reference dose is calculated by using a safety factor of 
1000x the LOAEL (lowest observable adverse effect level) (Vandenberg 2009).  
A systematic review of recent publications on “low dose” BPA exposure in humans 
has a wide range of definitions for low dose. In a systematic review of 123 adult exposure 
studies only 13% contained a dose in the adult exposure range and of those only 3% were a 
human relevant oral exposure (Teeguarden 2013). Epidemiology studies define an adult 
external human exposure upper limit as 0.27 µg/kg/day derived from NHANES data (Lakind 
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2008, Lakind 2010), and for 1 month to 11 year old children an external human exposure 
upper limit was set at 1.61 µg/kg derived from World Health Organization data. The “low 
dose” exposures used for the studies in this Thesis were derived from a study by Jenkins et al 
which was published in 2011, before the systematic review was published in 2013 (Jenkins 
2011, Teeguarden 2013). The doses we used were based on the Jenkins et al calculations of a 
human relevant dose of 0.5 µg/kg, a high human relevant dose of 5 µg/kg, and an EPA 
reference dose of 50 µg/kg (Jenkins 2011). Once we had started using these doses we 






ELISA detects higher BPA levels in the drinking water of mice dosed with BPA 
 Levels of BPA dissolved in the drinking water were confirmed using ELISA to 
determine if the calculated doses correlated to detectable levels. We found a significant 
difference between groups (p =0.04) (Fig 1). There were significantly higher levels of BPA 
in the 25 (p=0.02) and 250 (p= 0.01) µg/L doses of water compared to control water (Fig 1). 
Although the BPA levels determined by ELISA were significantly increased at higher doses, 
the BPA concentrations determined by the ELISA did not match the mathematically 
calculated doses. This is not surprising because ELISA is considered to be a poor method for 
accurately determining BPA levels in water or sera. However, at this stage of the research 
project we had not yet developed collaborators who could assess BPA levels using liquid 
chromatography-mass spectrometry/ mass spectrometry (LC-MS/MS). 
 
Figure 1. BPA concentration in water bottles was increased in higher doses of BPA when 
measured by ELISA. BPA levels were assessed in water bottles dosed with BPA prior to treating 
mice; x-axis represents BPA levels used for exposure and y-axis BPA levels determined by ELISA. 
The ELISA was performed according to the manufactures’ instructions. Data show the mean +/-SEM 
using 3-4 samples obtained from water bottles/ group. Significance was calculated using one-way 
121 
 
ANOVA (p=0.04) followed by one-way Student’s t tests comparing individual BPA dilutions to 0 
control group. 
 
BPA exposure increases CVB3 myocarditis in female BALB/c mice 
 Studies have found that BPA exposure increases cardiac, autoimmune and 
inflammatory diseases such as cardiac arrhythmias (Orton 2004, Weinstock-Guttman 2003, 
Kendziorski 2012, Melzer 2012, Shankar 2012, Gao 2014, O’Brien 2014, Jochmanova 2015, 
Ranciere 2015, Han 2016, He 2016). Sex hormones like testosterone are known to influence 
cardiac diseases such as CVB3 myocarditis (Frisancho-Kiss 2009, Coronado 2012). To 
assess the effect of BPA exposure on CVB3 myocarditis, 6-8 week old female BALB/c mice 
were given varying doses of BPA in their drinking water for two weeks prior to infecting 
mice with CVB3 ip on day 0. Mice were housed in typical plastic cages using plastic water 
bottles, but were provided bedding and food free of soy which contains genistein, an 
estrogenic agent. The doses of BPA that were administered were 2.5, 25, and 250 µg BPA/L 
in drinking water, which is equivalent to an estimated intake of 0.5, 5, and 50 µg BPA/kg 
body weight (BW), respectively, based on daily water intake by Jenkins et al. Examining the 
dose response of BPA was important to determine whether there was a dose effect on 
myocarditis. BPA treatment was continued from day 0 after infection until the harvest at day 
10 pi. Myocarditis was assessed histologically at day 10 pi, during acute myocarditis, by 
determining % inflammation in heart sections corrected for the size of the heart. 
We found that BPA exposure of mice increased CVB3-induced myocarditis (p=0.01). 
Controlling for multiple comparisons revealed that the 25 µg BPA/L dose, which is 
equivalent to an estimated intake of 5 µg BPA/kg BW, significantly increased myocarditis at 
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day 10 pi compared to control water containing no supplemental BPA (p<0.01) (Fig 2). 
Representative photos of the effect of BPA exposure on CVB3 myocarditis are shown in 
Figure 3. Although the 50 µg/kg dose of BPA was found to be significant compared to the 0 
BPA control (p=0.04), this dose was no longer significant when multiple comparisons were 
taken into consideration. These data suggest that exposure to BPA is not demonstrating a 
dose-effect, but that the estimated “high human exposure” dose (25 µg BPA/L water or 5 µg 
BPA/kg BW) increases myocarditis. Future studies will assess the effect of BPA on 
inflammation without viral infection to determine if co-exposure is nessessary. 
 
Figure 2. BPA increases myocarditis in BALB/c female mice in plastic cages. Female BALB/c 
mice were given increasing doses of bisphenol A (BPA) in drinking water for 2 weeks and then 
injected ip with 103 PFU of CVB3 ip on day 0 and inflammation examined at day 10 pi, during peak 
myocarditis. BPA exposure continued from day 0 to 10 pi. Myocarditis was assessed as the % 
inflammation in the heart using H&E compared to the overall size of the heart section by histology 
using an eyepiece grid. Estimated BPA intakes were determined as follows: 0, 0.5, 5, and 50 µg 
BPA/kg body weight (BW) were obtained by dosing water with 0, 2.5, 25 or 250 µg BPA/L, 
respectively. Data show the mean +/-SEM, n=9-20/group. One-way ANOVA found a significant 
difference existed between groups (p=0.01). After controlling for multiple comparisons, the 5 µg 




Figure 3. Representative photos of the effect of BPA exposure on CVB3 myocarditis. Female 
BALB/c mice were given increasing doses of bisphenol A (BPA) in drinking water for 2 weeks and 
then injected ip with 103 PFU of CVB3 ip on day 0 and inflammation examined at day 10 pi, during 
peak myocarditis. BPA exposure continued from day 0 to 10 pi. Inflammation in the heart was 
assessed using H&E stain where cardiac tissue appears pink and inflammation dark purple. 
Representative photos depict A) 0, B) 0.5, C) 5, and D) 50 µg BPA/kg BW. The bar is 300 µm in 
length. 
 
BPA exposure increases pericarditis in female BALB/c mice after CVB3 infection 
 Myocarditis in patients often includes inflammation and/or damage of the 
pericardium, a single layer of cells surrounding the heart, which is called pericarditis (Imazio 
2013). When myocarditis and pericarditis occur together it is often termed myopericarditis or 
perimyocarditis (used interchangeably) (Imazio 2013). Male mice in our CVB3 myocarditis 
model also often develop pericarditis/ myopericarditis (Fairweather 2004A, Fairweather 
2006). Representative photos of pericarditis are shown in Figure 4. Normal pericardium 
consists of one layer of pericardial cells on the outer surface of the myocardium as depicted 
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in Figure 4A. Damaged pericardium lifts from the myocardium with a “lacey-like” 
appearance (Fig 4B). More severe pericarditis develops multiple layers with or without 
inflammatory cells (Fig 4C-D). In this study we found that BPA exposure increased the level 
of pericarditis and/or pericardial damage during CVB3 myocarditis (one-way ANOVA, 
p=0.002) (Fig 5). Controlling for multiple comparisons revealed that the 5 and 50 µg BPA/kg 
BW doses significantly increased pericarditis at day 10 pi compared to control water (p<0.05 
and p<0.001, respectively) (Fig 5). These data indicate that BPA exposure at the estimated 
“high human exposure” and “EPA reference” dose increase CVB3-induced pericarditis. 
 
Figure 4. Representative photos of the effect of BPA on CVB3 pericarditis in female mice. 
Female BALB/c mice were given increasing doses of bisphenol A (BPA) in drinking water for 2 
weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and pericarditis examined at day 10 pi. 
BPA exposure continued from day 0 to 10 pi. Pericarditis was assessed using H&E stain. 
Representative photos depict A) 0, B) 0.5, C) 5, and D) 50 µg BPA/kg BW. The bar is 200 µm in 
length. Normal pericardium consists of one layer of cells on the outer surface of the myocardium as 




Figure 5. BPA increases pericarditis in BALB/c female mice. Female BALB/c mice were given 
increasing doses of bisphenol A (BPA) in drinking water for 2 weeks and then injected ip with 103 
PFU of CVB3 ip on day 0 and inflammation examined at day 10 pi, during peak myocarditis. BPA 
exposure continued from day 0 to 10 pi. Pericarditis was assessed as follows: pericarditis that ran 
through 3 grid squares in the eyepiece grid was counted as a value of 1. The % pericarditis was 
calculated as the number of sets of 3 squares with pericarditis (values ranging from 1 to 6 in a typical 
heart section) compared to the overall size of the heart section using an eyepiece grid. Estimated BPA 
intakes were determined as follows: 0, 0.5, 5, and 50 µg BPA/kg BW obtained by dosing water with 
0, 2.5, 25 or 250 µg BPA/L, respectively. Data show the mean +/-SEM, n=9-10/group. One-way 
ANOVA found a significant difference existed between groups (p=0.002). After controlling for 
multiple comparisons, the 5 and 50 µg BPA/kg BW doses were significantly increased compared to 
control water (*, p<0.05; ***, p<0.001). 
 
BPA does not significantly alter viral gene expression in the heart during myocarditis 
We examined whether BPA exposure altered CVB3 replication in the heart during 
acute myocarditis. We used a primer/probe set directed to the CVB3 genome according to 
Antoniak et al (Antoniak 2013). We found that BPA had no significant effect on viral 
replication in the heart during acute myocarditis at day 10 pi by qRT-PCR (p=0.62) (Fig 6). 
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Thus, increased myocardial inflammation from BPA exposure was not due to increased viral 
replication during acute myocarditis. 
 
Figure 6. Viral gene expression in the heart was not effected by BPA treatment. Female BALB/c 
mice were given increasing doses of bisphenol A (BPA) in drinking water for 2 weeks and then 
injected ip with 103 plaque forming units (PFU) of CVB3 ip on day 0 and hearts were harvested at 
day 10 pi. BPA exposure continued from day 0 to 10 pi. CVB3 levels in the heart were measured 
using qRT-PCR to determine relative gene expression (RGE) of viral genome compared to the 
housekeeping gene Hprt. Data show the mean +/-SEM, n=9-10/group. Significant differences 
between groups were assessed using one-way ANOVA for multiple comparisons. Estimated BPA 
intakes were determined as follows: 0, 0.5, 5, and 50 µg BPA/kg BW obtained by dosing water with 
0, 2.5, 25 or 250 µg BPA/L, respectively. 
 
BPA exposure increases CD4+ T cells during CVB3 myocarditis in female mice 
Because myocarditis was significantly increased only in the high human relevant dose 
(i.e., 5 µg BPA/kg BW) (Fig 2), all future analysis compared only 0 to 5µg BPA/kg BW 
groups. The effect of BPA exposure on specific cardiac immune cells during acute 
myocarditis at day 10 pi was assessed using qRT-PCR of whole hearts (i.e., not isolated 
cells). We found that BPA exposure of BALB/c female mice significantly increased 
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expression of CD4, a marker for CD4+ T cells, in the heart during CVB3 myocarditis 
compared to 0 BPA controls (p=0.04) (Fig 7). We also examined expression of CD45 (total 
immune cells), GR1 (neutrophils), CD11b (includes macrophages, neutrophils, mast cells and 
some dendritic cells), F4/80 (macrophages), CD3 (all T cells), CD8 (CD8+ T cell), and 
Foxp3 (regulatory T cells), but found no significant difference between 5 µg BPA and 0 BPA 
control water for any of these immune cell markers (Fig 7). Am increase in CD4+ T cells 
during acute myocarditis following BPA exposure is consistent with the increased 
inflammation observed with histology for the 5µg BPA/kg BW dose (Fig 2). 
 
Figure 7. CD4+ T cells were significantly increased by BPA exposure. Female BALB/c mice were 
given 0 or 5 µg bisphenol A (0 BPA vs. 5 BPA) /kg BW in their drinking water for 2 weeks and then 
injected ip with 103 PFU of CVB3 ip on day 0 and hearts were harvested at day 10 pi. BPA exposure 
continued from day 0 to 10 pi. Immune cell populations from the whole heart were examined using 
qRT-PCR for relative gene expression (RGE) of the gene of interest vs. the housekeeping gene Hprt 
for CD45 (total immune cells), GR1 (neutrophils), CD11b (includes macrophages, neutrophils, mast 
cells and some dendritic cells), F4/80 (macrophages), CD3 (all T cells), CD4 (CD4+ T cells), CD8 
(CD8+ T cell), and Foxp3 (regulatory T cells). Data are shown as the mean +/-SEM using a two-
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tailed Student’s t or Mann-Whitney rank test with 8-10 mice/ group. 5 µg BPA/kg BW was obtained 
by dosing water with 25 µg BPA/L. 
 
BPA significantly increases IFNγ and IL-17 levels, an indicator of a Th1 and Th17-type 
immune response 
BPA exposure has been shown to increase both Th1 and Th2 immune responses in 
various inflammatory animal models, such as the OVA model of asthma (Yoshino 2003, 
Yoshino 2004, Rogers 2013). Because CD4+ T cells were increased during CVB3 
myocarditis by BPA exposure, we examined whether IFNγ, IL-4, and/or IL-17A (IL-17) 
cytokine levels were altered in the heart during acute CVB3 myocarditis following BPA 
exposure. Changes in these cytokines are often used to indicate whether a Th1, Th2 or Th17 
response is dominant, respectively (Fairweather 2004C, Zhu 2010). We found that IFNγ was 
significantly increased by 5 µg/kg BW BPA exposure during acute myocarditis (Fig 8A), IL-
4 levels were not altered (Fig 8B), and IL-17 was also significantly increased (Fig 8C). 
These results suggest that a Th2-type immune response was not altered by BPA exposure 
during CVB3 myocarditis. However, Th1 and Th17-type immune responses were 
significantly increased by BPA exposure during acute CVB3 myocarditis. Th1 and Th17 
responses have been demonstrated to increase acute viral and autoimmune myocarditis in 
mice (Frisancho-Kiss 2006B, Baldeviano 2010, Wu 2014). IL-17, but not IFNγ, has been 
shown to drive progression from acute myocarditis to chronic myocarditis and DCM 
(Fairweather 2004A, Baldeviano 2010, Wu 2014). 
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Figure 8. Cardiac IFNγ and IL-17A levels significantly increased by BPA exposure. Female 
BALB/c mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 BPA) in their drinking water 
for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. BPA exposure continued from 
day 0 to 10 pi. Hearts were harvested at day 10 pi and homogenized and the supernatant used to 
measure A) IFNγ, B) IL-4, and C) IL-17A levels in the heart by ELISA. Data show the mean +/-SEM 
using a one-tailed (IL-17A) or two-tailed Student’s t (IFNγ and IL-4) or Mann-Whitney rank test with 
10 mice/ group. 5 µg BPA/kg BW was obtained by dosing water with 25 µg BPA/L. 
 
BPA does not skew the M1 vs. M2 macrophage profile in the heart during myocarditis 
Classically activated M1 macrophages are driven by IFNs/Th1 responses and are 
increased in male BALB/c during CVB3 myocarditis, while alternatively activated M2 
macrophages are anti-inflammatory and are elevated in female BALB/c mice who typically 
have far lower levels of myocarditis compared to males (Li 2009, Fairweather 2009, Abston 
2013). Markers of M2 macrophages in mice include arginase-1 (Arg1), Ym1 (eosinophilic 
protein from chitinase family), and TGFβ, while M1 markers include Cxcl9 and Cxcl10 
(Siracusa 2008, Fairweather 2009, Abston 2012A). Here we found that female BALB/c mice 
exposed to 5 µg/kg BW BPA had no significant change in the anti-inflammatory M2 
macrophage markers arginase-1, Ym1, TGFβ1 (0 BPA 1.29 +/-0.06 vs. 5 PBA 1.43 +/-0.1, 
p=0.61) or TGFβ2 (0 BPA 2.89+/-0.38 vs. 5 BPA 3.33+/-0.07, p=0.74) (Fig 9A) or the M1 
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markers Cxcl9 or Cxcl10 (Fig 9B) compared to 0 BPA control water by qRT-PCR. These 
data suggest that the elevated IFNγ in the heart from BPA exposure is derived from T cells 
rather than macrophages (Darwich 2009), and that the elevated IFNγ in response to BPA is 
not significantly shifting the M1/M2 profile of cardiac macrophages during CVB3 
myocarditis. 
Figure 9. BPA exposure does not alter M1 vs. M2 macrophage profile during myocarditis. 
Female BALB/c mice were given 0 or 5 µg/kg BW BPA (0 BPA vs. 5 BPA) in their drinking water 
for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. BPA exposure continued from 
day 0 to 10 pi. Hearts were harvested at day 10 pi during acute myocarditis. Relative gene expression 
(RGE) of A) M2 macrophage markers (Arg1, Ym1) and B) M1 markers (Cxcl9, Cxcl10) vs. Hprt 
controls were assessed in whole hearts using qRT-PCR at day 10 pi comparing 0 and 5 µg BPA/kg 
BW groups. Data show the mean ±SEM using a two-tailed Student’s t or Mann-Whitney rank test 
with 9-10 mice/ group. 5 µg BPA/kg BW was obtained by dosing water with 25 µg BPA/L. 
 
BPA exposure increases the number of mast cells in the heart during myocarditis 
Previously, BPA exposure was found to increase mast cell activation and numbers in 
in vitro studies (O’Brien 2014A, O’Brien 2014B). The effect of BPA exposure on cardiac 
mast cells during acute myocarditis at day 10 pi was assessed using toluidine blue stain with 
histology, which detects mast cell granules, and qRT-PCR for cKit (also called stem cell 
factor/SCF). We found that 5 µg BPA/ kg BW exposure to BALB/c female mice in plastic 
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cages significantly increased the total number of mast cells in the heart by histology 
(p=0.007) (Fig 10A), and significantly increased cKit (CD117) expression in whole hearts by 
qRT-PCR (p=0.004) (Fig 10B) compared to 0 BPA control water during CVB3 myocarditis. 
cKit is also called SCF and a marker used to detect both mast cells and stem cells (Draber 
2016, Huang 2016). Thus, exposure of BPA to female BALB/c mice may increase 
myocarditis by increasing the number of mast cells in the heart during acute myocarditis. 
 
Figure 10. BPA exposure increases the number of cardiac mast cells. Female BALB/c mice were 
given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 BPA) in their drinking water for 2 weeks and then 
injected ip with 103 PFU of CVB3 ip on day 0. BPA exposure continued from day 0 to 10 pi. Hearts 
were harvested at day 10 pi during acute myocarditis. A) Toluidine blue was used to detect mast cells 
(detects mast cell granules) by histology and the number of mast cells were normalized to the size of 
the heart using an eyepiece grid. B) Relative gene expression (RGE) of CD117 (cKit) was used to 
detect mast cell numbers using qRT-PCR of whole hearts vs. HPRT controls at day 10 pi comparing 0 
and 5 µg BPA/kg BW groups. Data show the mean ±SEM using a two-tailed Student’s t or Mann-
Whitney rank test with 10-20 mice/ group. 5 µg BPA/kg BW was obtained by dosing water with 25 
µg BPA/L. 
 
BPA exposure increases degranulating mast cells in the heart during myocarditis 
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 Previously, we found that mast cell degranulation was associated with increased 
CVB3 myocarditis, pericarditis, DCM and heart failure in mice (Fairweather 2004A, 
Fairweather 2006). In order to determine whether BPA exposure affected mast cell 
degranulation during CVB3 myocarditis in BALB/c female mice we counted the number of 
degranulating vs. non-degranulating mast cells using toluidine blue-stained histology 
sections. Figure 11 shows representative examples of non-degranulating vs. degranulating 
mast cells stained with toluidine blue. 
 
Figure 11. Example of non-degranulating and degranulating mast cells. Toluidine blue was used 
to detect cardiac mast cells with histology by staining mast cell granules purple. Cell nuclei appear 
pale blue. Eosin (pink) was used as a counterstain to detect cardiac tissue. Red blood cells also appear 
pink. A representative example of a A) non-degranulating (dense granules within the cell) and B) 
degranulating (cells have the appearance as if they had “exploded”) mast cells are shown. 
Magnification approximately 400x. 
 
We found that during acute myocarditis more mast cells were not degranulating (i.e., 
intact) compared to those that were degranulating (p<0.0001) (Fig 12), which is typical in 
our experience with this model. BPA was found to have a significant effect on increasing 
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mast cells in the heart overall (degranulating and non-degranulating) (p=0.0006) (Fig 12), 
confirming the data shown in Figure 10A. An exposure of 5 µg BPA/kg BW (5 BPA) had no 
significant effect on mast cells that were not degranulating (NOT), but significantly increased 
the number of degranulating mast cells (Degran) during myocarditis (p<0.05) compared to 
the 0 BPA group (Fig 12). 
 
Figure 12. BPA exposure increases the number of degranulating cardiac mast cells. Female 
BALB/c mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 BPA) in their drinking water 
for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. BPA exposure continued from 
day 0 to 10 pi. Hearts were harvested at day 10 pi during acute myocarditis. Toluidine blue was used 
to detect mast cells (detects mast cell granules) by histology and the number of mast cells that were 
not degranulating (NOT) (i.e., intact) or degranulating (Degran) for each group were normalized to 
the size of the heart using an eyepiece grid. Data show the mean ±SEM with 10 mice/ group using 2-
way ANOVA with Tukey’s multiple comparisons test. Two-way ANOVA found significant results 
for degranulation p<0.0001 and BPA p=0.0006. The 5 BPA exposure significantly increased the 
number of degranulating mast cells during myocarditis compared to the 0 BPA group (*, p<0.05). 5 
µg BPA/kg BW was obtained by dosing water with 25 µg BPA/L. 
 
BPA exposure increases pericardial mast cell degranulation during myocarditis 
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Previously, we found that pericardial mast cell degranulation was associated with 
increased pericarditis, immune complex deposition along the pericardium, DCM and heart 
failure in mice (Fairweather 2004A, Fairweather 2006). In order to determine whether BPA 
exposure affected pericardial mast cell degranulation during CVB3 myocarditis in BALB/c 
female mice we counted the number of degranulating (Degran) vs. non-degranulating (NOT) 
mast cells that were located on the outer pericardial layer of the heart using toluidine blue-
stained histology sections. We found that during acute myocarditis more pericardial mast 
cells were not degranulating (i.e., intact) compared to those that were degranulating 
(p<0.0002) (Fig 13, Fig 14). BPA was found to have a significant effect on increasing 
pericardial mast cells in the heart overall (degranulating and non-degranulating) (p=0.0004) 
(Fig 13). An exposure of 5 µg BPA/kg BW (5 BPA) had no significant effect on pericardial 
mast cells that were not degranulating, but significantly increased the number of 
degranulating pericardial mast cells during myocarditis (p<0.01) compared to the 0 BPA 
group (Fig 13). In contrast to total degranulating mast cells (Fig 12), pericardial mast cell 
degranulation was less only without BPA exposure (0 BPA group) compared to non-
degranulating pericardial mast cells (p<0.0001) (Fig 13). This indicates that BPA exposure 




Figure 13. BPA exposure increases the number of degranulating pericardial mast cells. Female 
BALB/c mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 BPA) in their drinking water 
for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. BPA exposure continued from 
day 0 to 10 pi. Hearts were harvested at day 10 pi during acute myocarditis. Toluidine blue was used 
to detect mast cells (detects mast cell granules) by histology and the number of pericardial mast cells 
that were not degranulating (NOT) (i.e., intact) or degranulating (Degran) for each group were 
normalized to the size of the heart using an eyepiece grid. Data show the mean ±SEM with 10 mice/ 
group using 2-way ANOVA with Tukey’s multiple comparisons test. Two-way ANOVA found 
significant results for degranulation p<0.0002 and BPA p=0.0004. BPA significantly increased the 
number of pericardial degranulating mast cells during myocarditis compared to the 0 BPA group (**, 
p<0.01). 5 µg BPA/kg BW was obtained by dosing water with 25 µg BPA/L. 
 
Figure 14. Example of non-degranulating and degranulating pericardial mast cells. Toluidine 
blue was used to detect pericardial mast cells with histology by staining mast cell granules purple. 
Cell nuclei appear pale blue. Eosin (pink) was used as a counterstain to detect cardiac tissue. Red 
blood cells also appear pink. A representative example of a A&C) non-degranulating pericardial and 





BPA exposure does not alter degranulation of myocardial mast cells during myocarditis 
 Mast cells leave the bone marrow as undifferentiated cells and migrate to the heart 
where they differentiate to form two types of resident mast cell populations: one type 
contains tryptase and chymotrypsin (also called Serpin A3n) granules and is termed a TC 
mast cell and the other type of mast cell contains only tryptase granules and is termed a T 
mast cell (Irani 1986, Fairweather 2008B). It is not known whether one type of mast cell 
resides along the pericardium and the other in the myocardium, but this is a possibility. To 
determine whether BPA exposure altered degranulation of mast cells located in the 
myocardium we examined the degranulation state of myocardial mast cells using histology. 
A representative photo of pericardial vs. myocardial mast cells is shown in Figure 15. 
By 2-way ANOVA we found that during acute myocarditis more myocardial mast 
cells were not degranulating (i.e., intact) compared to those that were degranulating 
(p<0.0001) (Fig 16). BPA did not increase myocardial mast cells in the heart overall 
(p=0.71) (Fig 16). Two-way ANOVA and a Student’s t test (p=0.09) comparison of 0 BPA 
to 5 BPA degranulating myocardial mast cells did not find a significant difference in 





Figure 15. Example of pericardial, myocardial and vessel-associated mast cells. Toluidine blue 
was used to detect cardiac mast cells by location with histology by staining their granules purple 
compared to the eosin counterstain of tissue cells, which is pink. Nuclei of all types of cardiac cells 
stain a pale blue. Representative examples of A) pericardial, B) myocardial, and C) vessel-associated 
mast cells are shown. B) If mast cell is not near a vessel or red blood cells it was counted as a 
“myocardial” mast cell (arrow). C) Arrows indicate vessels located above and below purple stained 




Figure 16. BPA exposure does not alter myocardial mast cell numbers during myocarditis. 
Female BALB/c mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 BPA) in their drinking 
water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. BPA exposure continued 
from day 0 to 10 pi. Hearts were harvested at day 10 pi during acute myocarditis. Toluidine blue was 
used to detect mast cells (detects mast cell granules) by histology and the number of myocardial mast 
cells that were not degranulating (NOT) or degranulating (Degran) for each group were normalized to 
the size of the heart using an eyepiece grid. Data show the mean ±SEM with 10 mice/ group using 2-
way ANOVA with Tukey’s multiple comparisons test. Two-way ANOVA found significant results 
for degranulation only (p<0.0001). 5 µg BPA/kg BW was obtained by dosing water with 25 µg 
BPA/L. 
 
BPA exposure may increase degranulation of “vessel-associated” mast cells 
 Mast cells are released from bone marrow and reside in tissues. Basophils remain in 
the circulation. Basophils can be recruited to sites of inflammation (Otsuka 2016). Infiltrating 
mast cells or basophils would be expected to be found near vessels. Mast cells found near 
vessels have been termed “vessel-associated” mast cells for this analysis and are assumed to 
be mast cells recruited to the heart from the circulation rather than resident mast cells. Mast 
cells in the myocardium that were not near vessels or evidence of red blood cells were 
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defined as “myocardial” mast cells. It is likely that there is a certain amount of overlap 
between “myocardial” and “vessel-associated” mast cells due to the inability to detect vessels 
depending on the cut of the histology section. Representative photos of pericardial, 
myocardial, and vessel-associated mast cells are shown in Figure 15. To determine whether 
BPA exposure altered degranulation of mast cells located near vessels we examined the 
degranulation state of “vessel-associated” mast cells using histology. 
We found that during acute myocarditis more “vessel-associated” mast cells were not 
degranulating compared to those that were degranulating regardless of BPA exposure 
(p<0.0001) (Fig 17). BPA did not increase “vessel-associated” mast cells in the heart overall 
(degranulating and non-degranulating) (p=0.11) (Fig 17). By 2-way ANOVA there was no 
significant difference between the 0 BPA and 5 BPA groups for “vessel-associated” 
degranulating mast cells (Fig 17). However, a Student’s t test comparison of 0 BPA to 5 BPA 
degranulating “vessel” mast cells suggests that BPA may increase degranulation of these 
cells (p=0.005). These data raise the possibility that BPA exposure may increase 
degranulation of mast cells near vessels during myocarditis. 
 
Figure 17. BPA exposure does not significantly alter “vessel-associated” mast cell numbers 
during myocarditis. Female BALB/c mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 
BPA) in their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. 
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BPA exposure continued from day 0 to 10 pi. Hearts were harvested at day 10 pi during acute 
myocarditis. Toluidine blue was used to detect mast cells (detects mast cell granules) by histology 
and the number of “vessel-associated” or “vascular” mast cells that were not degranulating (NOT) or 
degranulating (Degran) for each group were normalized to the size of the heart using an eyepiece 
grid. Data show the mean ±SEM with 10 mice/ group using 2-way ANOVA with Tukey’s multiple 
comparisons test. Two-way ANOVA found significant results for degranulation only (p<0.0001). 
However, a Student’s t test comparison of 0 BPA to 5 BPA degranulating “vessel/vascular” mast cells 
suggests that BPA may increase degranulation of these cells (p=0.005). 5 µg BPA/kg BW was 
obtained by dosing water with 25 µg BPA/L. 
 
BPA exposure increases expression of the mast cell anaphylatoxin receptor C3aR1 
Coxsackievirus infection activates the complement pathway, which in turn activates 
mast cells and macrophages via CD11b, also known as complement receptor 3 (CR3), 
leading to increased inflammation (Fairweather 2006, Fairweather 2008B, Onyimba 2011, 
Coronado 2012). In addition to the complement receptor CD11b, mast cells are also activated 
by the mast cell-specific anaphylatoxin receptors C3aR and C5aR (Arbore 2016). Although 
complement activation of mast cells would be expected to peak during the innate immune 
response (hours and first few days after infection), we have found complement activation in 
the heart during CVB3 myocarditis (Fairweather 2006). Because we had found that BPA 
exposure increased mast cell numbers (Fig 10) and degranulation (Fig 12, Fig 13), we 
examined whether the complement anaphylatoxin receptors, which are specific for mast 
cells, were altered by BPA. We found that BPA exposure significantly increased expression 
of the mast cell anaphylatoxin receptor C3aR1 during acute myocarditis by qRT-PCR of 
whole hearts (p=0.04) (Fig 18A), but not C5aR1 (Fig 18B) or the complement receptor 
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ligands C3 (Fig 18C) and C4b (Fig 18D) at day 10 pi. Elevation of C3aR1 expression in the 
heart during acute myocarditis following BPA exposure is a further indication that BPA 
activates mast cells. 
 
Figure 18. BPA exposure activates the mast cell anaphylatoxin receptor C3aR1. Female BALB/c 
mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 BPA) in their drinking water for 2 weeks 
and then injected ip with 103 PFU of CVB3 ip on day 0. BPA exposure continued from day 0 to 10 pi. 
Hearts were harvested at day 10 pi during acute myocarditis. Relative gene expression (RGE) of 
complement genes vs. the housekeeping control Hprt was examined for A) C3aR1, B) C5aR1, C) C3 
and D) C4b mRNA by qRT-PCR at day 10 pi comparing 0 to 5 µg BPA/kg BW estimated intake 
groups. Data show the mean +/-SEM using a two-tailed Student’s t or Mann-Whitney rank test with 
7-10 mice/ group. 5 µg BPA/kg BW was obtained by dosing water with 25 µg BPA/L. 
  
BPA exposure decreases CR1, an inhibitor of complement activation on mast cells 
CR1 is the primary receptor in the heart that regulates complement activation on 
macrophages and mast cells (Fairweather 2006, Alcorlo 2015). We showed previously that 
CR1 protects against autoimmune and viral myocarditis in mice (Kaya 2001, Fairweather 
2006). CR1 deficient mice develop severe myocarditis, pericarditis, pericardial immune 
complex deposition and fibrosis and rapidly progress to DCM and heart failure following 
CVB3 infection, indicating the critical role for CR1 in preventing myopericarditis 
(Fairweather 2006). For this reason we examined CR1 expression in the heart during 
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myocarditis following BPA exposure using qRT-PCR. In humans, separate genes code for 
CR1 and CR2 on immune cells (Kurtz 1990). In mice, CR1 and CR2 are the result of 
alternative mRNA splicing of the same gene so that CR1 and CR2 gene expression cannot be 
readily distinguished in mice using qRT-PCR. CR1 regulates/inhibits complement activation 
on mast cells and macrophages, whereas CR2 is primarily expressed on B cells and activates 
B cells in response to complement (Fairweather 2006, Roosendaal and Carroll 2007, 
Jacobson and Weis 2008). 
In this study, we found that CR1/2 expression in the heart was significantly decreased 
by exposure to BPA during acute CVB3 myocarditis (p=0.02) (Fig 19A). CR2 forms a B cell 
receptor complex with CD19 and CD81 is needed for complement activation of B cells. So 
we examined the level of CD19 by qRT-PCR, a marker often used for gene expression to 
detect B cells. We found that CD19 was also significantly decreased by BPA exposure 
during acute myocarditis (p=0.03) (Fig 19B), which indicates that BPA decreases CR2 
leading to reduced numbers and/or activation of B cells. These data show that BPA 
downregulates CR1, which could contribute to increased mast cell activation (i.e., 
degranulation) with viral and BPA co-exposure. 
 
Figure 19. BPA exposure decreases CR1 and CD19/CR2 expression in the heart during 
myocarditis. Female BALB/c mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 BPA) in 
their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. BPA 
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exposure continued from day 0 to 10 pi. Hearts were harvested at day 10 pi during acute myocarditis. 
Relative gene expression (RGE) of A) CR1/2 and B) CD19 (part of the complement-activated CR2 
signaling complex on B cells) were compared to Hprt controls in the heart by qRT-PCR at day 10 pi 
comparing 0 to 5 µg BPA/kg BW estimated intake groups. Data show the mean +/-SEM using a two-
tailed Student’s t or Mann-Whitney rank test with 7-9 mice/ group. 5 µg BPA/kg BW was obtained 
by dosing water with 25 µg BPA/L. 
 
BPA treatment increases TLR4/IL-1R/caspase-1/IL-1β pathway activation in the heart 
during myocarditis 
We showed previously that components of IL-1R-mediated signaling (i.e., TLR4, IL-
1R antagonist, caspase-1, IL-1β and IL-18) are upregulated in the heart during CVB3 
myocarditis in mice and that testosterone elevates this pathway on mast cells and 
macrophages during the innate and adaptive immune response to CVB3 (Frisancho-Kiss 
2006A, Frisancho-Kiss 2007, Frisancho-Kiss 2009, Coronado 2012, Roberts 2013, 
Fairweather 2015). In this study we found that BPA exposure significantly increased 
expression of components of this pathway in the heart during acute CVB3 myocarditis in 
female BALB/c mice (Fig 20). We found that TLR4 (p=0.01), caspase-1 (p=0.001) and IL-
1β (p=0.009) levels were significantly increased by BPA exposure compared to 0 BPA 
control water (Fig 20). IL-1R2, which is part of the IL-1R/TLR complex, was not 
significantly different between groups (p=0.06) (Fig 20). Expression of ST2 receptor, which 
is part of the TLR/IL-1R signaling family and expressed on mast cells and macrophages, was 
also significantly increased in the heart by BPA exposure during myocarditis using qRT-PCR 




Figure 20. BPA exposure activates TLR4 pathway genes during myocarditis. Female BALB/c 
mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 BPA) in their drinking water for 2 weeks 
and then injected ip with 103 PFU of CVB3 ip on day 0. BPA exposure continued from day 0 to 10 pi. 
Hearts were harvested at day 10 pi during acute myocarditis. Relative gene expression (RGE) of 
genes vs. the housekeeping control Hprt for TLR4, IL-1R2, and caspase-1 were examined in whole 
hearts by qRT-PCR at day 10 pi comparing 0 to 5 µg BPA/kg BW groups. IL-1β levels were 
determined using ELISA from homogenized whole heart supernatants. Data show the mean +/-SEM 
using a two-tailed Student’s t or Mann-Whitney rank test with 7-10 mice/ group. 5 µg BPA/kg BW 
was obtained by dosing water with 25 µg BPA/L. 
 
BPA alters cardiac Mmp9, IL-1β and IL-17: factors associated with cardiac remodeling 
during CVB3 myocarditis in male mice 
We and others have shown previously that elevated TLR4/IL-1β/inflammasome 
activation, mast cell activation, IL-17, complement activation, reduced complement 
regulation by CR1, and decreased Mmp3 and Mmp9 during acute CVB3 myocarditis lead to 
remodeling and fibrosis and the progression to DCM and chronic heart failure in male 
BALB/c mice (Fairweather 2004A, Fairweather 2006, Baldeviano 2010, Coronado 2012, Wu 
2014). Previously, it has been shown using knockout mice that tissue inhibitor of 
metalloproteinases (Timp) exacerbates remodeling during CVB3 myocarditis by regulating 
Mmp expression in the heart (Crocker 2007). 
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Because BPA exposure was found to increase the TLR4 signaling pathway, mast cell 
degranulation, IL-17A, complement activation, and reduced complement regulation by CR1, 
we examined whether BPA promoted factors associated with cardiac remodeling during 
acute myocarditis- a timepoint when profibrotic genes/proteins are elevated but histologic 
fibrosis (i.e., collagen deposition) is not yet present (Coronado 2012).We found that BPA 
exposure did not significantly alter expression of Timp1 or Mmp3 in the heart, but 
significantly decreased Mmp9 (p=0.04) (Fig 21), which could lead to increased remodeling 
in the heart. (Fig 21A). As shown previously, BPA exposure significantly increases the 
profibrotic cytokines IL-1β and IL-17A in the heart by ELISA, but did not alter transforming 
growth factor (TGF)β gene expression by qRT-PCR (Fig 21B). However, in the future TGF-
β1 levels in the heart should be examined using ELISA because gene expression often does 
not relate to active protein levels. 
        
Figure 21. BPA exposure increases certain remodeling factors in the heart during myocarditis. 
Female BALB/c mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 BPA) in their drinking 
water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. BPA exposure continued 
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from day 0 to 10 pi. Hearts were harvested at day 10 pi during acute myocarditis. Relative gene 
expression (RGE) of A) Timp1, Mmp3, Mmp9 and B) TGFβ vs. the housekeeping gene Hprt were 
analyzed in whole hearts by qRT-PCR at day 10 pi comparing 0 to 5 µg BPA/kg BW groups. In a 
separate experiment hearts were harvested at day 10 pi, homogenized and the supernatant used to 
measure B) IL-1β and IL-17A levels in the heart by ELISA. Data show the mean +/-SEM using a 
two-tailed Student’s t or Mann-Whitney rank test with 9-10 mice/ group. 5 µg BPA/kg BW was 
obtained by dosing water with 25 µg BPA/L. 
 
BPA exposure causes increased pericardial, vascular and myocardial fibrosis during acute 
myocarditis 
 Fibrosis, assessed histologically as collagen deposition using Trichrome blue stain, is 
not present in the heart of male or female mice during acute CVB3 myocarditis, and only 
begins to appear during chronic myocarditis around day 35 pi (Fairweather 2004A, 
Fairweather 2005). However, remodeling genes are upregulated in the heart during acute 
myocarditis rather than during chronic myocarditis (Coronado 2012). Thus, typically 
collagen deposition, which stains bright blue with Trichrome blue staining, occurs around 2-3 
weeks after upregulation of profibrotic genes in the heart. We have shown previously that 
this process can be accelerated and occur during acute myocarditis if certain pathways are 
dysregulated like CR1, TRIF or IL-33/ST2 (Fairweather 2006, Abston 2012A, Abston 
2012B). Because we saw a decrease in CR1 and Mmp9 and an increase in IL-1β and IL-17A 
from BPA exposure- all factors that increase cardiac fibrosis, we examined whether BPA 
exposure could alter fibrosis in the heart during acute myocarditis. We found that that almost 
all mice exposed to 5 µg BPA/kg BW had increased pericardial fibrosis, shown in 
representative photos in Figure 22B. Most of the mice exposed to BPA also had greater 
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perivascular (Fig 22D) and myocardial (Fig 23B) fibrosis compared to mice with control 
water. In future studies the sections will be re-stained with Sirius red, which is easier to 
quantify using imaging software than Trichrome blue (Huang 2013). These data indicate that 
BPA exposure is able to hasten the onset of remodeling and fibrosis, which usually takes 
several weeks to develop. The mice had not yet developed DCM based on gross assessment 
of histology sections. However, pericardial fibrosis can cause changes in cardiac function 
that are able to be detected by echocardiography (i.e., restrictive phenotype or DCM). In 
future studies we will assess whether exposure to BPA led to increased cardiac dysfunction 
using echocardiography. 
 
Figure 22. Representative photos of pericardial and perivascular fibrosis. Female BALB/c mice 
were given 0 or 5 µg/kg BW bisphenol A in their drinking water for 2 weeks and then injected ip with 
103 PFU of CVB3 ip on day 0. BPA exposure continued from day 0 to 10 pi. Hearts were harvested at 
day 10 pi during acute myocarditis. Fibrosis was assessed using Trichrome blue to detect collagen 
deposition, which stains bright blue. A) Normal pericardial layer; arrow points to a single layer of 
pericardial cells that stain blue with Trichrome. B) Severe pericarditis with fibrosis that stains bright 
blue (arrow). C) Normal level of perivascular fibrosis; arrows point to two vessels. D) Severe 
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perivascular fibrosis (arrow). Photos depict A) and C) 0 µg BPA/kg BW; B) and D) 5 µg BPA/kg 
BW. Grey bar is 200µm in length. 
     
Figure 23. Representative photos of myocardial fibrosis. Female BALB/c mice were given A) 0 or 
B) 5 µg/kg BW bisphenol A in their drinking water for 2 weeks and then injected ip with 103 PFU of 
CVB3 ip on day 0. BPA exposure continued from day 0 to 10 pi. Hearts were harvested at day 10 pi 
during acute myocarditis. Fibrosis was assessed using Trichrome blue to detect collagen deposition, 
which stains bright blue. Grey bar is 200µm in length. 
 
BPA exposure decreases ERα and increases ERβ in the heart during CVB3 myocarditis 
 Estrogen receptors (ERs) are located on/in immune cells, cardiomyocytes, endothelial 
cells, and cardiac fibroblasts (Regitz-Zagrosek 2008, Vitale 2009, Gilliver 2010, Villablanca 
2010, Buskiewicz 2016). ERα is believed to mediate most of the cardioprotective effects of 
estrogen in women based on studies in patients and animal models of hypertrophy, DCM and 
fibrosis (Regitz-Zagrosek 2008). In contrast, ERβ has been shown to have negative effects on 
cardiac function during these diseases in cell culture and mouse models (Liang 2014, Belcher 
2015). Little is known about the effect of ERRγ signaling on/in immune cells or cardiac 
physiology or disease (Kuiper 1997, Zaid 2015). The role of ERα and ERβ signaling has not 
been previously investigated in myocarditis. In Chapter 2, we showed that gonadectomy of 
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female BALB/c mice (in plastic caging) significantly increased acute CVB3 myocarditis and 
this effect was significantly reversed using estradiol pellets (Chapter 2, Fig 2), indicating 
that estrogen reduces CVB3-induced myocarditis in mice. 
BPA binds ERs (Kuiper 1997, Hiroi 1999, Molina-Molina 2013, Li 2015, Zaid 2015) 
and so exposure to BPA has the potential to alter myocarditis. BPA binds to ERα and ERβ at 
a 10,000 fold lower affinity than natural estrogen, but binds ERRγ with a higher affinity 
(Kuiper 1997, Zaid 2015). Interestingly, BPA treatment of cultured cardiomyocytes was 
found to induce arrhythmias via ERβ (Belcher 2012), suggesting that detrimental effects of 
BPA on cardiomyocytes may be mediated via ERβ rather than ERα. In this study, we found 
that BPA exposure decreased the mRNA expression of ERα in the heart during CVB3 
myocarditis (p=0.02) (Fig 24A), increased the expression of ERβ (p=0.04) (Fig 24B), but 
had no significant effect on ERRγ (p=0.38) (Fig 24C) and the androgen receptor (AR) 
(p=0.91) (Fig 24D). ERRγ levels were barely detectable above the housekeeping gene Hprt 
(i.e., RGE at 1) (Fig 24D), suggesting that this ER plays a minimal role in increasing 
inflammation following BPA exposure. Although it is not believed that BPA binds to the AR 
directly, one study found that BPA can act as both an agonist and antagonist for the AR 
(Molina-Molina 2013). Additionally, it is possible that changes in ERs may alter the 
expression of the AR and so the receptor was examined for completeness. Based on our 
finding that BPA exposure increased acute myocarditis in female BALB/c mice (Chapter 4, 
Fig 2), these data suggest that ERα signaling reduces while ERβ signaling increases 
myocarditis- similar to the role for these receptors in other cardiovascular diseases. These 
findings also suggest that BPA mediates its effect by altering ERα and ERβ expression levels 
in the heart and/or on cardiac inflammation. 
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Figure 24. BPA exposure decreases ERα, but increases ERβ mRNA levels in the heart during 
myocarditis. Female BALB/c mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 BPA) in 
their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. BPA 
exposure continued from day 0 to 10 pi. Hearts were harvested at day 10 pi during acute myocarditis. 
Relative gene expression (RGE) of A) ERα, B) ERβ, C) ERRγ and D) AR vs. the housekeeping gene 
HPRT were analyzed in whole hearts by qRT-PCR at day 10 pi comparing 0 to 5 µg BPA/kg BW 
groups. Data show the mean +/-SEM using a two-tailed Student’s t or Mann-Whitney rank test with 
8-10 mice/ group. 5 µg BPA/kg BW was obtained by dosing water with 25 µg BPA/L. 
 
BPA exposure increases activation of cardiac ERα and ERβ during myocarditis 
 In order to determine whether BPA exposure altered ERs at the protein level we 
conducted Western blots. Activation of ERs requires phosphorylation (Campesi 2016). We 
assessed if BPA altered activation of ERα and/or ERβ by determining protein levels of the 
phosphorylated form of the receptors. We found that BPA exposure did not significantly alter 
total protein levels of ERα (Fig 25) or ERβ (Fig 26), contrary to the mRNA results (Fig 24) 
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where we found that BPA decreased mRNA levels of ERα and increased expression of ERβ. 
We found that BPA exposure significantly increased protien levels of phosphorylated-ERα 
(p-ERα) (Fig 25) and phosphorylated-ERβ (p-ERβ) (Fig 26) in the heart of female BALB/c 
mice during myocarditis. These data confirm that BPA was able to activate cardiac ERα and 
ERβ during myocarditis. Westerns were conducted only one time using 5 mice per group and 
so should be repeated with larger numbers per group to strengthen these findings. 
 
Figure 25. BPA exposure significantly increases phosphorylation of ERα (p-ERα) in the heart 
during myocarditis. Female BALB/c mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 
BPA) in their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. 
BPA exposure continued from day 0 to 10 pi. Hearts were harvested at day 10 pi during acute 
myocarditis. A) Western blot images for ERα, p-ERα and Hprt. B) Quantitation of western blot data 
for ERα (left) and p-ERα (right) adjusted against Hprt levels. Data show the mean ±SEM using a 
two-tailed Mann-Whitney rank test with 5 mice/ group. 5 µg BPA/kg BW was obtained by dosing 




Figure 26. BPA exposure significantly increases phosphorylation of ERβ (p-ERβ) in the heart 
during myocarditis. Female BALB/c mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 
BPA) in their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. 
BPA exposure continued from day 0 to 10 pi. Hearts were harvested at day 10 pi during acute 
myocarditis. A) Western blot images for ERβ, p-ERβ and Hprt. B) Quantitation of western blot data 
for ERβ (left) and p-ERβ (right) adjusted against Hprt levels. Data show the mean ±SEM using a one-
tailed Mann-Whitney rank test with 5 mice/ group. 5 µg BPA/kg BW was obtained by dosing water 
with 25 µg BPA/L. 
 
BPA exposure increases ERα and ERβ mRNA at 24 hours pi in the spleen 
 To assess whether BPA exposure altered ER expression on/in immune cells during 
the innate immune response to CVB3 infection, we exposed mice for 2 weeks prior to ip 
injection with CVB3 with various doses of BPA in their drinking water and examined ERα, 
ERβ, ERRγ and AR expression by qRT-PCR from spleens at 24 hours pi. BPA exposure in 
drinking water continued until harvest. Data are shown only for the 0 and 5 µg/kg BW dose 
of BPA. We found that BPA exposure significantly increased ERα (p=0.04) (Fig 27A) and 
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ERβ (p=0.001) (Fig 27B) levels in the spleen, but had no significant effect on ERRγ (p=0.19) 
(Fig 27C) or the AR (p=0.84) (Fig 27D) levels compared to 0 BPA control water at 24 hours 
pi. Notice that ERRγ and AR levels are close to the housekeeping gene level of 1 RGE 
compared to the high activation level of ERα and ERβ (Fig 27). These data suggest that BPA 
exposure upregulates and/or activates ERs on/in immune cells during the innate immune 
response to CVB3 because the spleen is primarily composed of immune cells. 
 
Figure 27. BPA exposure upregulates ERα and ERβ mRNA at 24 hours pi in the spleen. Female 
BALB/c mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 BPA) in their drinking water 
for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. BPA exposure continued from 
day 0 to 24 hours pi. Spleens were harvested at 24 hours pi during the innate immune response to 
CVB3. Relative gene expression (RGE) of A) ERα, B) ERβ, C) ERRγ and D) AR vs. the 
housekeeping gene Hprt were analyzed in whole spleens by qRT-PCR at 24 hours pi comparing 0 to 5 
µg BPA/kg BW groups. Data show the mean +/-SEM using a two-tailed Mann-Whitney rank test 




BPA exposure decreases VDR expression in the heart of females during myocarditis 
We have found that estradiol replacement after ovariectomy increases VDR 
expression in the heart of females where it plays a protective role (Chapter 3, Fig 2A). ERα 
has been reported as a VDRE gene and we found that ERα is upregulated during myocarditis 
(Chapter 3, Supplemental Table 1). In Chapter 3 we showed that VDR deficient female 
mice had significantly increased acute myocarditis (p=0.02) (Chapter 3, Fig 3), indicating 
that VDR signaling reduces CVB3 myocarditis in female mice. Furthermore, we found that 
VDR deficient female mice had significantly increased T cells (Chapter 3, Fig 4), IFNγ and 
IL-17A (Chapter 3, Fig 5), and TLR4 pathway activation (Chapter 3, Fig 7) in the heart 
during acute CVB3 myocarditis. These are precisely the same findings we observed in WT 
female mice with CVB3 myocarditis exposed to BPA (Chapter 4, Figures 2, 7B, 8, 18). For 
this reason we examined the expression of the VDR and the Cyps that lead to active VitD in 
the heart during acute myocarditis in female mice exposed to BPA. Recall that VitD obtained 
from exposure to the sun or from dietary sources is hydroxylated in the liver (and other 
organs) by 25-hydroxylase (Cyp2R1) and carried in the bloodstream by VitD binding protein 
(DBP) to the kidney where it is converted by 25-OH-D-1-hydroxylase (Cyp27B1) to the 
active form of VitD (i.e., 1,25-dihydroxyvitamin D3), which binds the VDR (Plum 2010, 
Zittermann 2010, Rowling 2007, Zhu 2013). VitD is regulated in part by Cyp24A1, which 
actively down-regulates VitD levels (Zittermann 2010). We have found that all of these 
VitD-related Cyps are present in the heart during CVB3 myocarditis (Chapter 3, Table 1). 
Here we found that BPA exposure significantly decreased VDR (p=0.02) and 
Cyp27B1 (p=0.01) expression in the heart during myocarditis by qRT-PCR, but had no 
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significant effect on Cyp2R1 (p=0.41) or Cyp24A1 (p=0.88) levels (Fig 28). Our findings 
suggest that one way that BPA could increase inflammation in the heart of female mice is by 
reducing VDR levels. 
 
Figure 28. BPA exposure decreases VDR expression in the heart of females with myocarditis. 
Female BALB/c mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 BPA) in their drinking 
water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. BPA exposure continued 
from day 0 to 10 pi. Hearts were harvested at day 10 pi during acute myocarditis. Relative gene 
expression (RGE) of A) VDR, B) Cyp27B1, C) Cyp2R1 and D) Cyp24A1 vs. the housekeeping gene 
Hprt were analyzed in whole hearts by qRT-PCR at day 10 pi comparing 0 to 5 µg BPA/kg BW 
groups. Data show the mean +/-SEM using a two-tailed Mann-Whitney rank test with 6-10 mice/ 
group. 5 µg BPA/kg BW was obtained by dosing water with 25 µg BPA/L. 
 
BPA exposure did not alter protein levels of VDR in the heart during myocarditis 
 We used Western blots to determine whether BPA exposure altered VDR protein 
levels in the whole heart during myocarditis. We found that BPA exposure did not 
significantly alter total protien levels of VDR in the heart of female BALB/c mice with 
myocarditis (Fig 29) in contrast to our finding that VDR mRNA expression was decreased by 
qRT-PCR (Fig 28). An antibody against phosphorylated VDR was not available to check 
activation of the receptor. However, this Western was conducted only one time using 5 mice 
per group and so should be repeated with larger numbers per group to confirm these findings. 
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Figure 29. BPA exposure did not alter protein levels of VDR in the heart during myocarditis. 
Female BALB/c mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 BPA) in their drinking 
water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. BPA exposure continued 
from day 0 to 10 pi. Hearts were harvested at day 10 pi during acute myocarditis. A) Western blot 
images for VDR and Hprt. B) Quantitation of western blot data for VDR adjusted against Hprt levels. 
Data show the mean ±SEM using a two-tailed Student’s t test with 5 mice/ group. 5 µg BPA/kg BW 
was obtained by dosing water with 25 µg BPA/L. 
 
BPA exposure does not alter VDR expression in the spleen at 24 hours pi 
 To assess whether BPA exposure altered VDR expression on/in immune cells during 
the innate immune response to CVB3 infection, we exposed mice for 2 weeks prior to ip 
injection with CVB3 with various doses of BPA in their drinking water and VDR expression 
by qRT-PCR from spleens at 24 hours pi. BPA exposure in drinking water continued until 
harvest. Data are shown only for the 0 and 5 µg/kg BW dose of BPA. We found that BPA 
exposure did not significantly alter VDR levels in the spleen at 24 hours pi (p=0.04) (Fig 30). 
VDR is expressed on monocyte macrophages and mast cells (Bickle 2011), which are cell 
types present in the spleen of BALB/c mice (Fairweather 2004B). These data suggest that the 
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ability of BPA to reduce VDR expression in the heart may occur on cardiac immune or tissue 
cells. 
 
Figure 30. BPA exposure does not alter VDR expression in the spleen at 24 hours pi. Female 
BALB/c mice were given 0 or 5 µg/kg BW bisphenol A (0 BPA vs. 5 BPA) in their drinking water 
for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. BPA exposure continued from 
day 0 to 24 hours pi. Spleens were harvested at 24 hours pi during the innate immune response to 
CVB3. Relative gene expression (RGE) of VDR vs. the housekeeping gene Hprt was analyzed in 
whole spleens by qRT-PCR at 24 hours pi comparing 0 to 5 µg BPA/kg BW groups. Data show the 
mean +/-SEM using a two-tailed Student’s t test with 9-10 mice/ group. 5 µg BPA/kg BW was 





In this study we found that BPA exposure to adult female BALB/c mice housed in 
plastic caging significantly increased myocarditis at day 10 pi at a high human relevant dose 
(25 µg BPA/L water or 5 µg BPA/kg BW) compared to control water (Fig 2&3). Using qRT-
PCR to determine virus expression in the heart revealed that viral levels were not 
significantly altered by BPA exposure (Fig 6), suggesting that increased myocarditis was not 
due to BPA altering viral replication. The primary effect of BPA exposure on acute CVB3 
myocarditis was to increase the number of infiltrating CD4+ T cells, according to qRT-PCR 
(Fig 7B). Interestingly, BPA exposure at all doses that we tested increased pericarditis (Fig 
4&5) and mast cell degranulation along the pericardium (Fig 13), which is known to 
contribute to cardiac dysfunction (Afanasyeva 2004, Fairweather 2004A). When mast cells 
were assessed histologically using toluidine blue to detect granules we saw the primary effect 
of BPA on the heart was to induce degranulation of pericardial mast cells rather than 
myocardial or mast cells near vessels. BPA exposure significantly decreased ERα (Fig 24) 
and VDR (Fig 28) expression in the heart by qRT-PCR of females during myocarditis- 
receptors that usually protect females from myocarditis (Chapter 3 Fig 3). In contrast, BPA 
exposure significantly increased ERβ in the heart of females by qRT-PCR during myocarditis 
(Fig 24)- a receptor that has been hypothesized to be associated with worse cardiac function 
(Liang 2014). We found that BPA exposure activated both ERα and ERβ during myocarditis 
(Fig 25&26). Inflammatory signaling pathways known to increase myocarditis and DCM in 
males and that are associated with mast cell activation (i.e., TLR4, IL-1β, 
complement/anaphylaxis, TIMP-1) were significantly increased in females after BPA 
exposure (Kaya 2001, Fairweather 2006, Coronado 2012). BPA exposure in mouse models 
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of lupus and human immune cells have also found that BPA activates the TLR4 pathway 
causing the release of mature IL-1β and IL-18 (Panchanathan 2015). Thus, BPA exposure 
appears to have converted the cardioprotective female immune response to a 
proinflammatory and profibrotic immune response that is typically associated with increased 
myocarditis in males (Fig 31). 
 
Figure 31. Possible mechanisms to explain how BPA increases myocarditis in female BALB/c 
mice housed in plastic cages. BPA decreases ERα expression in the heart during CVB3 myocarditis. 
ERα transcriptionally regulates VDR levels and causes a decrease in VDR expression in the heart. 
Mast cells, especially along the pericardium, are activated without the inhibitory effect of ERα and 
VDR to control them. Mast cells are key cells that are involved in complement and 
TLR4/inflammasome pathways, and without the regulating effect of ERα and VDR mast cells 
increase these mediators, which are usually characteristic of males. BPA also increases ERβ, which 
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may also lead to increased mast cells or T cells and overall increased levels of myocardial 
inflammation. We showed in Chapter 3 that VDR signaling protects female mice from CVB3 
myocarditis. Data from this Chapter further suggests that VDR signaling in females is protective 
because it occurs in the context of ERα signaling. Thus, BPA exposure to females disrupts these two 
key signaling pathways that prevent damaging pathology after CVB3 infection. 
 
A recent study in a rat model assessed the effect of BPA on the uterus and found that 
BPA treatment downregulated ERα and upregulated ERβ mRNA in a manner similar to our 
findings in BALB/c female mice with CVB3 myocarditis housed in plastic cages (Zaid 
2015). Another study in mice found BPA increased ERβ levels which promoted cardiac 
arrhythmias and worse cardiac handling, while ERα was protective (Liang 2014). The 
opposing action of the two main ERs in these studies has been investigated and it has been 
found that ERα and ERβ transcriptionally cross-regulate each other (Hall 1999, La Rosa 
2012, Acconcia 2015). But it is also thought that ERRγ, which BPA strongly binds to, can 
also regulate ERα by heterodimerizing leading to transcriptional repression (Matsushima 
2007, Zaid 2015). Additionally, BPA can act as a ERβ antagonist rather than an agonist and 
prevent estrogen-driven non-genomic signaling pathways that could possibly be protective 
(Bolli 2010, Marino 2012, Acconcia 2015). 
Our studies found that BPA increases myocarditis in BALB/c female mice housed in 
traditional plastic caging primarily by increasing CD4 T cell expression and activating 
pericardial mast cells. Two recent in vitro studies using bone marrow-derived mast cells from 
mice found that mast cells were activated by BPA indicating that BPA could cause mast cell 
degranulation (O’Brien 2014A, O’Brien 2014B). Interestingly, we noticed that BPA 
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exposure appeared to cause fat accumulation in the heart during acute myocarditis (data not 
shown). In future studies we will stain histology sections to assess lipid content. If this 
observation is found to be true, it would agree with epidemiological studies indicating that 
BPA exposure increases the risk for type II diabetes (Bodin 2014, Rezg 2014), and a study in 
a mouse model of atherosclerosis that found that BPA exposure increased subcutaneous and 
visceral adipose tissue (Fang 2014). 
 Here we found that BPA exposure increased IL-1β, IFNγ and IL-17 in females during 
myocarditis (Fig 8)- a cytokine profile usually associated with myocarditis in males. BALB/c 
females typically have elevated Th2-type immune responses with elevated IL-4, IL-33 and 
ST2 levels in the heart during CVB3 myocarditis (Frisancho-Kiss 2007, Coronado 2012). 
BPA has been found to cause shifts from a Th2 (IL-4) to Th1 (IFNγ)-type immune (Youn 
2002A, Youn 2002B, Tain 2004, Kharrazian 2014, Thompson 2015), which agrees with our 
findings. BPA treatment in cell culture of a monocyte-like cell line derived from a leukemia 
patient and human peripheral blood macrophages have been found to release the 
proinflammatory cytokines TNFα and IL-6 and to decrease the anti-inflammatory/ regulatory 
cytokines IL-10 and TGFβ (Lui 2014). Lui et al showed that this effect on cytokines by BPA 
was mediated through ERs (both ERα and ERβ) (Lui 2014). BPA has been found to increase 
IFNγ in mouse bone marrow cells and isolated CD11b+ cells through via ERα 
(Panchanathan 2015, Youn 2002), suggesting that BPA could be acting through ERs located 
directly on immune cells to shift the cytokine profile in the heart. 
 Overall, our data in this Chapter shows that BPA at all doses studied has the potential 
to cause cardiac dysfunction by activating mast cells and inducing pericarditis, and that the 
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high human relevant dose of 25 µg BPA/L water or 5 µg BPA/kg BW significantly increases 








Comparison of plastic vs. glass cages in male and 
female BALB/c mice: 
 
Plastic cages increase mast cells and AR expression in 











Myocarditis is an inflammatory heart disease that leads to DCM and heart failure in 
men and male mice. ERα is believed to protect women from severe myocarditis, DCM and 
heart failure while ERβ is thought to negatively impact cardiac function. The human 
population is widely exposed to the endocrine disruptor BPA from plastics, such as water 
bottles, plastic food containers, and receipts. Thus, BPA could increase myocarditis in 
females through deleterious actions of the ERβ rather than beneficial effects via ERα. 
Traditional plastic cages and water bottles used to house mice are believed to leach plastics 
into the drinking water by surface contact that could affect experiments. To our knowledge 
no one has examined the role of plastic caging as an exposure to an endocine disruptor in 
animal models such as myocarditis. In this study, we found that female BALB/c mice 
exposed to plastic caging alone compared to mice housed in glass cages with glass water 
bottles significantly increased mast cell numbers (cKit via qRT-PCR) and AR expression in 
the heart during CVB3 myocarditis. The same experiment in male BALB/c mice revealed 
that plastic caging alone increased myocarditis with elevated levels of CD11b (marker on 
macropahges and mast cells and other cells) and GR1 (neutrophil marker) by qRT-PCR. 
Plastic caging also increased genes in the heart of male BALB/c mice related to pathways 
known to increase myocarditis in males including complement (C4b, C5aR1), the TLR4/IL-
1R (IL-1R2), remodeling genes (TIMP-1), and appeared to shift macrophages from an M1 to 
M2 phenotype. BPA also increased ERβ and decreased ERα and AR expression in males 
with myocarditis compared to glass caging. These findings suggest that traditional plastic 
cages and water bottles used for mouse experiments could be leaching BPA and/or other 
endocrine disruptors and affecting animal experiments in a sex-specific manner. Our data 
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suggest that the sex difference that we see in many animal models of disease may actually be 
driven by exposure to BPA/plastics leaching from the plastic cages used by almost every 
laboratory. Interestingly, the same sex differences we observe in many animal models mirror 
sex differences in the human population (myocarditis for example) which may indicate that 
the widespread exposures to plastics in our environment and food may be driving sex 








Dr. Ana Soto from Tufts has been working on endocrine disruptors since 1989 and is 
one of the leading experts. Dr. Soto was the first person to discover that laboratory supplies 
contain endocrine disrupting chemicals such as BPA and nonylphenol (Sonnenschein 1998). 
Dr. Soto first discovered that laboratory supplies contained endocrine disruptors because it 
was effecting her laboratory cell culture experiments and she wanted to determine what was 
causing the abnormality. 
Recent articles have begun to address concerns associated with animal studies that are 
attempting to understand the role of endocrine disruptors, such as BPA, on immune function 
and/or disease. These articles have identified a number of potentially confounding issues 
including plastic cages, food and bedding containing genestein from soy or other 
phytoestrogens, enormous variation in the doses of BPA used in experiments, and varying 
exposure methods (Mirmina 2014). All of these factors could be affecting experiments that 
are assessing the effect of endocrine disruptors on normal physiology or disease. These 
factors could also be affecting all of our experiments aside from the studies examining the 
role of endocrine disruptors. This is a virtually unstudied area of research. Here we wanted to 
determine the effect of plastic cages and water bottles alone (without the addition of BPA to 
drinking water) on CVB3 myocarditis in female and male BALB/c mice compared to glass 
cages and water bottles that should not leach plastics/ BPA. Our studies were performed 
using soy free bedding and food to prevent additional estrogens from confounding our 





Plastic cages increase cKit expression (mast cells) in BALB/c females during CVB3 
myocarditis 
Laboratory animals are traditionally housed in polycarbonate cages with polysulfone 
water bottles. Both of these plastics contain BPA as one of the monomers that make up their 
structure, and the chemical can leach from the plastic especially when heated as occurs 
routinely when cages are autoclaved in order to sterilize them between uses and higher levels 
of plastics can be released from older cages (Howdeshell 2003). In order to determine 
whether the plastic cages and water bottles used in our experiments affected myocarditis, we 
compared glass cages and water bottles (no BPA) to plastic cages and water bottles (possible 
BPA or other chemicals/plastics released due to leaching). We used soy-free bedding and 
food to remove the effect of these estrogenic compounds from complicating the outcome. 
The water bottles in glass and plastic cages contained MilliQ water (i.e., did not contain 
additional BPA) throughout the experiment. Female BALB/c mice were infected on day 0 
and myocarditis, individual immune cells, and viral levels assessed at day 10 pi, as 
previously. 
We found that plastic cages significantly increased cKit expression (i.e., mast cell 
levels) in females (p=0.04) (Fig 1), but did not alter myocarditis/ inflammatory infiltrates 
(Fig 2) or viral levels (Fig 3) in the heart by qRT-PCR. These findings indicate that the 
plastic cages and water bottles could possibly contribute to mast cell proliferation/activation 
in female BALB/c mice aside from the dose of BPA added to the water in the experiments 
shown in Chapter 4. These findings will need to be confirmed using histology and/or flow 




Figure 1. Plastic cages/water bottles alone increase cKit expression (i.e., mast cell numbers) in 
BALB/c females. Female BALB/c mice were given normal drinking water (no BPA) for 2 weeks 
when housed in glass cages/water bottles (0 BPA) vs. plastic cages/water bottles (possible BPA 
leaching) using soy-free food and bedding. Mice were injected ip with 103 PFU of CVB3 ip on day 0. 
Hearts were harvested at day 10 pi during acute myocarditis. Relative gene expression (RGE) of cKit/ 
CD117 (mast cells) vs. the housekeeping gene Hprt was analyzed in whole hearts by qRT-PCR at day 
10 pi comparing mice in glass vs. plastic cages. Data show the mean +/-SEM using a two-tailed 
Student’s t test with 9-10 mice/ group.  
 
Figure 2. Plastic cages/water bottles do not alter myocardial inflammation in female BALB/c 
mice. Female BALB/c mice were given normal drinking water (no BPA) for 2 weeks when housed in 
glass cages/water bottles (0 BPA) vs. plastic cages/water bottles (possible BPA leaching) using soy-
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free food and bedding. Mice were injected ip with 103 PFU of CVB3 ip on day 0. Hearts were 
harvested at day 10 pi during acute myocarditis. A) Myocarditis was assessed as the % inflammation 
compared to the size of the total heart section using H&E stained sections and a microscope grid. 
Relative gene expression (RGE) was used to assess B) total lymphocytes (CD45), C) CD11b+ cells 
(i.e., macrophages, neutrophils, mast cells), D) F4/80+ macrophages, E) all T cells (CD3), F) CD4+ T 
cells, G) CD8+ T cells, and H) CD19+ B cells compared to the housekeeping gene Hprt in whole 
hearts by qRT-PCR at day 10 pi comparing mice in glass vs. plastic cages. Data show the mean +/-
SEM using a two-tailed Student’s t test or the Mann-Whitney rank test with 10 mice/ group. 
 
Figure 3. Viral gene expression in the heart of females was not effected by plastic cages. Female 
BALB/c mice were given normal drinking water (no BPA) for 2 weeks when housed in glass 
cages/water bottles (0 BPA) vs. plastic cages/water bottles (possible BPA leaching) using soy-free 
food and bedding. Mice were injected ip with 103 PFU of CVB3 ip on day 0. Hearts were harvested at 
day 10 pi during acute myocarditis. CVB3 levels in the heart were measured using qRT-PCR to 
determine relative gene expression (RGE) of viral genome compared to the housekeeping gene Hprt. 
Data show the mean +/-SEM using a two-tailed Student’s t test or the Mann-Whitney rank test with 
7-9/group. 
 
Plastic cages increase androgen receptor expression in the hearts of female BALB/c mice 
during myocarditis  
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Since BPA is a known component of most plastic cages used in laboratory animal 
housing and we have found that BPA activates hormone receptors using Western blots 
(Chapter 4), we investigated whether glass vs. plastic cages altered sex hormone receptor 
expression in the heart of female BALB/c mice at day 10 pi with CVB3. We found that 
plastic cages significantly increased AR expression in females during acute myocarditis 
compared to glass cages using qRT-PCR (p=0.04) (Fig 4A), but had no significant effect on 
the expression of other sex hormone receptors (i.e., VDR, ERα, ERβ, and ERRγ) (Fig 4). 
Quite surprisingly we found that plastic cages and water bottles independently increased AR 
expression in the heart of female BALB/c mice during acute myocarditis when soy food and 
bedding were not present. 
 
Figure 4. Plastic cages increase AR expression in the hearts of female BALB/c mice during 
myocarditis cages. Female BALB/c mice were given MilliQ drinking water (no BPA) for 2 weeks 
when housed in glass cages/water bottles (0 BPA) vs. plastic cages/water bottles (possible BPA 
leaching) using soy-free food and bedding. Mice were injected ip with 103 PFU of CVB3 ip on day 0. 
Hearts were harvested at day 10 pi during acute myocarditis. Relative gene expression (RGE) vs. Hprt 
controls for A) AR, B) VDR, C) ERα, D) ERβ,  and E) ERRγ  mRNA by qRT-PCR at day 10 pi 
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comparing glass to plastic cages. Data show the mean ±SEM using a two-tailed Student’s t or Mann-
Whitney rank test with 10 mice/ group. 
 
Plastic cages increase myocarditis in male BALB/c mice during CVB3 myocarditis  
In this study, we compared glass cages and water bottles to traditional plastic cages 
and water bottles during myocarditis in male BALB/c mice using control water (containing 
no BPA) to assess the effect of caging on myocarditis. Mice received soy-free food and 
bedding. We found that plastic cages significantly increased myocarditis in males compared 
to glass cages assessed histologically (p=0.01) (Fig 5). Male BALB/c mice in our model of 
CVB3 myocarditis typically have inflammation ranging from 30-50% of the heart section, 
and these data were obtained with traditional plastic caging (Coronado 2012). These data 
suggest that the plastic cages used to house mice have been increasing myocarditis in male 
BALB/c mice, creating a “sex-difference” in myocarditis and DCM. Plastic cages (no 
additional BPA) increased cKit expression (i.e., mast cells) but not myocardial inflammation 
in BALB/c females (Fig 1 and 2). Interestingly, the same sex difference that we observe for 
myocarditis and DCM in BALB/c mice housed in plastic cages (i.e., worse in males) exists 
for myocarditis and DCM patients (McNamara 2011, Fairweather 2013). Because we found 
that plastic cages are affecting myocarditis in males (aside from BPA exposure), in future 





Figure 5. Plastic cages increase myocarditis in male mice. Male BALB/c mice were given normal 
drinking water (no BPA) for 2 weeks and housed either in glass cages/water bottles (0 BPA) vs. 
plastic cages/water bottles (possible BPA leaching) using soy-free food and bedding. Mice were 
injected ip with 103 PFU of CVB3 ip on day 0. Hearts were harvested at day 10 pi during acute 
myocarditis. A) Myocarditis was assessed as the % inflammation compared to the size of the total 
heart section using H&E stained sections and a microscope grid comparing mice in glass vs. plastic 
cages. Data show the mean +/-SEM using a two-tailed Student’s t test with 18-20 mice/ group. 
Representative photos of heart sections stained with H&E for B) glass and C) plastic housed mice. 
The grey bar represents 300µm. 
 
Plastic cages increase GR1, CD11b and CD14, but decrease cKit (mast cells) in males 
during myocarditis  
Comparing traditional plastic cages and water bottles to glass cages and water bottles 
(soy-free food and bedding and no BPA added to drinking water), we found that housing 
male BALB/c mice in plastic cages significantly increased expression of GR1 (p=0.01), 
CD11b (p=0.0007), and CD14 (p=0.003), but significantly decreased cKit (p=0.00003)- a 
marker of mast cells (Fig 6) using qRT-PCR. Plastic cages did not significantly alter CD45 
(p=0.42) or F4/80 (p=0.56) expression in the heart of males with myocarditis compared to 
glass cages (Fig 6). These data suggest that the dominant increase in CD11b+ cells in males 
with myocarditis is mediated at least in part by exposure to plastics/ chemicals that leach 
from plastic cages and water bottles. 
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Figure 6. Plastic cages increase GR1, CD11b and CD14 expression in the heart during 
myocarditis. Male BALB/c mice were given normal drinking water (no BPA) for 2 weeks and 
housed either in glass cages/water bottles (0 BPA) vs. plastic cages/water bottles (possible BPA 
leaching) using soy-free food and bedding. Mice were injected ip with 103 PFU of CVB3 ip on day 0. 
Hearts were harvested at day 10 pi during acute myocarditis. Relative gene expression (RGE) was 
used to assess A) CD45 (total lymphocytes), B) GR1 (neutrophils), C) CD11b+ cells (i.e., 
macrophages, neutrophils, mast cells), D) F4/80+ macrophages, E) CD14 (part of TLR4 signaling 
complex on macrophages and mast cells), and F) cKit (mast cells and stem cells) compared to the 
housekeeping gene Hprt in whole hearts by qRT-PCR at day 10 pi comparing mice in glass vs. plastic 
cages. Data show the mean +/-SEM using a two-tailed Student’s t test with 10 mice/ group. 
 
Plastic cages have no significant effect on T or B cell markers in males during myocarditis 
Comparing traditional plastic cages and water bottles to glass cages and water bottles 
(soy-free food and bedding and no BPA added to drinking water), we found that housing 
male BALB/c mice in plastic cages had no significant effect on CD3 (p=0.14), CD4 
(p=0.97), CD8 (p=0.33), CD19 (p=0.34) or Foxp3 (p=0.41) expression compared to mice 
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housed in glass cages using qRT-PCR (Fig 7). We have shown previously that T cells do not 
play a major role in sex differences in myocarditis in BALB/c mice (Frisancho-Kiss 2009, 
Coronado 2012). These data further confirm that the elevated myocarditis observed in male 
BALB/c mice is mediated at least in part by being housed in plastic cages. 
        
Figure 7. Plastic cages have no significant effect on T or B cell markers in males during 
myocarditis. Male BALB/c mice were given normal drinking water (no BPA) for 2 weeks and 
housed either in glass cages/water bottles (0 BPA) vs. plastic cages/water bottles (possible BPA 
leaching) using soy-free food and bedding. Mice were injected ip with 103 PFU of CVB3 ip on day 0. 
Hearts were harvested at day 10 pi during acute myocarditis. Relative gene expression (RGE) was 
used to assess A) CD3 (total T cells), B) CD4, C) CD8, D) CD19 (as a marker for B cells), and E) 
Foxp3 (Treg) compared to the housekeeping gene Hprt in whole hearts by qRT-PCR at day 10 pi 
comparing mice in glass vs. plastic cages. Data show the mean +/-SEM using a two-tailed Student’s t 
test with 10 mice/ group. 
 




Comparing traditional plastic cages and water bottles to glass cages and water bottles 
(soy-free food and bedding and no BPA added to drinking water), we found that housing 
male BALB/c mice in plastic cages had no significant effect on CVB3 genome expression in 
the heart by qRT-PCR (p=0.40). These data indicate that the increase in myocarditis found in 
male BALB/c mice in plastic compared to glass cages is not due to increased virus levels in 
the heart. Additionally, we do not see a sex difference in viral replication when mice are 
housed in plastic cages (Fairweather 2001, Frisancho-Kiss 2007, Coronado 2012). 
 
Figure 8. Viral gene expression in the heart of males was not effected by plastic cages. Male 
BALB/c mice were given normal drinking water (no BPA) for 2 weeks and housed either in glass 
cages/water bottles (0 BPA) vs. plastic cages/water bottles (possible BPA leaching) using soy-free 
food and bedding. Mice were injected ip with 103 PFU of CVB3 ip on day 0. Hearts were harvested at 
day 10 pi during acute myocarditis. CVB3 levels in the heart were measured using qRT-PCR to 
determine relative gene expression (RGE) of viral genome compared to the housekeeping gene Hprt. 
Data show the mean +/-SEM using a two-tailed Student’s t test with 10 mice/ group. 
 
Plastic cages shift the M1/ M2 profile in males during myocarditis (no BPA added to 
water) 
 Comparing traditional plastic cages and water bottles to glass cages and water bottles 
(soy-free food and bedding and no BPA added to drinking water), we found that housing 
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male BALB/c mice in plastic cages significantly decreased the M1 marker Cxcl10 (p=0.04) 
and significantly increased the M2 marker Ym1 (p=0.04) (Fig 9) using qRT-PCR, suggesting 
a shift to a more Th2-type immune response in the macrophage population. We showed 
previously that the dominant CD11b+ population in males during myocarditis has 
characteristics of M2 or myeloid-derived suppressor cells (MDSCs) as well as expressing 
TLR4 (Frisancho-Kiss 2007, Frisancho-Kiss 2009, Abston 2012B, Coronado 2012, 
Fairweather 2015). These findings suggest that the plastic cages that males are housed in are 
contributing to this phenotype during myocarditis. In future experiments we will examine 
cytokine profiles in the heart in plastic vs. glass cages in male mice with myocarditis. 
 
Figure 9. Plastic cages shift the M1/M2 profile in males during myocarditis. Male BALB/c mice 
were given normal drinking water (no BPA) for 2 weeks and housed either in glass cages/water 
bottles (0 BPA) vs. plastic cages/water bottles (possible BPA leaching) using soy-free food and 
bedding. Mice were injected ip with 103 PFU of CVB3 ip on day 0. Hearts were harvested at day 10 
pi during acute myocarditis. Relative gene expression (RGE) was used to assess A) Cxcl10 (a marker 
of M1 macrophages) and B) Ym1 (a marker of M2 macrophages) compared to the housekeeping gene 
Hprt in whole hearts by qRT-PCR at day 10 pi comparing mice in glass vs. plastic cages. Data show 




Plastic cages increase fibrosis/remodeling-associated genes in the heart of males during 
myocarditis  
 We have reported previously that increased complement activation, TLR4/IL-1R 
family members (i.e., inflammasome-related genes), and Timp1 in male BALB/c mice during 
acute myocarditis leads to increased remodeling, fibrosis and DCM during the chronic stage 
of myocarditis (Fairweather 2006, Coronado 2012, Abston 2012B). Comparing traditional 
plastic cages and water bottles to glass cages and water bottles (soy-free food and bedding 
and no BPA added to drinking water), we found that housing male BALB/c mice in plastic 
cages significantly increased cardiac expression of C4b (p=0.02), C5aR1 (p=0.003), IL1R2 
(p=0.0005), and Timp1 (p=0.01) during myocarditis compared to glass cages using qRT-
PCR (Fig 10). In future experiments we will examine more complement, inflammasome and 
remodeling genes in males with myocarditis that have been housed in plastic cages compared 
to glass cages, and assess whether males develop fibrosis during acute myocarditis. These 
data indicate that plastics/ chemicals that leach from plastic cages and water bottles 




      
Figure 10. Plastic cages increase fibrosis/remodeling-associated genes in the heart of males 
during myocarditis. Male BALB/c mice were given normal drinking water (no BPA) for 2 weeks 
and housed either in glass cages/water bottles (0 BPA) vs. plastic cages/water bottles (possible BPA 
leaching) using soy-free food and bedding. Mice were injected ip with 103 PFU of CVB3 ip on day 0. 
Hearts were harvested at day 10 pi during acute myocarditis. Relative gene expression (RGE) was 
used to assess A) C4b, B) C5aR1, C) IL1R2, and D) Timp1 compared to the housekeeping gene Hprt 
in whole hearts by qRT-PCR at day 10 pi comparing mice in glass vs. plastic cages. Data show the 
mean +/-SEM using a two-tailed Student’s t test with 10 mice/ group. 
 
Plastic cages decrease ERα and AR expression in the heart of males during myocarditis, 
but increase ERβ  
Comparing traditional plastic cages and water bottles to glass cages and water bottles 
(soy-free food and bedding and no BPA added to drinking water), we found that housing 
male BALB/c mice in plastic cages significantly decreased cardiac expression of ERα 
(p=0.007) and AR (p=0.0009), but significantly increased expression of ERβ (p=0.02) from 
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whole hearts by qRT-PCR (Fig 11). Plastic cages had no significant effect on ERRγ 
expression in the heart of males with myocarditis compared to glass cages using qRT-PCR 
(p=0.10) (Fig 11D). These data indicate that plastic cages and water bottles alone are 
significantly altering sex hormone receptor expression in the heart during myocarditis in 
BALB/c males. This change in the ratio of ERs and ARs could contribute to sex differences 
in myocarditis. 
 
Figure 11. Plastic cages decrease ERα and AR expression in the heart of males during 
myocarditis, but increase ERβ. Male BALB/c mice were given normal drinking water (no BPA) for 
2 weeks and housed either in glass cages/water bottles (0 BPA) vs. plastic cages/water bottles 
(possible BPA leaching) using soy-free food and bedding. Mice were injected ip with 103 PFU of 
CVB3 ip on day 0. Hearts were harvested at day 10 pi during acute myocarditis. Relative gene 
expression (RGE) vs. Hprt controls of A) ERα, B) ERβ, C) ERRγ, and  D) AR mRNA by qRT-PCR 
at day 10 pi comparing glass caging to plastic caging. Data show the mean ±SEM using a two-tailed 




Plastic cages increase VDR expression in the heart of males during myocarditis  
Comparing traditional plastic cages and water bottles to glass cages and water bottles 
(soy-free food and bedding and no BPA added to drinking water), we found that housing 
male BALB/c mice in plastic cages significantly increased VDR expression in the heart 
during myocarditis by qRT-PCR (p=0.001) (Fig 12). We showed in Chapter 3 that VDR 
increased myocarditis in male mice (Chapter 3, Fig 3). These data indicate that plastics/ 
chemicals that leach from plastic cages lead to increased expression of VDR in the heart of 
males during CVB3 myocarditis, contributing to the sex differences in disease in this model. 
 
Figure 12. Plastic cages increase VDR expression in the heart of males during myocarditis. Male 
BALB/c mice were given normal drinking water (no BPA) for 2 weeks and housed either in glass 
cages/water bottles (0 BPA) vs. plastic cages/water bottles (possible BPA leaching) using soy-free 
food and bedding. Mice were injected ip with 103 PFU of CVB3 ip on day 0. Hearts were harvested at 
day 10 pi during acute myocarditis. Relative gene expression (RGE) vs. Hprt controls of VDR mRNA 
by qRT-PCR at day 10 pi comparing glass caging to plastic caging. Data show the mean ±SEM using 






In Chapter 4, Figure 31 we showed how BPA exposure in the drinking water of 
female BALB/c mice allowed increased myocarditis by decreasing ERα and VDR in the 
heart. In this Chapter we show the same Figure and now highlight how plastic cages and 
water bottles themselves (presumably plastics/ BPA leached from the cages) are able to 
increase AR and cKit (mast cells) expression in female BALB/c mice, which are factors 
known to increase myocarditis (Fig 13). The overall myocarditis score in females was 
probably not significantly altered by plastic cages because the caging did not significantly 
alter ERs, the VDR or T cells. Thus, the caging does not appear to affect female BALB/c 
mice as strongly as it does male mice. 
 
 
Figure 13. Possible mechanisms to explain how plastic cages increase myocarditis in female 
BALB/c mice. In this Chapter we found that the plastic cages that the female BALB/c mice were 
housed in caused an increase in AR and cKit expression (i.e., mast cells) assessed by qRT-PCR in the 
heart during CVB3 myocarditis. Elevated AR and mast cells in females are likely to increase 
myocarditis. 
 
We have shown that male BALB/c mice have increased CVB3 myocarditis due to a 
testosterone-mediated increase in CD11b+ macrophages and mast cells compared to females 
(Frisancho-Kiss 2009, Coronado 2012, Fairweather 2015). However, testosterone was only 
able to partially mediate the sex difference (i.e., gonadectomy did not prevent myocarditis). 
Surprisingly, housing male BALB/c mice in plastic cages had a significant effect on CVB3 
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myocarditis (Fig 5). In males we found that plastic cages and water bottles significantly 
increased myocarditis at day 10 pi compared to glass cages with a large increase in CD11b 
expression in the heart measured by qRT-PCR (Fig 6C). Previously when male BALB/c 
mice underwent gonadectomy to remove circulating testosterone levels we found that the 
only inflammatory cells significantly affected during CVB3 myocarditis were those 
expressing CD11b (Frisancho-Kiss 2009). Additionally, the dominant cell population in the 
heart during myocarditis in male BALB/c mice and myocarditis biopsies from patients is 
CD11b+ cells (Fairweather 2014). We have found that CD11b+ macrophages and mast cells 
in male BALB/c mice express TLR4 and IL-1β and are involved in promoting remodeling in 
males that leads to DCM and heart failure (Fairweather 2003, Fairweather 2004B, Frisancho-
Kiss 2009, Onyimba 2011, Coronado 2012, Fairweather 2014). Recall that CD11b is also 
called CR3. A proteomic study of sera from myocarditis patients that examined the factors 
during acute myocarditis that predicted progression from myocarditis to DCM found that 
complement pathways were primarily responsible (Cooper 2010). When we examined the 
data from that study by sex we found that the top gene predicting progression from 
myocarditis to DCM in men with myocarditis was VitD binding protein, which works with 
complement pathways to activate mast cells and macrophages and TLR4/ inflammasome 
pathways (Rook 1986, Wang 2004, Baroni 2007, Liu 2006, Liu 2007, Christakos 2016). In 
Chapter 3 we showed that the VDR increases myocarditis in male mice, and here we found 
that plastic cages increased VDR expression in the heart of male BALB/c mice by qRT-PCR 
(Fig 12). Additionally, plastic cages decreased ERα and increased ERβ in male BALB/c 
mice during CVB3 myocarditis (Fig 11), which is likely to enhance disease in males. Both 
males and females express ERs and the AR and it is likely that the ratio of these receptors is 
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key in how inflammation is regulated by sex hormones. Additionally, plastic cages appear to 
shift macrophages from a M1 to M2-type phenotype in males with myocarditis. This mixed 
Th1/Th2, M2b-type response (M2b macrophages express TLR4 and release IL-1β and are 
highly profibrotic as well as being proinflammatory) is characteristic of our analysis of the 
type of immune cells that allow the damaging remodeling in male mice with myocarditis that 
leads to DCM (Fairweather 2006, Coronado 2012, Fairweather 2012A). 
 
Figure 14. Possible mechanisms to explain how plastic cages increase myocarditis in male 
BALB/c mice. In this Chapter we found that the plastic cages that the male BALB/c mice were 
housed in caused an increase in myocarditis and immune cell populations assessed by qRT-PCR in 




We do not observe a sex difference in viral replication in the heart of BALB/c male 
and female mice (Frisancho-Kiss 2007, Frisancho-Kiss 2009, Coronado 2012). Here we 
found that plastic cages had no significant effect on viral levels in the heart during 
myocarditis in male or female mice by qRT-PCR (Fig 3&8) and plaque assay (data not 
shown). These data further suggest that the cages are mediating the sex difference in CVB3 
myocarditis in BALB/c mice by amplifying a damaging type of inflammation that has no 
direct relationship to viral replication in the heart. Overall, this data suggests that there is an 







BPA exposure decreases myocarditis in female BALB/c 














Myocarditis is an inflammatory heart disease that leads to DCM and heart failure. Sex 
hormones play a vital role in development of myocarditis with testosterone driving disease in 
males whereas, estrogen mediates cardioprotection in females. Since myocarditis is 
influenced by sex hormones, it is highly probable that endocrine disruptors, which interfere 
with natural hormones and ERs in particular, could play a part in the progression of the 
disease. The human population is exposed to the endocrine disruptor BPA from plastics like 
water bottles, plastic food containers, and receipts, for example. To our knowledge no one 
has examined the role of endocrine disruptors like BPA on myocarditis. Glass cages and soy-
free food and bedding were used in these experiments in order to assess the effect of BPA on 
female BALB/c mice without the confounding effect of plastics, BPA or other chemicals 
leaching from plastic caging. We found that all doses of BPA decreased myocarditis in 
female BALB/c mice compared to water controls, and we chose the high human relevant 
dose (25 µg/L or 5 µg BPA/kg BW) of BPA for continued analysis. BPA exposure decreased 
expression of all CD11b+ populations including GR1, F4/80, CD14 and cKit (mast cells), but 
had no significant effect on T cells. Interestingly, BPA exposure significantly decreased viral 
RNA levels and viral replication in the heart even though it decreased IFNγ (which can 
decrease virus) and increased IL-4. Decreased IFNγ may be the result of BPA strongly 
inhibiting the TLR4 signaling, which is able to increase IFNs. BPA significantly decreased 
ERα expression in the heart of females in glass cages, but had no significant effect on VDR 
or other hormone expression. BPA exposure for the same amount of time as in other 
experiments had no significant effect on ER expression in the heart of uninfected female 
BALB/c mice suggesting co-exposure (i.e., BPA exposure plus viral infection) is important 
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in mediating the effect of BPA. These data show that BPA exposure that is carefully 
controlled for (i.e., no other sources of BPA to confound the results) by using glass cages and 
water bottles and soy-free bedding and food is able to decrease CVB3 myocarditis in 
females. Because populations are likely to be exposed to BPA and other plastics from a wide 
variety of sources (i.e., food, water, receipts, photocopy paper, etc.) and exposure routes (i.e., 
oral, cutaneous, inhalation) future experiments will need to examine the effect of BPA 





Recent articles have begun to address concerns associated with animal studies that are 
attempting to understand the role of endocrine disruptors, such as BPA, on immune function 
and/or disease. These articles have brought up a number of potentially confounding issues 
including plastic cages, food and bedding containing the phytoestrogen soy or other 
phytoestrogens, enormous variation in the doses of BPA used, and varying exposure methods 
(Mirmina 2014). All of these factors could be affecting experiments that are assessing the 
effect of endocrine disruptors on normal physiology or disease. In Chapter 5 we found that 
plastic cages and water bottles (without the addition of BPA in the drinking water) 
significantly increased myocarditis in male BALB/c mice, and increased cKit (mast cells) 
and AR expression in the heart of female BALB/c mice with myocarditis. These data were 
not influenced by phytoestrogens, because the experiments were performed with soy-free 
food and bedding. These findings indicate that caging is indeed affecting our experiments in 
a sex-specific manner. 
Here we wanted to determine the effect of BPA exposure on female BALB/c mice 
without the potentially confounding effect of the presence of plastic cages and water bottles. 
In order to do this we used glass cages and water bottles as well as soy-free food and 
bedding. We exposed mice to BPA at various concentrations, as before, for 2 weeks and then 
examined myocarditis at day 10 pi. BPA exposure was continued from day 0 to day 10 pi, as 
previously. We have not found any published reports of investigators examining the effect of 
BPA on normal physiology or disease using glass cages and water bottles to prevent plastics 





BPA decreases CVB3 myocarditis in female BALB/c mice housed in glass cages 
 In Chapter 4 we showed that BPA exposure of female BALB/c mice in standard 
plastic cages/water bottles significantly increased myocarditis (Chapter 4, Fig 2). 
Additionally, we found that plastic cages and water bottles in themselves (e.i., no BPA added 
to water) increased cKit expression/ mast cells (Chapter 5, Fig 1) and AR expression in the 
heart of females with myocarditis (Chapter 5, Fig 4). In this chapter we wanted to determine 
whether the same result would occur if glass cages and water bottles were used instead of 
plastic cages to remove any possibility of plastic products leaching out and altering the dose 
of BPA. To assess the effect of BPA exposure on CVB3 myocarditis in glass cages with 
glass water bottles, 6-8 week old female BALB/c mice were given varying doses of BPA in 
their drinking water for two weeks prior to infection with CVB3 ip on day 0, as previously. 
Mice in all of the experiments in this Chapter were housed in glass cages using glass water 
bottles and were provided bedding and food free of soy, an estrogenic agent. As a positive 
control, we also included a set of mice in plastic cages/water bottles with 0 BPA, but we have 
not shown the data in the figures in this Chapter. The doses of BPA that were administered 
were the same as in Chapter 4 and included 2.5, 25, and 250 µg BPA/L in drinking water, 
which is equivalent to an estimated intake of 0.5, 5, and 50 µg BPA/kg BW, respectively. 
Three doses were used in order to determine whether the concentration of BPA altered 
myocarditis when mice were housed in glass cages instead of plastic cages (i.e., is there a 
dose effect for BPA?). BPA treatment was continued from day 0 after infection until harvest 
at day 10 pi. Myocarditis was assessed histologically at day 10 pi, during acute myocarditis, 
by determining the % inflammation in heart sections corrected for the size of the heart. 
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We found that BPA exposure of mice housed in glass cages/ water bottles 
significantly decreased myocarditis (p=0.0001). Controlling for multiple comparisons 
revealed that the 2.5 µg BPA/L water dose which is equivalent to an estimated intake of 0.5 
µg BPA/kg BW, the 25 µg BPA/L water dose which is equivalent to an estimated intake of 5 
µg BPA/kg BW, and the 250 µg BPA/L water dose which is equivalent to an estimated 
intake of 50 µg BPA/kg BW, significantly decreased myocarditis at day 10 pi compared to 
control water containing no BPA when mice were housed in glass cages (p<0.001) (Fig 1). 
Representative photos of the effect of BPA exposure on CVB3 myocarditis using glass cages 
and water bottles are shown in Figure 2. These data further indicate that chemicals/ plastics 
released from plastic cages and water bottles alter myocarditis in female BALB/c mice. 
Regardless of dose, BPA exposure significantly reduced myocarditis in female mice if they 
were housed in glass cages/water bottles. Thus, the lowest concentration of BPA that we 
tested significantly decreased myocarditis. Additionally, there were no significant differences 
between doses indicating that there was no dose effect of BPA exposure. 
 
Figure 1. BPA decreases myocarditis in BALB/c female mice housed in glass cages with glass 
water bottles. Female BALB/c mice were given increasing doses of BPA in drinking water for 2 
weeks and then injected ip with 103 PFU of CVB3 ip on day 0 inflammation examined at day 10 pi, 
during peak myocarditis. Soy-free bedding and food and glass cages and water bottles were used. 
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BPA exposure was continued from day 0 to harvest at day 10 pi. Myocarditis was assessed as the % 
inflammation in the heart H&E compared to the overall size of the heart section by histology using an 
eyepiece grid. Estimated BPA intakes were determined as follows: 0 (0 BPA), 0.5 (0.5 BPA), 5 (5 
BPA), and 50 (50 BPA) µg BPA/kg BW were obtained by dosing water with 0, 2.5, 25 or 250 µg 
BPA/L, respectively. Data show the mean +/-SEM, n=18-37/group. One-way ANOVA found a 
significant difference existed between groups (p=0.004). After controlling for multiple comparisons, 
the 0.5 µg BPA/kg BW and 5 µg BPA/kg BW doses were significantly decreased compared to control 
water using post-hoc Student’s t tests (****, p<0.0001) as well as 50 µg BPA/kg BW dose (***, 
p<0.001). 
                  
Figure 2. Representative photos of the effect of BPA exposure on CVB3 myocarditis in female 
mice housed in glass cages. Female BALB/c mice were given increasing doses of BPA in drinking 
water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 inflammation examined at 
day 10 pi, during peak myocarditis. Soy-free bedding and food and glass cages and water bottles were 
used. BPA exposure was continued from day 0 to harvest at day 10 pi. Estimated BPA intakes were 
determined as follows: 0, 0.5, 5, and 50 µg BPA/kg BW were obtained by dosing water with 0, 2.5, 
25 or 250 µg BPA/L, respectively. Inflammation in the heart was assessed using H&E stain where 
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cardiac tissue appears pink and inflammation dark purple. Representative photos depict A) 0, B) 0.5, 
C) 5, and D) 50 µg BPA/kg BW. The grey bar is 300µm in length. 
 
BPA significantly decreases viral gene expression and viral replication in the heart during 
myocarditis when female mice are housed in glass cages 
We examined whether BPA exposure altered CVB3 levels/ replication in the heart 
during acute myocarditis when mice were housed in glass cages with glass water bottles. We 
found that BPA significantly decreased viral gene expression in the heart during acute 
myocarditis at day 10 pi by qRT-PCR if mice were housed in glass cages (one-way ANOVA, 
p=0.003). Controlling for multiple comparisons revealed that the 0.5, 5 and 50 µg BPA/kg 
BW doses significantly decreased viral gene expression at day 10 pi compared to control 
water (p<0.01, p<0.01, p<0.05, respectively) (Fig 3A). We also found that BPA decreased 
active viral replication by plaque assay in the heart at a 5µg BPA/kg BW dose (p=0.007) (Fig 
3B). Thus, the decrease in inflammation due to BPA exposure when mice were housed in 
glass cages could be a result of decreased viral replication in the heart. 
         
Figure 3. Viral gene expression and replication in the heart were significantly decreased by 
BPA exposure to female mice housed in glass cages. Female BALB/c mice were given increasing 
doses of BPA in drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 
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inflammation examined at day 10 pi, during peak myocarditis. Soy-free bedding and food and glass 
cages and water bottles were used. BPA exposure was continued from day 0 to harvest at day 10 pi. 
A) CVB3 levels in the heart were measured using qRT-PCR to determine RGE of viral genome 
compared to the housekeeping gene Hprt. B) Viral replication was measured using plaque assay to 
determine PFU/g heart. Data show the mean +/-SEM, n=7-10/group. A) Significant differences were 
assessed using one-way ANOVA for multiple comparisons with post-hoc Student’s t tests, and B) 
Student’s t test for viral replication comparing the BPA group to control water. Estimated BPA 
intakes were determined as follows: 0 (0 BPA), 0.5 (0.5 BPA), 5 (5 BPA), and 50 (50 BPA) µg 
BPA/kg BW were obtained by dosing water with 0, 2.5, 25 or 250 µg BPA/L, respectively. 
 
BPA exposure does not affect body weight in female mice housed in glass cages 
Because BPA exposure has been found to increase the risk for type II diabetes (Bodin 
2014, Rezg 2014), we examined whether BPA exposure to mice in glass cages/ water bottles 
altered the whole body weight of mice. Data are shown for the 5 µg BPA/kg BW dose only. 
We found that BPA exposure in glass cages/ water bottles had no significant effect on body 
weight during acute myocarditis at day 10 pi (p=0.62) (Fig 4). 
 
Figure 4. Body weight of female mice was not altered by BPA exposure in glass cages. Female 
BALB/c mice were exposed to control water (0 BPA) or 5 µg BPA/kg BW (5 BPA) for 2 weeks 
and then injected ip with 103 PFU of CVB3 ip on day 0 and body weight examined at day 10 pi, 
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during peak myocarditis. Soy-free bedding and food and glass cages and water bottles were used. 
BPA exposure was continued from day 0 to harvest at day 10 pi. Data are shown as the mean +/-SEM 
using the Student’s t test with 38 mice/ group. Estimated BPA intakes were determined as follows: 5 
µg BPA/kg BW was obtained by dosing drinking water with 25 µg BPA/L. 
 
BPA exposure in glass cages decreases expression of markers for macrophages, 
neutrophils, and mast cells in female mice during CVB3 myocarditis 
Because BPA exposure to female BALB/c mice in glass cages significantly decreased 
myocarditis (Fig 1), we wanted to examine the specific immune cell types that were altered 
by BPA exposure. We chose to examine markers for immune cells from the high human 
relevant dose (i.e., 5 µg BPA/kg BW) in these experiments because it was the same dose that 
we found a significant increase in myocarditis when plastic cages were used (Chapter 4, Fig 
2). The effect of BPA exposure on specific cardiac immune cell markers during acute 
myocarditis at day 10 pi was assessed using qRT-PCR. We found that 5µg BPA/ kg BW 
exposure to BALB/c female mice housed in glass cages significantly decreased expression of 
CD45 (all lymphocytes) (p=0.007), CD11b (i.e., macrophages, mast cells, neutrophils, some 
dendritic cells) (p=7x10-5), GR1 (neutrophils) (p=0.03), F4/80 (macrophages) (p=0.06), 
CD14 (macrophages and mast cells, part of TLR4 signaling complex) (p=0.03), and cKit/ 
CD117 (mast cells, stem cells) (p=0.002) in the heart compared to control water without BPA 
during CVB3 myocarditis (Fig 5). The decrease in CD45+ total immune cells and other 
major populations like GR1+ neutrophils and CD11b+ cells during acute myocarditis 
following BPA exposure is consistent with the decreased inflammation observed with 
histology (Fig 1 and Fig 2). 
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Figure 5. BPA exposure decreases macrophages, neutrophils and mast cells in female BALB/c 
mice with myocarditis in glass cages. Female BALB/c mice were given 0 or 5 µg BPA (0 BPA vs. 5 
BPA) /kg BW in their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on 
day 0 and hearts were harvested at day 10 pi. Soy-free bedding and food and glass cages and water 
bottles were used. BPA exposure continued from day 0 to 10 pi. Immune cell populations from the 
whole heart were examined using qRT-PCR for relative gene expression (RGE) of the genes of 
interest vs. the housekeeping gene Hprt for A) CD45 (total immune cells), B) CD11b (includes 
macrophages, neutrophils, mast cells and some dendritic cells), C) GR1 (neutrophils), D) F4/80 
(macrophages), E) CD14 (macrophages and mast cells, part of TLR4 signaling complex), and F) 
cKit/ CD117 (mast cells). Data are shown as the mean +/-SEM using a two-tailed Student’s t or 
Mann-Whitney rank test with 8-18 mice/ group. 5 µg BPA/kg BW was obtained by dosing water with 
25 µg BPA/L. 
 
BPA exposure in glass cages does not affect T cell marker expression in female BALB/c 
mice during myocarditis 
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Because T cells were a dominant immune cell type affected in female BALB/c mice 
exposed to BPA in plastic cages (Chapter 4, Fig 7), we examined whether BPA exposure in 
glass cages had the same effect. We found that the 5µg BPA/ kg BW exposure to BALB/c 
female mice housed in glass cages and water bottles had no significant effect on the 
expression of CD3 (p=0.30), CD4 (p=0.33), CD8 (p=0.15), and Foxp3+ Treg (data not 
shown, p=0.39) in the heart compared to 0 µg BPA/kg BW (control water) during CVB3 
myocarditis by qRT-PCR (Fig 6). These data indicate that the immune mechanisms involved 
in regulating cardiac inflammation in glass vs. plastic cages are different. 
 
Figure 6. BPA exposure has no effect on T cells in female BALB/c mice with myocarditis in 
glass cages. Female BALB/c mice were given 0 or 5 µg BPA (0 BPA vs. 5 BPA) /kg BW in their 
drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts were 
harvested at day 10 pi. Soy-free bedding and food and glass cages and water bottles were used. BPA 
exposure continued from day 0 to 10 pi. Immune cell populations from the whole heart were 
examined using qRT-PCR for relative gene expression (RGE) of the genes of interest vs. the 
housekeeping gene Hprt for A) CD3+ T cells (total T cells), B) CD4+ T cells, and C) CD8+ T cells. 
Data are shown as the mean +/-SEM using a two-tailed Student’s t with 9-10 mice/ group. 5 µg 




BPA exposure in glass cages significantly decreases IFNγ levels, an indicator of a Th1-
type immune response, and increases IL-4 an indicator of a Th2-type immune response 
In Chapter 4 we had found that BPA exposure in plastic cages had significantly 
increased IFNγ and IL-17 levels in the heart during myocarditis (Chapter 4, Fig 8). In 
contrast, we found that BPA exposure in glass cages and water bottles significantly decreased 
IFNγ (Fig 7A) and significantly increased IL-4 levels (Fig 7B) in the heart compared to 
water controls using ELISA. IL-17A was not significantly affected by BPA exposure in glass 
cages compared to water controls (Fig 7C). Typically BALB/c female mice develop a Th2-
associated immune response during myocarditis with elevated IL-4 levels (Frisancho-Kiss 
2009, Coronado 2012). These results suggest that BPA exposure in glass cages and water 
bottles further increases a Th2-type immune response during CVB3 myocarditis in female 
BALB/c mice. 
Figure 7. BPA exposure in glass cages decreases cardiac IFNγ levels but increases IL-4 during 
CVB3 myocarditis in females. Female BALB/c mice were given 0 or 5 µg BPA (0 BPA vs. 5 BPA) 
/kg BW in their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 
and hearts were harvested at day 10 pi. Soy-free bedding and food and glass cages and water bottles 
were used. BPA exposure continued from day 0 to 10 pi and homogenized. The supernatant was used 
to measure A) IFNγ, B) IL-4, and C) IL-17A levels in the heart by ELISA. Data show the mean +/-
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SEM using a two-tailed Student’s t or Mann-Whitney rank test with 14-30 mice/ group. 5 µg BPA/kg 
BW was obtained by dosing water with 25 µg BPA/L. 
 
BPA exposure in glass cages does not skew the M1 vs. M2 macrophage profile in the heart 
of females based on arginase-1 and Cxcl9 expression levels 
Because we saw a significant change in IFNγ and IL-4 levels in response to BPA in 
glass cages (Fig 7), we wanted to determine whether there was a skewing of M1/M2 
macrophages in the heart. Markers of M2 macrophages in mice include arginase-1 (Arg1) 
while M1 markers include Cxcl9, an inducer of Th1-type immune responses (Siracusa 2008, 
Fairweather 2009, Abston 2012A). Here we found that female BALB/c mice exposed to 5 
µg/kg BW BPA in glass cages had no significant change in the M1 marker Cxcl9 (p=0.51) 
(Fig 8A) or the M2 macrophage marker arginase-1 (p=0.15) (Fig 8B) compared to 0 BPA 
control water by qRT-PCR. These data suggest that the shift in IFNγ and IL-4 in response to 
BPA in glass cages is not due to a shift in the M1/M2 profile of cardiac macrophages during 
CVB3 myocarditis. 
 
Figure 8. BPA exposure in glass cages does not alter M1 vs. M2 macrophage profile in females 
during myocarditis. Female BALB/c mice were given 0 or 5 µg BPA (0 BPA vs. 5 BPA) /kg BW in 
their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts 
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were harvested at day 10 pi. Soy-free bedding and food and glass cages and water bottles were used. 
BPA exposure continued from day 0 to 10 pi. Relative gene expression (RGE) of A) Cxcl9 (an M1 
macrophage marker) and B) arginase-1 (Arg1) an M2 macrophage markers vs. Hprt controls were 
assessed in whole hearts using qRT-PCR at day 10 pi comparing 0 and 5 µg BPA/kg BW groups. 
Data show the mean ±SEM using a two-tailed Student’s t or Mann-Whitney rank test with 9-10 mice/ 
group. 5 µg BPA/kg BW was obtained by dosing water with 25 µg BPA/L. 
 
BPA exposure in glass cages decreases expression of the mast cell anaphylatoxin receptor 
C3aR1 and C4b levels in the heart of females 
We found that BPA exposure in glass cages significantly decreased the expression of 
markers for macrophages and mast cells as well as CD11b/ CR3 during myocarditis (Fig 5), 
a receptor that is highly expressed on macrophages and mast cells during myocarditis 
(Fairweather 2006, Frisancho-Kiss 2009, Onyimba 2011, Coronado 2012, Fairweather 2014). 
For this reason we examined the level of other complement components using qRT-PCR. We 
found that BPA exposure in glass cages significantly decreased the expression of C4b 
(p=0.04) (Fig 9A) and the mast cell anaphylatoxin receptor C3aR1 (p=0.02) (Fig 9B) in the 
heart during myocarditis compared to the water control, but did not significantly alter C5aR1 
(p=0.67) (Fig 9C). Downregulation of C3aR1 suggests a decrease in mast cell activation. 
         
Figure 9. BPA exposure in glass cages decreases C4b and mast cell activation via C3aR1 in 
females. Female BALB/c mice were given 0 or 5 µg BPA (0 BPA vs. 5 BPA) /kg BW in their 
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drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts were 
harvested at day 10 pi. Soy-free bedding and food and glass cages and water bottles were used. BPA 
exposure continued from day 0 to 10 pi. Relative gene expression (RGE) of complement genes vs. the 
housekeeping control Hprt was examined for A) C4b B) C3aR1, and C) C5aR1 mRNA by qRT-PCR 
at day 10 pi comparing 0 to 5 µg BPA/kg BW estimated intake groups. Data show the mean +/-SEM 
using a two-tailed Student’s t or Mann-Whitney rank test with 9-18 mice/ group. 5 µg BPA/kg BW 
was obtained by dosing water with 25 µg BPA/L. 
 
BPA exposure has no effect on complement regulator CR1/2 or CD19 in females 
CR1 is the primary receptor in the heart that regulates complement activation and 
protects against autoimmune and viral myocarditis in mice (Kaya 2001, Fairweather 2006). 
CR1 deficient mice develop severe inflammation and fibrosis and rapidly progress to DCM 
and heart failure following CVB3 infection, indicating the critical role for CR1 in dampening 
the immune response to CVB3 (Fairweather 2006). For this reason we examined CR1 
expression in the heart during myocarditis following BPA exposure in glass cages using 
qRT-PCR. CR2 forms a B cell receptor complex with CD19 and CD81 needed for 
complement activation of B cells. So we also examined the level of CD19, a marker often 
used to detect B cells using qRT-PCR. We found that neither CR1/2 (p=0.77) (Fig 10A) nor 
CD19 (p=0.19) (Fig 10B) expression was significantly altered during myocarditis by BPA 
exposure compared to water controls in mice housed in glass cages, indicating that BPA 




Figure 10. BPA exposure in glass cages has no effect on the complement regulation via 
CR1/CR2/CD19 in females. Female BALB/c mice were given 0 or 5 µg BPA (0 BPA vs. 5 BPA) 
/kg BW in their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 
and hearts were harvested at day 10 pi. Soy-free bedding and food and glass cages and water bottles 
were used. BPA exposure continued from day 0 to 10 pi. Relative gene expression (RGE) of A) 
CR1/2 and B) CD19 (part of the CR2 signaling complex on B cells) were compared to Hprt controls 
in the heart by qRT-PCR at day 10 pi comparing 0 to 5 µg BPA/kg BW groups. Data show the mean 
+/-SEM using a two-tailed Student’s t test with 9-10 mice/ group. Estimated BPA intakes were 
determined as follows: 0 µg BPA/kg BW obtained by dosing water with 0 µg BPA/L water and 5 µg 
BPA/kg BW obtained by dosing water with 25 µg BPA/L water. 
 
BPA exposure in glass cages decreases TLR4/ IL1R pathway activation in the heart of 
females during myocarditis 
We showed previously that components of IL-1R signaling (i.e., TLR4, IL-1R 
antagonist, caspase-1, IL-1β and IL-18) are upregulated in the heart during CVB3 
myocarditis in male mice and that testosterone amplifies this response on mast cells and 
macrophages during the innate and adaptive immune response (Coronado 2012, Fairweather 
2015, Frisancho 2006, Frisancho 2007, Frisancho 2009, Roberts 2013). Because BPA 
exposure in glass cages decreased the expression of markers of macrophage and mast cell 
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populations in the heart during myocarditis (Fig 5), we examined its effect on TLR4 
signaling components. We found that BPA exposure in glass cages significantly decreased 
expression of TLR4 (p=0.03), caspase-1 (p=0.0007), and IL-1β (p=0.01) (Fig 11A-C). ST2 
receptor expression, which is a member of the TLR/IL-1R signaling family that includes IL-
1R2 and is expressed on mast cells and macrophages, was also significantly decreased in the 
heart during myocarditis following BPA exposure in glass cages when measured using qRT-
PCR; IL-1R2 (p=0.02) (Fig 11D), ST2 (p=0.002) (Fig 11E). Additionally, sST2 was 
significantly decreased in the heart by ELISA (p=0.005) (Fig 11F). These data indicate that 
BPA strongly influences TLR4/IL1R family members. 
 
Figure 11. BPA exposure in glass cages inhibits the inflammasome in females during 
myocarditis. Female BALB/c mice were given 0 or 5 µg BPA (0 BPA vs. 5 BPA) /kg BW in their 
drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts were 
harvested at day 10 pi. Soy-free bedding and food and glass cages and water bottles were used. BPA 
exposure continued from day 0 to 10 pi. Relative gene expression (RGE) of inflammasome genes vs. 
the housekeeping control Hprt for A) TLR4 (n=7-10/group), B) caspase-1 (n=8-10/group), D) IL-1R2 
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(n=7-10/group), and E) ST2 receptor (n=5-10/group) were examined in whole hearts by qRT-PCR at 
day 10 pi comparing 0 to 5 µg BPA/kg BW groups. C) IL-1β (n=14-20/group) and F) sST2 (n=24-
30) levels were determined using ELISA from homogenized heart supernatants. Data show the mean 
+/-SEM using a two-tailed Student’s t or Mann-Whitney rank test. 5 µg BPA/kg BW was obtained by 
dosing water with 25 µg BPA/L. 
 
BPA exposure in glass cages decreases factors associated with cardiac remodeling during 
myocarditis in females 
Because BPA exposure in glass cages was found to decrease IL-1β and markers for 
mast cells, macrophages, and complement activation, we examined whether BPA altered 
factors associated with cardiac remodeling during acute myocarditis- a timepoint when 
profibrotic genes/ proteins are elevated in male BALB/c mice with myocarditis but histologic 
fibrosis (i.e., collagen deposition) is not yet present (Coronado 2012). We found that BPA 
exposure in glass cages did not significantly alter expression of Timp1 (Fig 12A) in the heart, 
but did significantly decrease Serpin A3n (Fig 12B) and TGFβ1 (Fig 12C) levels. BPA 
exposure in glass cages also significantly decreased the profibrotic cytokine IL-1β in the 
heart by ELISA (Fig 11C). These data suggest that BPA exposure in glass cages reduces 
remodeling gene expression in the heart during acute myocarditis. 
       .  
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Figure 12. BPA exposure in glass cages decreases remodeling factors in the heart during 
myocarditis in females. Female BALB/c mice were given 0 or 5 µg BPA (0 BPA vs. 5 BPA) /kg 
BW in their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and 
hearts were harvested at day 10 pi. Soy-free bedding and food and glass cages and water bottles were 
used. BPA exposure continued from day 0 to 10 pi. Relative gene expression (RGE) of A) Timp1, B) 
Serpin A3n and C) TGFβ1 vs. the housekeeping gene Hprt were analyzed in whole hearts by qRT-
PCR at day 10 pi comparing 0 to 5 µg BPA/kg BW groups. Data show the mean +/-SEM using a two-
tailed Student’s t or Mann-Whitney rank test with 9-10 mice/ group. 5 µg BPA/kg BW was obtained 
by dosing water with 25 µg BPA/L. 
 
BPA in glass cages decreases ERα expression in the heart during myocarditis in females 
 We showed in Chapter 4 that BPA exposure in plastic cages activated ERα and ERβ 
in Western blots (Chapter 4, Fig 24 and Fig 25). By qRT-PCR, BPA was found to increase 
ERα and decrease ERβ expression in the heart in plastic cages (Chapter 4, Fig 23). So in 
this Chapter we wanted to examine the effect of BPA exposure when glass cages and water 
bottles were used. We found that ERα expression was significantly decreased in the heart of 
females after BPA exposure in glass cages by qRT-PCR (p=0.04) (Fig 13A), but ERβ, ERRγ 
and AR expression were not significantly altered (Fig 13). These data indicate that BPA 
exposure in glass cages decreases ERα in female BALB/c mice, similar to what we found 
using plastic cages (Chapter 4, Fig 23A). However, the relationship of ERα signaling to 
cardiac inflammation is less clear because BPA exposure at this dose in plastic cages 
increased myocarditis while the same dose in glass cages decreased myocarditis. Perhaps the 
ratio of ERα to ERβ expression is important in determining the effect of ERs on cardiac 
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inflammation, with BPA exposure in plastic cages in females decreasing ERα but increasing 
ERβ while BPA exposure in glass cages only decreased ERα. Future studies will need to 
examine ER activation using Western blot in female mice exposed to BPA in glass cages. 
 
Figure 13. BPA exposure in glass cages decreases ERα expression in the heart during 
myocarditis in females. Female BALB/c mice were given 0 or 5 µg BPA (0 BPA vs. 5 BPA) /kg 
BW in their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and 
hearts were harvested at day 10 pi. Soy-free bedding and food and glass cages and water bottles were 
used. BPA exposure continued from day 0 to 10 pi. Relative gene expression (RGE) of A) ERα, B) 
ERβ, C) ERRγ and D) AR vs. the housekeeping gene Hprt were analyzed in whole hearts by qRT-
PCR at day 10 pi comparing 0 to 5 µg BPA/kg BW groups. Data show the mean +/-SEM using a two-
tailed Student’s t or Mann-Whitney rank test with 9-10 mice/ group. 5 µg BPA/kg BW was obtained 
by dosing water with 25 µg BPA/L. 
 
BPA exposure does not alter VDR or enzymes that metabolize VitD in females 
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We previously showed that VDR signaling is protective during acute myocarditis in 
females and increases myocarditis in males (Chapter 3, Fig 3). Additionally, we found that 
BPA exposure in plastic cages significantly decreased VDR expression in the heart of female 
BALB/c mice with myocarditis (Chapter 4, Fig 27). BPA exposure in glass cages, however, 
did not significantly alter VDR expression or alter the enzymes involved in vitamin D 
metabolism in the heart of female BALB/c mice (Fig 14). 
 
Figure 14. BPA exposure in glass cages does not alter VDR expression in the heart of female 
mice with myocarditis. Female BALB/c mice were given 0 or 5 µg BPA (0 BPA vs. 5 BPA) /kg BW 
in their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts 
were harvested at day 10 pi. Soy-free bedding and food and glass cages and water bottles were used. 
BPA exposure continued from day 0 to 10 pi. Relative gene expression (RGE) of A) VDR, B) 
Cyp27B1, C) Cyp2R1 and D) Cyp24A1 vs. the housekeeping gene Hprt were analyzed in whole 
hearts by qRT-PCR at day 10 pi comparing 0 to 5 µg BPA/kg BW groups. Data show the mean +/-
SEM using a two-tailed Mann-Whitney rank test with 5-10 mice/ group. 5 µg BPA/kg BW was 
obtained by dosing water with 25 µg BPA/L. 
 
Free BPA and BPA-glucuronide levels in the urine of females were not significantly 
altered between 0 and 5 µg BPA/kg BW dose 
 To determine BPA levels released in the urine of female BALB/c mice exposed to 
BPA in glass cages we examined free BPA and BPA-glucuronide levels in urine by LC-
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MS/MS with collaborators at the University of Kentucky. We did not find a significant 
difference in urine BPA levels between BPA exposed female mice compared to control water 
(Fig 15). One potential cause for this result could be that the urine was stored for a year in 
plastic tubes, which may have leached plastics/ BPA/ chemicals into the urine confounding 
the results. Future studies analyzing BPA levels in water, urine, and blood will be collected 
in glass containers in order to prevent potential BPA leaching during storage that could affect 
the analysis. 
 
Figure 15. BPA concentration in urine of females detected by LC-MS/MS was not altered by 
BPA dose. A) Free BPA and B) BPA-glucuronide (BPA-GLU) levels were assessed in urine of 
female BALB/c mice treated with control water or BPA treated water. Urine was collected from 
individual mice on day 0, 3, 7, and 10 pi and days into plastic tubes, pooled for each mouse, and 
stored at -80C. Samples were sent to collaborators at University of Kentucky for analysis using LC-
MS/MS. Significance was calculated using Student’s t test or Mann-Whitney rank test comparing 
BPA exposure to 0 control group. Data show the mean ±SEM using pooled samples from 3 mice/ 
group. 5 µg BPA/kg BW was obtained by dosing water with 25 µg BPA/L. 
 
BPA exposure in glass cages did not alter hormone receptor levels in the heart of 
uninfected female BALB/c mice 
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 We wanted to determine if BPA exposure without virus could influence the gene 
expression of hormone receptors in the heart. Female 6-8 week old BALB/c mice were 
exposed to 5 µg BPA/kg BW for 2 weeks plus 10 days, so that mice were age-matched to 
previous experiments in this Chapter. They also received soy-free bedding and food. We 
found that BPA exposure had no significant effect on sex hormone expression levels in the 
heart compared to control water when myocardial inflammation was absent (Fig 16). We also 
investigated if BPA could influence the VDR and Cyps without infection and saw no change 
in expression (data not shown). These data suggest that changes in sex hormone receptor 
expression that we observed due to BPA exposure during CVB3 myocarditis are present 
on/in cardiac immune cells rather than cardiac myocytes, fibroblasts, and/or endothelial cells. 
It is also worth noting that BPA exposure alone does not cause myocarditis. Thus, BPA 
exposure prior to CVB3 infection (co-exposure) is able to significantly alter myocardial 
inflammation. 
 
Figure 16. BPA exposure in glass cages had no influence on hormone receptor expression in the 
heart of uninfected female BALB/c mice. Female BALB/c mice were given 0 or 5 µg BPA (0 BPA 
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vs. 5 BPA) /kg BW in their drinking water for 2 weeks plus 10 days and then hearts were harvested. 
Soy-free bedding and food and glass cages and water bottles were used. Relative gene expression 
(RGE) of A) ERα, B) ERβ, C) ERRγ and D) AR vs. the housekeeping gene Hprt were analyzed in 
whole hearts by qRT-PCR comparing 0 to 5 µg BPA/kg BW groups. Data show the mean +/-SEM 
using a two-tailed Student’s t with 9-10 mice/ group. 5 µg BPA/kg BW was obtained by dosing water 






In this study we found that BPA exposure to adult female mice housed in glass cages 
significantly decreased myocarditis at day 10 pi compared to control water for all doses of 
BPA (Fig 1). This indicates that there was no dose effect for BPA exposure on myocarditis 
when females were housed in glass cages at the doses investigated. In the future we will 
examine lower doses of BPA to determine if there is truly no dose response. Additionally, 
BPA was able to significantly decrease myocarditis at the lowest dose (human relevant dose) 
that we tested in drinking water, 2.5 µg BPA/L which is equivalent to an estimated intake of 
0.5 µg BPA/kg BW. Similar to our findings that BPA exposure decreased markers of CD11b 
and F4/80 macrophages (Fig 5), BPA exposure was found to decrease macrophages in the 
pancreas in an animal model of type I diabetes using BPA-free water bottles (Bodin 2013). 
Note that plastic BPA-free water bottles will contain BPS and potentially other plastics that 
can leach into the water (see Chapter 9). Thus, BPA exposure in glass cages appears to have 
“increased” the typical cardioprotective female immune response associated with decreased 
myocarditis in females. This unexpected finding could be due to the glass caging possibly 
decreasing the stress levels of the mice due to being able to better see out of the caging, 
having increased room, and/or being able to pull food out of the ceramic bowl. In the future, 
we could further investigate the effect of the glass caging on the stress levels in mice by 
examining their circulating glucorticoid levels. 
Decreased myocarditis following BPA exposure in female BALB/c mice in glass 
cages could also be due to the reduction in viral replication that we observed in the heart (Fig 
3). Additionally, BPA has been found to have an influence on body weight in animal models, 
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both increasing and decreasing weight depending on the dose (Markey 2001), but we found 
that BPA exposure during acute myocarditis did not affect the body weight of BALB/c mice. 
BPA exposure significantly decreased ERα levels in the heart of females during 
myocarditis, but AR, ERβ and ERRγ levels were unchanged according to qRT-PCR (Fig. 
13). This was an unexpected finding because we hypothesized that ERα signaling should be 
protective. Inflammatory signaling pathways known to be down-regulated during myocarditis 
and DCM in females and that are associated with mast cell activation and increased 
inflammation in males (i.e., TLR4, complement/anaphylaxis, Serpin A3n) (Kaya 2001, 
Fairweather 2006, Coronado 2012) were significantly decreased in females after BPA 
exposure in this study. We also found that BPA exposure increased the Th2 cytokine, IL-4, 
and decreased the Th1 cytokine, IFNγ (Fig 7), which was also found by Yan et al. They 
found that BPA exposure increased Th2-type cytokine release (i.e., IL-4, IL-10, and IL-13) in 
response to a bacterial infection (Yan 2008). Additionally, Teixeira et al found that BPA 
treatment of human peripheral blood monocyte-derived macrophages in vitro induced an M2 
macrophage phenotype (Teixeira 2015). We did not observe a change in M1 vs. M2 markers 
in this study (Fig 8), but we only examined one marker for each cell type and so more M1 vs. 
M2 markers should be examined in the future. 
To determine if co-exposure with BPA plus CVB3 infection to induce myocarditis 
was necessary for altering ER expression in the heart, we dosed BALB/c female mice with 
BPA without virus (in glass cages and water bottles with soy-free food and water for the 
same amount of time as other experiments) and found that BPA exposure did not 
significantly alter cardiac expression of ERs or the AR unless myocarditis was present. Thus, 
co-exposure is necessary. Perhaps because the sex hormone receptor changes that we are 
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observing are on/in infiltrating immune cells rather than resident cardiac cells like 
cardiomyocytes. Other investigators have made similar observations. Yurino et al found that 
BPA exposure alone had no significant effect on lymphocyte cell numbers or percentages in 
the spleen or peritoneal cavity (Yurino 2004). 
In this study we examined urinary BPA levels from pooled samples over time during 
acute myocarditis and then tested the urine for unconjugated and metabolize BPA by LC-
MS/MS. We found that the average unconjugated BPA concentration in BALB/c females 
housed in glass cages was 0.0014 µg/L. This value is low. Also there was no significant 
difference between the 0 control urine and unconjugated BPA exposed urine (there was also 
no difference in glucuronidated BPA). This indicates that something is wrong with our 
collection and/or method of detecting BPA in the urine. Glucuronidation is known to be the 
primary method of BPA metabolism (Corrales 2015). But BPA can also be metabolized by 
sulfation. So, one possibility to explain our findings is that BPA sulfation may be a more 
important method of metabolism of BPA than glucuronidation during acute CVB3 
myocardits and so our method is not detecting the metabolized levels accurately. In future 
studies this issue will need to be examined. Additionally, in the future we plan to examine 
BPA levels in the serum. Unconjugated BPA levels in the urine of people with “normal” 
BPA exposure have been found to be 2.16 µg/L compared to 5.45 µg/L in individuals who 
are exposed to higher levels of BPA through thermal receipts as an occupational exposure 
(Hehn 2016). Because populations are likely to be exposed to BPA and other plastics from a 
wide variety of sources (i.e., food, water, receipts, photocopy paper, etc.) and exposure routes 
(i.e., oral, cutaneous, inhalation) future experiments will need to examine the effect of BPA 
exposure from multiple sources on inflammatory diseases like myocarditis. Although BPA 
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exposure to female mice appears to protect against CVB3 myocarditis, it is likely that most 
of the population is exposed to multiple forms of endocrine disruptors. Regardless of the type 









BPA increases myocarditis in male BALB/c mice housed 















Myocarditis is an inflammatory heart disease that leads to DCM and heart failure. Sex 
hormones play a vital role in the development of myocarditis with testosterone driving 
disease in males. Since myocarditis is influenced by sex hormones, it is highly probable that 
endocrine disruptors, which interfere with natural hormones, will play a part in the 
progression of the disease. The human population is exposed to the endocrine disruptor BPA 
from plastics, such as water bottles, plastic food containers, and receipts, for example. BPA 
is thought to also be mildly androgenic and could elicit effects through both ERs and the AR. 
To our knowledge no one has examined the role of endocrine disruptors like BPA on 
myocarditis in male mice. In this study we found that all doses of BPA increased myocarditis 
in male BALB/c mice. Using the EPA reference dose, we found that BPA exposure 
significantly increased VDR and decreased ERRγ expression in the heart. We found that 
expression of markers for macrophages, neutrophils, and T cells were significantly increased 
by BPA exposure while cKit (a marker for mast cells) was decreased. The increase in 
myocarditis was associated with an increase in the TLR4 signaling pathway, IL-1R2, 
complement, C3aR1, C5aR1, and Timp-1. Thus, BPA exposure in male BALB/c mice 
upregulated all the key immune processes that are known increase myocarditis and lead to 





 BPA is primarily thought to mediate its effects through ERs, but it has also been 
shown that it can bind the AR as an agonist at a very low level (at about 20% of the binding 
efficiency of testosterone) (Molina-Molina 2013). However, BPA has also been found to act 
as an antagonist for the AR (Molina-Molina 2013). Interestingly, urinary BPA levels from 
NHANES data from 2003-2004 found that men had significantly higher BPA levels than 
women (Lakind 2008), indicating that BPA doses may be higher in men or metabolized 
differently than women. It has been shown that UDP-glucuronsyltransferases and 
sulfotransferances differ by tissue and sex in mice (Alnouti 2006, Buckley 2007). 
 Although AR expression is higher in men than women, and women express higher 
levels of ERs than men, cells express both ERs and the AR and it is likely the ratio of these 
receptors that determines cell function. Interestingly, it has been shown that ERβ is more 
highly expressed than ERα in the male reproductive system (Weihua 2001, Acconcia 2015). 
BPA has also been found to decrease ERα expression in the spleens of male rats (Miao 
2008). Similarly, BPA treatment of male human T cell lymphoblast lines in culture was 
found to increase ERβ expression using qRT-PCR (Cipelli 2014). 
 Few studies have examined whether BPA exposure could have an effect on normal 
physiology or disease in males. Some recent studies have found that BPA exposure is 
associated with male infertility and a low sperm count (Vitku 2015). BPA has also been 
found to significantly increase the number of microglia (which are CD11b+ brain 
macrophages) in the brain of male rats, but not in females (Rebuli 2016). Because men are 
exposed to BPA in the environment, BPA can influence the AR, and ERs may also affect 
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myocarditis in males, we decided to examine the effect of BPA exposure on male BALB/c 






BPA exposure increases CVB3 myocarditis in male BALB/c mice in glass cages at all 
doses 
 Many studies have found that BPA increases cardiac, autoimmune and inflammatory 
diseases (Weinstock-Guttman 2003, Orton 2004, Kendziorski 2012, Melzer 2012, Shankar 
2012, Gao 2014, O’Brien 2014, Jochmanova 2015, Ranciere 2015, Han 2016, He 2016). 
However, few studies have examined the effect of BPA exposure on males (Kendziorski 
2012, Vitku 2015, Rebuli 2016). It is well established that sex hormones influence cardiac 
diseases such as myocarditis (Coronado 2012). However, no studies have assessed whether 
BPA exposure could alter myocarditis in male mice. To assess the effect of BPA exposure on 
CVB3 myocarditis in male mice, 6-8 week old male BALB/c mice were given the same 
doses of BPA in water for 2 weeks using glass cages and water bottles prior to infection with 
CVB3 on day 0 as were given to female BALB/c mice in Chapter 4 and 5. Soy-free food 
and bedding were used. BPA exposure was continued from day 0 to 10 pi. Cardiac 
inflammation was assessed histologically at day 10 pi during acute myocarditis by 
determining % inflammation by H&E staining of heart sections. 
We found that the exposures of 2.5, 25 and 250 µg BPA/L water, which is equivalent 
to an estimated intake of 0.5, 5 and 50 µg BPA/kg BW, respectively, significantly increased 
myocarditis at day 10 pi compared to control water containing no BPA in male BALB/c mice 
housed in glass caging (p<0.0007) (Fig 1). Controlling for multiple comparisons found a 
significant increase in myocarditis with BPA exposure compared to water control for 0.5 µg 
BPA/kg BW (p<0.01), 5 µg BPA/kg BW (p<0.001), and 50 µg BPA/kg BW (p<0.05). Post-
hoc analyses using Student’s t tests indicated that all BPA doses significantly increased 
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myocarditis compared to control water; human relevant dose of 0.5 µg BPA/kg BW 
(p=0.001), high human relevant dose of 5 µg BPA/kg BW (p=0.0003), and the EPA 
reference dose of 50 µg BPA/kg BW (p=0.005) (Fig 1). Representative examples of the 
inflammation in males are shown in Figure 2. 
In all further analyses shown in this Chapter the EPA reference dose was used. This is 
because when the histology was originally assessed it was thought that this dose had the 
largest/ most significant effect. Thus, when the experiment was repeated to obtain tissue to 
conduct qRT-PCR, the 50 µg BPA/kg BW dose was used. When histology experiments were 
repeated it was realized that a mistake had occurred and that actually the 5 µg BPA/kg BW 
dose was most significantly increased, similar to results found for female BALB/c mice 
housed in plastic cages in Chapter 4. In future experiments in male mice with glass cages we 
will analyze the immune mechanisms involved with the 5 µg BPA/kg BW dose. 
 
Figure 1. BPA exposure increases myocarditis in BALB/c male mice housed in glass cages. Male 
BALB/c mice were given 0 (0 BPA), 0.5 (0.5 BPA), 5 (5 BPA), and 50 (50 BPA) µg BPA/kg BW in 
drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and cardiac 
inflammation examined at day 10 pi, during peak myocarditis. Soy-free bedding and food and glass 
cages and water bottles were used. BPA exposure continued from day 0 to 10 pi. Myocarditis was 
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assessed as the % inflammation in the heart compared to the overall size of the heart section by 
histology using an eyepiece grid. Estimated BPA intakes were determined as follows: 0, 0.5, 5, and 
50 µg BPA/kg BW were obtained by dosing water with 0, 2.5, 25 or 250 µg BPA/L, respectively. 
One-way ANOVA found a significant difference existed between groups (p<0.0007). After 
controlling for multiple comparisons, the 0.5 (**, p<0.01), 5 (***, p<0.001), and 50 (*, p<0.05) µg 
BPA/kg BW dose were significantly increased compared to control water. Data show the mean +/-
SEM of 10 mice/ group. The same finding was observed when the experiment was repeated for a total 
of 18-20 mice/ group. 
 
Figure 2. Representative photos of the effect of BPA exposure on CVB3 myocarditis in male 
mice in glass cages. Male BALB/c mice were given increasing doses of BPA in drinking water using 
glass cages and water bottles for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and 
cardiac inflammation examined at day 10 pi, during peak myocarditis. Soy-free bedding and food 
were used. BPA exposure continued from day 0 to 10 pi. Inflammation in the heart was assessed 
using H&E stain where cardiac tissue appears pink and inflammation dark purple. Representative 
photos depict A) 0, B) 0.5, C) 5, and D) 50 µg BPA/kg BW. The grey bar is 300µm in length. 
 
BPA exposure does not significantly alter viral gene expression in the heart during 
myocarditis in males 
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We examined whether BPA exposure altered CVB3 gene expression in the heart 
during acute myocarditis in male mice in glass cages. We used a primer/probe set directed to 
the CVB3 genome according to Antoniak et al. (Antoniak 2013). We found that BPA 
exposure had no significant effect on viral gene expression levels in the heart during acute 
myocarditis in males at day 10 pi by qRT-PCR (p=0.74) (Fig 3). Thus, increased myocardial 
inflammation from BPA exposure in males using glass cages was not due to increased viral 
replication during acute CVB3 myocarditis. 
 
Figure 3. Viral gene expression in the heart was not altered by BPA treatment of male mice in 
glass cages. Male BALB/c mice were given 0 (0 BPA) or 50 (50 BPA) µg BPA/kg BW in drinking 
water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts were harvested 
at day 10 pi. Soy-free bedding and food and glass cages and water bottles were used. BPA exposure 
continued from day 0 to 10 pi. CVB3 levels in the heart were measured using qRT-PCR to determine 
relative gene expression (RGE) of viral genome compared to the housekeeping gene Hprt. Data show 
the mean +/-SEM, n=10/group Significant differences between groups were assessed using Student’s 
t test. 50 µg BPA/kg BW was obtained by dosing water with 250 µg BPA/L. 
 




In order to determine the effect of BPA exposure on individual immune cell types in 
the heart during CVB3 myocarditis in male mice housed in glass cages we conducted qRT-
PCR of whole hearts (i.e., not isolated cells) at day 10 pi using mice exposed to the EPA 
reference dose. We found that the 50 µg BPA/kg BW exposure dose significantly increased 
expression of CD45 (p=0.01), CD11b (p=0.03), F4/80 (p=0.02), GR1 (p=0.04), CD14 
(p=0.03), CD3 (p=0.006), CD4 (p=0.01), CD8 (p=0.03), and Foxp3 (data not shown, 
p=0.0002) in the heart compared to 0 BPA control water during CVB3 myocarditis (Fig 4). 
However, this dose of BPA had no significant effect on cKit/ CD117 (i.e., mast cells) 
(p=0.08) expression in the heart compared to 0 BPA control water during CVB3 myocarditis 
(Fig 4F). This increase in immune cell populations determined by qRT-PCR following BPA 




Figure 4. Immune cell markers were significantly increased by BPA exposure in males in glass 
cages. Male BALB/c mice were given 0 (0 BPA) or 50 (50 BPA) µg BPA/kg BW in drinking water 
for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts were harvested at day 
10 pi. Soy-free bedding and food and glass cages and water bottles were used. BPA exposure 
continued from day 0 to 10 pi. Immune cell populations in the heart were examined using qRT-PCR 
for relative gene expression (RGE) of the gene of interest vs. the housekeeping gene Hprt for CD45 
(total immune cells), CD11b (includes macrophages, neutrophils, mast cells and some dendritic cells), 
F4/80 (macrophages), GR1 (neutrophils), CD14 (part of TLR4 signaling complex on macrophages 
and mast cells), CD3 (all T cells), CD4 (CD4+ T cells), and CD8 (CD8+ T cell). Data are shown as 
the mean +/-SEM using a two-tailed Student’s t or Mann-Whitney rank test with 10 mice/ group. 50 
µg BPA/kg BW was obtained by dosing water with 250 µg BPA/L. 
 
BPA exposure does not alter M1 vs. M2 macrophage markers in the heart of males in glass 
cages during myocarditis 
Markers of M2 macrophages in mice include arginase-1 (Arg1) and Ym1 
(eosinophilic protein from chitinase family), while M1 markers include Cxcl9 and Cxcl10 
(Siracusa 2008, Fairweather 2009). Here we found that male BALB/c mice exposed to the 
EPA reference dose of BPA had no significant change in M2 macrophage markers arginase-1 
(p=0.59) and Ym1 (p=0.22) or M1 macrophage markers Cxcl9 (p=0.13) and Cxcl10 (p=0.19) 




Figure 5. BPA exposure does not change the relative gene expression of M1 or M2 macrophage 
markers in males in glass cages during myocarditis. Male BALB/c mice were given 0 (0 BPA) or 
50 (50 BPA) µg BPA/kg BW in drinking water for 2 weeks and then injected ip with 103 PFU of 
CVB3 ip on day 0 and hearts were harvested at day 10 pi. Soy-free bedding and food and glass cages 
and water bottles were used. BPA exposure continued from day 0 to 10 pi. Relative gene expression 
(RGE) of A) M2 macrophage markers (Arg1, Ym1) and B) M1 markers (Cxcl9, Cxcl10) vs. Hprt 
controls were assessed in whole hearts using qRT-PCR at day 10 pi comparing 0 and 50 µg BPA/kg 
BW groups. Data show the mean ±SEM using a two-tailed Student’s t test with 10 mice/ group. 50 µg 
BPA/kg BW was obtained by dosing water with 250 µg BPA/L. 
 
BPA exposure increases expression of mast cell anaphylatoxin receptors C3aR1 and 
C5aR1 in males 
Because of the important role of the complement pathway in the pathogenesis of 
CVB3 myocarditis in male mice (Fairweather 2006) and because the EPA reference dose 
increased CD11b/CR3 expression in males with myocarditis (Fig 4B), we examined the 
expression of complement components and receptors in the heart of BPA exposed male mice 
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with myocarditis that had been housed in glass cages. We found that BPA exposure had no 
significant effect on C3 (p=0.29) or C4b (p=0.13), but significantly increased expression of 
the mast cell anaphylatoxin receptors C3aR1 (p=0.04) and C5aR1 (p=0.03) in male mice 
with myocarditis by qRT-PCR during acute myocarditis (Fig 6). We also found that the 
complement regulator CR1/2 was not significantly increased in males with the BPA EPA 
reference dose during acute myocarditis (data not shown, p=0.05). Thus, even though mast 
cell numbers did not increase with BPA exposure in males (Fig 4F), increased expression of 
C3aR1 and C5aR1 suggest that BPA activates mast cells in males. In future studies we will 
examine whether there is evidence of mast cell degranulation in the heart by histology. 
        
Figure 6. BPA exposure increases the mast cell anaphylatoxin receptors C3aR1 and C5aR1 
during myocarditis in male mice housed in glass cages. Male BALB/c mice were given 0 (0 BPA) 
or 50 (50 BPA) µg BPA/kg BW in drinking water for 2 weeks and then injected ip with 103 PFU of 
CVB3 ip on day 0 and hearts were harvested at day 10 pi. Soy-free bedding and food and glass cages 
and water bottles were used. BPA exposure continued from day 0 to 10 pi. Relative gene expression 
(RGE) of complement genes vs. the housekeeping control Hprt was examined for A) C3, B) C4b, C) 
C3aR1, and D) C5aR1 mRNA by qRT-PCR at day 10 pi comparing 0 to 50 µg BPA/kg BW groups. 
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Data show the mean +/-SEM using a two-tailed Student’s t or Mann-Whitney rank test with 10 mice/ 
group. 50 µg BPA/kg BW was obtained by dosing water with 250 µg BPA/L. 
 
BPA exposure to male mice in glass cages increases IL-1R2 gene expression 
TLR4/inflammasome activation is a key feature of the cardiac immune response in 
male BALB/c mice with CVB3 myocarditis (Fairweather 2003, Frisancho-Kiss 2006, 
Frisancho-Kiss 2007, Coronado 2012). Because myocarditis was increased with BPA 
exposure in male mice (Fig 1) and there was an increase in cardiac immune cells that can 
express TLR4 and the inflammasome (Fig 4), we examined TLR4 pathway-related genes 
using qRT-PCR. We found that BPA exposure at the EPA reference dose did not 
significantly alter most TLR4-related genes except for IL-1R2, which was significantly 
increased compared to control water (p=0.002) (Fig 7D). These data suggest that the primary 
mechanism where BPA increases myocarditis is not via the inflammasome. However, future 
experiments will need to determine whether active IL-1β is altered by BPA in males or if 




Figure 7. BPA exposure of male BALB/c mice increased IL-1R2 expression during myocarditis. 
Male BALB/c mice were given 0 (0 BPA) or 50 (50 BPA) µg BPA/kg BW in drinking water for 2 
weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts were harvested at day 10 pi. 
Soy-free bedding and food and glass cages and water bottles were used. BPA exposure continued 
from day 0 to 10 pi. Relative gene expression (RGE) of inflammasome-related genes vs. the 
housekeeping control Hprt for A) TLR2, B) TLR4, C) caspase-1, and D) IL-1R2 were examined in 
whole hearts by qRT-PCR at day 10 pi comparing 0 to 50 µg BPA/kg BW groups. Data show the 
mean +/-SEM using a two-tailed Student’s t test with 10 mice/ group. 50 µg BPA/kg BW was 
obtained by dosing water with 250 µg BPA/L. 
 
BPA exposure in male mice in glass cages increases the remodeling gene Timp1 during 
myocarditis 
We showed previously that testosterone increases Timp1 expression in the heart 
during CVB3 myocarditis in male mice (Coronado 2012). Elevated cardiac TIMP-1 mRNA 
levels have been found to correlate with LV fibrosis in patients with chronic pressure 
overload (Heymans 2005), and elevated TIMP-1 levels in the sera predict the progression to 
heart failure in patients with coronary artery disease (Lubos 2005). Thus, elevated Timp1 
contributes to cardiac remodeling in male BALB/c mice with CVB3 myocarditis, resulting in 
the progression to chronic cardiomyopathy. Because BPA exposure was found to increase 
myocarditis in males we examined whether BPA altered Timp1 levels. We found that BPA 
exposure at the EPA reference dose significantly increased Timp1 in the heart by qRT-PCR 





Figure 8. BPA exposure in male mice in glass cages increases Timp1 expression during 
myocarditis. Male BALB/c mice were given 0 (0 BPA) or 50 (50 BPA) µg BPA/kg BW in drinking 
water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts were harvested 
at day 10 pi. Soy-free bedding and food and glass cages and water bottles were used. BPA exposure 
continued from day 0 to 10 pi. Relative gene expression (RGE) of Timp1 vs. the housekeeping gene 
Hprt were analyzed in whole hearts by qRT-PCR at day 10 pi comparing 0 to 50 µg BPA/kg BW 
groups. Data show the mean +/-SEM using a two-tailed Mann-Whitney rank test with 10 mice/ group. 
50 µg BPA/kg BW was obtained by dosing water with 250 µg BPA/L. 
 
BPA exposure decreases ERRγ in males in glass cages with myocarditis, but has no 
significant effect on other sex hormone receptors 
 ERs and the AR are located on/in immune cells, cardiomyocytes, endothelial cells, 
and cardiac fibroblasts in both males and females (Regitz-Zagrosek 2008, Vitale 
2009, Fairweather 2012A, Buskiewicz 2016). It is likely that the ratio of ERs to AR on/in 
immune cells is critical in sex hormone regulation of inflammation (Regitz-Zagrosek 2008, 
Vitale 2009, Fairweather 2012A, Buskiewicz 2016). However, this is a rapidly growing area 
of research with many questions that still remain. In this Chapter, we found that BPA 
exposure had no significant effect on the expression of ERα (p=0.51), ERβ (p=0.15), and AR 
(p=0.17), but there was a significant decrease in ERRγ (p=0.03) expression in the heart 
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compared to control water in male mice with CVB3 myocarditis by qRT-PCR (Fig 9). The 
role of ERRγ on/in inflammatory or resident cardiac cells is not yet known, but our data 
suggest that the EPA reference dose is able to significantly alter this ER in the heart during 
myocarditis in males. 
 
Figure 9. BPA exposure alters ERRγ in male BALB/c mice housed in glass caging. Male BALB/c 
mice were given 0 (0 BPA) or 50 (50 BPA) µg BPA/kg BW in drinking water for 2 weeks and then 
injected ip with 103 PFU of CVB3 ip on day 0 and hearts were harvested at day 10 pi. Soy-free 
bedding and food and glass cages and water bottles were used. BPA exposure continued from day 0 
to 10 pi. Relative gene expression (RGE) vs. Hprt controls of A) ERα B) ERβ C)  ERRγ, and D) AR  
mRNA by qRT-PCR at day 10 pi comparing 0 to 50 µg BPA/kg BW groups. Data show the mean 
±SEM using a two-tailed Student’s t or Mann-Whitney rank test with 10 mice/ group. 50 µg BPA/kg 
BW was obtained by dosing water with 250 µg BPA/L. 
 
BPA increases VDR expression in the heart of males with myocarditis in glass cages 
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In Chapter 3 we showed that VDR increases CVB3 myocarditis in male mice by 
increasing TLR4 pathway-related genes (Chapter 3, Fig 3). Here we found that BPA 
exposure in male BALB/c mice significantly increased VDR expression in the heart by qRT-
PCR (p=0.03) (Fig 10), but had no significant effect on Cyp enzymes that metabolize VitD to 
its active form (data not shown); Cyp2R1 (p=0.23), Cyp27B1 (p=0.31), and Cyp24A1 
(p=0.24). This data suggests that at least one mechanism whereby BPA exposure can 
increase myocarditis is by elevating VDR expression in the heart. Plastic cages also had this 
effect on VDR expression in males. 
 
Figure 10. BPA increases VDR expression in the heart of males with myocarditis in glass cages. 
Male BALB/c mice were given 0 (0 BPA) or 50 (50 BPA) µg BPA/kg BW in drinking water for 2 
weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts were harvested at day 10 pi. 
Soy-free bedding and food and glass cages and water bottles were used. BPA exposure continued 
from day 0 to 10 pi. Relative gene expression (RGE) of VDR vs. the housekeeping gene Hprt were 
analyzed in whole hearts by qRT-PCR at day 10 pi comparing 0 to 50 µg BPA/kg BW groups. Data 
show the mean +/-SEM using a two-tailed Student’s t test with 10 mice/ group. 50 µg BPA/kg BW 





In this study we found that BPA exposure to adult male BALB/c mice housed in glass 
cages significantly increased myocarditis at day 10 pi at all BPA doses compared to control 
water (Fig 1). BPA exposure did not significantly alter viral levels in the heart of males (Fig 
3), suggesting that increased myocarditis in males was not due to effects of BPA on viral 
replication. BPA increased the expression of nearly all infiltrating immune cell markers in 
male mice including macrophages, neutrophils, and T cells (Fig 4). ERRγ expression in the 
heart during CVB3 myocarditis was significantly lower after BPA exposure and VDR was 
significantly higher in males, but the other ERs were unchanged in males. Almost no studies 
exist for the effect of BPA on ERRγ. One study found that BPA works through ERRγ to 
induce developmental damage in a zebrafish model (Tohme 2014). 
We found that many of the inflammatory pathways increased by VDR signaling in 
males in Chapter 3 were increased by BPA treatment in males in glass cages (i.e., CD11b, 
complement anaphylactic receptors, Timp1). This suggests that BPA may be mediating its 
affect by altering VDR expression in the heart of males. However, more analysis of the 
effects of BPA in the pathogenesis of myocarditis in males is needed. The upregulation of 
C3aR1 and C5aR1 suggest mast cell activation, yet cKit levels were not significantly altered 
in the heart by BPA exposure. Thus, whether BPA is activating mast cells is unclear. In 
future experiments we need to examine the number and degranulation of mast cells in males 
using histology and/or flow cytometry. A recent cross-sectional study found that BPA 
exposure in men led to higher testosterone expression (Rochester 2013). Testosterone has 
been found to be responsible for the increase in CVB3 myocarditis in male mice compared to 
females (Coronado 2012). If BPA is leading to increased testosterone levels that could 
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explain, at least in part, the ability of BPA to increase myocarditis in males. Importantly, 
BPA has been found to affect the metabolism of Cyps involved in hormone metabolism and 
TSPO/ STAR which involves cholesterol transport into mitochondria for metabolism of sex 
steroids in macrophages and other cells (DeCoster 2012, Peretz 2013, Acconcia 2015). We 
have shown previously that TSPO is expressed only in CD11b+ immune cells compared to 
other immune cells during acute CVB3 myocarditis and that these CD11b+TSPO+ cells 
express TLR4 and release IL-1β and are responsible for the progression from acute to 
chronic myocarditis in male BALB/c mice (Onyimba 2011, Coronado 2012, Fairweather 
2014). Other studies also suggested that BPA can bind to the AR, which could then directly 
activate the AR leading to increased disease in males (Molina-Molina 2013). We did not see 
an increase in AR expression in this study, but it may have been elevated during the innate 
immune response (Onyimba 2011), as cell surface receptors are known to cycle. Overall, our 
data show that BPA exposure is able to increase CVB3 myocarditis in male BALB/c mice 
using glass cages. In future studies we will need to assess the effect of BPA exposure at 
lower doses on myocarditis in males using glass cages and also examine the effect of BPA on 







Bisphenol A has no effect on myocarditis in female 
















Since myocarditis is influenced by sex hormones, it is highly probable that endocrine 
disruptors, which interfere with natural hormones, will play a part in the progression of the 
disease. The human population is exposed to the endocrine disruptor BPA from plastics, such 
as water bottles, plastic food containers, and receipts, for example. To our knowledge no one 
has examined the role of endocrine disruptors like BPA on myocarditis in C57BL/6 (BL/6) 
mice. In this study we examined the role of BPA exposure on female BL/6 mice using glass 
cages and water bottles as well as soy-free food and bedding. We found that BPA exposure 
to BL/6 female mice had no significant effect on CVB3 myocarditis or immune cell 
populations in the heart. There was also no significant change in viral replication, body 
weight, or Th1/Th2/Th17-associated cytokines due to BPA exposure. We also assessed the 
effect of BPA exposure on complement and TLR4 signaling genes, two pathways that are 
known to increase CVB3 myocarditis, and found no significant change due to BPA exposure 
in female BL/6 mice. Lastly, we assessed if BPA could alter hormone expression in female 
BL/6 mice during CVB3 myocarditis and found no significant change in expression levels in 
the heart for any receptor. These results show that the effect of BPA is strain specific, which 




 Human diseases including CVDs are known to differ in incidence and/or severity 
according to the race of the population under analysis (Fonseca 2016, McEvoy 2016, Zhang 
2016). One way to assess race in experimental animal models is by using different strains of 
mice. Few studies have examined the effect of BPA on BL/6 mice. One study by Yan et al 
assessed the effect of BPA exposure on the immune response to Leishmania and found that 
inflammation was increased in BALB/c mice but was unchanged in BL/6 mice (Yan 2008). 
We have shown previously that black background mice develop severe acute 
myocarditis after CVB3 infection with heart-passaged virus, but they do not progress to 
DCM (Fairweather 2001, Abston 2012A, Abston 2013). BL/6 mice respond to CVB3 
infection with a strong IFN/Th1-type immune response that prevents progression to DCM 
(Fairweather 2004A, Abston 2012A, Abston 2013). Additionally, BL/6 mice have few mast 
cells in their spleen and peritoneum, and mast cells are critical in driving a mixed Th1/Th2-
type immune response to CVB3 in male BALB/c mice that is both proinflammatory and 
profibrotic (Fairweather 2004A, Fairweather 2004B). Because of the different susceptibility 
to DCM following CVB3 myocarditis in BALB/c vs. BL/6 mice and because BPA had been 
found to activate mast cells in Chapter 4, we decided to examine whether BPA could alter 
CVB3 myocarditis in female BL/6 mice using glass cages and water bottles (and soy-free 
food and bedding). An additional reason we wanted to examine BL/6 mice was that ERα and 
ERβ knockout mice are available on a BL/6 background and if BPA altered myocarditis in 
female BL/6 mice, then we could use the knockout mice to explore mechanism without the 





BPA exposure has no effect on myocarditis in C57BL/6 female mice in glass cages 
 Myocarditis develops in response to CVB3 infection (our model of CVB3-induced 
myocarditis as well as other models of viral myocarditis) for all mouse strains that have been 
tested so far (i.e., BALB/c, C57BL/6, A/J, mixed BL background mice, etc.) (Fairweather 
2001, Fairweather 2004A, Abston 2012A, Abston 2013). However, only BALB/c and A/J 
mice progress from myocarditis to chronic myocarditis and DCM (Fairweather 2001, 
Fairweather 2004A, Fairweather 2006, Coronado 2012). We showed previously that BL/6 
mice develop a dominant Th1-type immune response that prevents remodeling and fibrosis, 
whereas A/J and BALB/c mice develop a dominant Th2 response that contributes to 
remodeling (Frisancho-Kiss 2007, Coronado 2012, Fairweather 2012B). Additionally, we 
previously published that BALB/c mice have abundant mast cells that contribute to a Th2-
type immune response and release profibrotic cytokines and enzymes that drive remodeling 
in the heart (Fairweather 2004A, Fairweather 2004B). In contrast, BL/6 mice have very few 
mast cells. 
To assess the effect of BPA on CVB3 myocarditis in BL/6 mice, 6-8 week old female 
BL/6 mice were given varying doses of BPA in water for 2 weeks prior to infection with 
CVB3 on day 0, as in previous Chapters. BPA treatment continued from day 0 to day 10 pi 
when mice were harvested. Soy-free food and bedding was used with glass cages and water 
bottles. Myocarditis was assessed histologically at day 10 pi during acute myocarditis by 
determining the % inflammation by H&E staining of heart sections. We found that BPA 
exposure did not significantly alter myocarditis at any dose in female BL/6 mice housed in 




Figure 1. BPA has no effect on myocarditis at any BPA dose in female BL/6 mice in glass cages. 
Female BL/6 mice were given 0 (0 BPA), 0.5 (0.5 BPA), 5 (5 BPA), and 50 (50 BPA) µg BPA/kg 
BW in drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and 
inflammation examined at day 10 pi, during peak myocarditis. BPA exposure continued from day 0 to 
10 pi. Mice were housed using soy-free bedding and food. Myocarditis was assessed as the % 
inflammation in the heart using H&E compared to the overall size of the heart section by histology 
using an eyepiece grid. 0, 0.5, 5, and 50 µg BPA/kg BW estimated intakes were obtained by dosing 
water with 0, 2.5, 25 or 250 µg BPA/L, respectively. Data show the mean +/-SEM by one-way 
ANOVA for multiple comparisons (p=0.09), n=9-10 mice/ group. 
 
Figure 2. Representative photos of the effect of BPA exposure on myocarditis in BL/6 females in 
glass cages. Female BL/6 mice were given A) 0, B) 0.5, C) 5 , and D) 50 µg BPA/kg BW in drinking 
water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and inflammation 
examined at day 10 pi, during peak myocarditis. BPA exposure continued from day 0 to 10 pi. Mice 
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were housed using soy-free bedding and food. 0, 0.5, 5, and 50 µg BPA/kg BW estimated intakes 
were obtained by dosing water with 0, 2.5, 25 or 250 µg BPA/L, respectively. Inflammation in the 
heart was assessed using H&E stain where cardiac tissue appears pink and inflammation dark purple. 
The bar is 300µm in length. 
 
BPA does not significantly alter viral gene expression or replication in the heart during 
myocarditis 
We examined whether BPA exposure altered CVB3 replication in the heart during 
acute myocarditis. We used a primer/probe set directed to the CVB3 genome according to 
Antoniak et al (Antoniak 2013). We found that BPA had no significant effect on viral gene 
expression in the heart during acute myocarditis at day 10 pi by qRT-PCR (p=0.54) (Fig 3A) 
or viral replication by plaque assay (p=0.55) (Fig 3B). 
 
Figure 3. Viral gene expression in the heart was not effected by BPA treatment in BL/6 females 
in glass cages. Female BL/6 mice were given 0 (0 BPA), 0.5 (0.5 BPA), 5 (5 BPA), and 50 (50 BPA) 
µg BPA/kg BW in drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 
and virus examined at day 10 pi, during peak myocarditis. BPA exposure continued from day 0 to 10 
pi. Mice were housed using soy-free bedding and food. A) CVB3 levels in the heart were measured 
using qRT-PCR to determine relative gene expression (RGE) of viral genome compared to the 
housekeeping gene Hprt. Data show the mean +/-SEM by one-way ANOVA for multiple 
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comparisons (p=0.54), n=9-10 mice/ group. B) Viral replication was measured using plaque assay to 
determine PFU/g heart. Data show the mean +/-SEM by Student’s t test (p=0.55), n=10 mice/ group. 
0, 0.5, 5, and 50 µg BPA/kg BW estimated intakes were obtained by dosing water with 0, 2.5, 25 or 
250 µg BPA/L, respectively. 
 
BPA exposure does not affect body weight of BL/6 female mice in glass cages 
BPA has been found to increase type II diabetes (Bodin 2014, Rezg 2014). Body 
weight was assessed to determine if BPA dosing in the water caused a change in body weight 
in BL/6 female mice housed in glass cages. We found that BPA had no significant effect on 
body weight in the heart during acute myocarditis at day 10 pi (p=0.07) (Fig 4). 
 
Figure 4. BPA did not affect body weight during acute myocarditis in BL/6 female mice in glass 
cages. Female BL/6 mice were given 0 (0 BPA), 0.5 (0.5 BPA), 5 (5 BPA), and 50 (50 BPA) µg 
BPA/kg BW in drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 
and body weight examined at day 10 pi, during peak myocarditis. BPA exposure continued from day 
0 to 10 pi. Mice were housed using soy-free bedding and food. Body weight was determined at day 
10 pi. Data are shown as the mean +/-SEM using one-way ANOVA for multiple comparisons with 9-
10 mice/ group (p=0.07). 0, 0.5, 5, and 50 µg BPA/kg BW were obtained by dosing water with 0, 2.5, 




BPA exposure has no effect on markers for individual immune cell populations in the 
heart of BL/6 females in glass cages 
Although we saw no difference in myocarditis by histology (Fig 1), it is possible for 
cell populations to differ/shift based on treatments and so we examined markers for major 
immune cell populations in the heart by qRT-PCR in BL/6 females housed in glass cages and 
exposed to various doses of BPA. We found BPA exposure had no effect on CD45 (p=0.86), 
CD11b (p=0.15), or cKit (p=0.31) in BL/6 female mice housed in glass cages (Fig 5). We 
also saw no significant difference in CD3 (p=0.58), CD4 (p=0.53), CD8 (p=0.42) or CD19 







Figure 5. CD45, CD11b and cKit expression were not altered by BPA exposure in BL/6 female 
mice in glass cages. Female BL/6 mice were given 0 (0 BPA), 0.5 (0.5 BPA), 5 (5 BPA), and 50 (50 
BPA) µg BPA/kg BW in drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip 
on day 0 and immune cells examined at day 10 pi, during peak myocarditis. BPA exposure continued 
from day 0 to 10 pi. Mice were housed using soy-free bedding and food. Immune cell populations 
from the heart were examined using qRT-PCR for relative gene expression (RGE) of the gene of 
interest vs. the housekeeping gene Hprt for A) CD45 (total immune cells) (p=0.86), B) CD11b 
(includes macrophages, neutrophils, mast cells and some dendritic cells) (p=0.15), and C) cKit (mast 
cells) (p=0.31). Data are shown as the mean +/-SEM using one way ANOVA for multiple 
comparisons with 7-10 mice/ group. 0, 0.5, 5, and 50 µg BPA/kg BW were obtained by dosing water 




Figure 6. CD3, CD4, CD8 and CD19 expression were not altered by BPA exposure in BL/6 
female mice in glass cages. Female BL/6 mice were given 0 (0 BPA), 0.5 (0.5 BPA), 5 (5 BPA), and 
50 (50 BPA) µg BPA/kg BW in drinking water for 2 weeks and then injected ip with 103 PFU of 
CVB3 ip on day 0 and immune cells examined at day 10 pi, during peak myocarditis. BPA exposure 
continued from day 0 to 10 pi. Mice were housed using soy-free bedding and food. Immune cell 
populations from the heart were examined using qRT-PCR for relative gene expression (RGE) of the 
gene of interest vs. the housekeeping gene Hprt for A) CD3 (total T cells) (p=0.58), B) CD4 (CD4+ T 
cells) (p=0.53), C) CD8 (CD8+ T cells) (p=0.42), and D) CD19 (B cells) (p=0.83). Data are shown as 
the mean +/-SEM using one way ANOVA for multiple comparisons with 9-10 mice/ group. 0, 0.5, 5, 
and 50 µg BPA/kg BW were obtained by dosing water with 0, 2.5, 25 or 250 µg BPA/L, respectively. 
 
BPA exposure had no influence on cardiac cytokine levels in BL/6 female mice housed in 
glass cages 
We examined whether IFNγ, IL-4, IL-17A, and IL-1β cytokine levels were altered in 
the heart during acute CVB3 myocarditis following 5 µg BPA /kg BW exposure in BL/6 
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females housed in glass cages. Changes in IFNγ, IL-4, and IL-17A are often used to indicate 
whether a Th1, Th2 or Th17 response is dominant, respectively (Fairweather 2004C, Zhu 
2010). We found that IFNγ (p=0.05), IL-4γ (p=0.35), IL-17 (p=0.61), and IL-1β (p=0.15) 
were not significantly changed due to BPA exposure in BL/6 females during acute 
myocarditis (Fig 7). 
                          
Figure 7. Cardiac cytokine levels were not altered by BPA exposure during CVB3 myocarditis. 
Female BL/6 mice were given 0 (0 BPA) or 5 (5 BPA) µg BPA/kg BW in drinking water for 2 weeks 
and then injected ip with 103 PFU of CVB3 ip on day 0 and cytokines examined from homogenized 
heart supernatant at day 10 pi, during peak myocarditis. BPA exposure continued from day 0 to 10 pi. 
Mice were housed using soy-free bedding and food. The supernatant was used to measure A) IFNγ, 
B) IL-4, C) IL-17A, and D) IL-1β levels in the heart by ELISA. Data show the mean +/-SEM using a 
two-tailed Mann-Whitney rank test with 28-29 mice/ group. 5 µg BPA/kg BW was obtained by 




BPA exposure decreases C3aR1 at high human relevant dose, but has no effect on other 
complement components in BL/6 females in glass cages 
Because of the important role of complement components in the induction of CVB3 
myocarditis in BALB/c and A/J mice (Fairweather 2006) and because their levels were 
affected by BPA in Chapter 4, we examined whether BPA exposure altered complement 
components in the heart of female BL/6 mice housed in glass cages with myocarditis (Fig 8). 
We found that BPA exposure significantly decreased C3aR1 (p=0.01) (Fig 8C), but had no 
significant effect on other complement components including C3 (p=0.85), C4b (p=0.16), 
C5aR1 (p=0.15), CD11b/CR3 (p=0.15), or CR1/2 (p=0.79) (Fig 8). 
     
Figure 8. Effect of BPA exposure on complement components in BL/6 female in glass during 
myocarditis. Female BL/6 mice were given 0 (0 BPA), 0.5 (0.5 BPA), 5 (5 BPA), and 50 (50 BPA) 
µg BPA/kg BW in drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 
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and complement components examined at day 10 pi, during peak myocarditis. BPA exposure 
continued from day 0 to 10 pi. Mice were housed using soy-free bedding and food. Relative gene 
expression (RGE) of complement genes vs. the housekeeping control Hprt was examined for A) C3, 
B) C4b, C) C3aR1, D) C5aR1, E) CR1/2, and F) CR3/CD11b mRNA by qRT-PCR at day 10 pi 
comparing 0 µg BPA/kg BW to increasing BPA estimated intake groups. Data are shown as the mean 
+/-SEM using one-way ANOVA for multiple comparisons with 9-10 mice/ group (**Post hoc test, 
p<0.01). 0, 0.5, 5, and 50 µg BPA/kg BW were obtained by dosing water with 0, 2.5, 25 or 250 µg 
BPA/L, respectively. 
 
BPA exposure decreases TLR4 expression at EPA reference dose, but has no effect on 
caspase-1 in the heart of female BL/6 in glass cages during myocarditis 
When we examined components of TLR4 signaling, we found that BPA exposure 
significantly decreased TLR4 expression at the highest BPA dose (i.e., EPA reference dose) 
(one-way ANOVA, p<0.0001, Student’s t test p=0.000003) (Fig 9A), but did not have a 
significantly affect on caspase-1 (p=0.39) (Fig 9B) or IL-1β (p=0.15) (Fig 7D) in the heart of 
female BL/6 mice in glass cages during acute myocarditis. 
          
Figure 9. EPA reference dose of BPA decreases TLR4 in the heart of BL/6 female mice in glass 
cages during myocarditis. Female BL/6 mice were given 0 (0 BPA), 0.5 (0.5 BPA), 5 (5 BPA), and 
50 (50 BPA) µg BPA/kg BW in drinking water for 2 weeks and then injected ip with 103 PFU of 
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CVB3 ip on day 0 and complement components examined at day 10 pi, during peak myocarditis. 
BPA exposure continued from day 0 to 10 pi. Mice were housed using soy-free bedding and food. 
Relative gene expression (RGE) of inflammasome genes vs. the housekeeping control Hprt for A) 
TLR4 and B) caspase-1 were examined in whole hearts by qRT-PCR at day 10 pi comparing control 
water to BPA treatment Data are shown as the mean +/-SEM using one-way ANOVA for multiple 
comparisons with 9-10 mice/ group for gene expression. 0, 0.5, 5, and 50 µg BPA/kg BW were 
obtained by dosing water with 0, 2.5, 25 or 250 µg BPA/L, respectively. 
 
BPA exposure has no effect on sex hormone receptor expression in the heart of BL/6 
females in glass cages 
 When we examined ERs and AR expression in the heart by qRT-PCR of BL/6 female 
mice with myocarditis that had been housed in glass cages, we found that BPA exposure had 
no significant effect on hormone expression of ERα (p=0.37), ERβ (p=0.29), ERRγ (p=0.73), 
or AR (p=0.90) in the heart during CVB3 myocarditis (Fig 10). 
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Figure 10. BPA exposure has no effect on sex hormone receptor expression in the heart of BL/6 
females in glass cages. Female BL/6 mice were given 0 (0 BPA), 0.5 (0.5 BPA), 5 (5 BPA), and 50 
(50 BPA) µg BPA/kg BW in drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 
ip on day 0 and complement components examined at day 10 pi, during peak myocarditis. BPA 
exposure continued from day 0 to 10 pi. Mice were housed using soy-free bedding and food. Relative 
gene expression (RGE) vs. Hprt controls of A) ERα, B) ERβ C) ERRγ and D) AR mRNA by qRT-
PCR at day 10 pi. Data show the mean +/-SEM, n=7-10/group. Significant differences were 
calculated using one-way ANOVA for multiple comparisons. 0, 0.5, 5, and 50 µg BPA/kg BW were 
obtained by dosing water with 0, 2.5, 25 or 250 µg BPA/L, respectively. 
 
Free BPA and BPA-glucuronide levels were not significantly altered between 0 and 25 µg 
BPA/L water doses in female BL/6 mice in glass cages 
 Free BPA and BPA-glucuronide levels were measured by LC-MS/MS in the urine of 
female BL/6 mice exposed to control or BPA-treated water after infection. No significant 
differences were found in BPA levels between BPA-treated water compared to control water 
without BPA: free BPA (p=0.73) and BPA-glucuronide (p=0.96) (Fig 11). The inability to 
detect a significant difference in BPA levels in the urine of BL/6 mice assessed by LC-
MS/MS could have arisen from a number of situations. Another cause could be due to the 
urine being stored for a year in plastic Eppendorf tubes, which may have leached BPA and 
altered the levels in the samples (Vandenberg 2009). In future studies we will collect water, 
urine and blood to test BPA levels in glass containers in order to prevent potential BPA 




Figure 11. BPA concentration in urine of female BL/6 mice was unchanged by BPA dose when 
assessed by LC-MS/MS. Female BL/6 mice were given 0 (0 BPA) or 5 (5 BPA) µg BPA/kg BW in 
drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. BPA exposure 
continued from day 0 to 10 pi. Mice were housed using soy-free bedding and food using glass cages 
and water bottles. A) Free BPA and B) BPA-glucuronide levels were assessed in the urine of mice. 
Urine was collected from individual mice on day 0, 3, 7, 10 pi and samples were pooled for each 
mouse. Samples were sent to our collaborators at University of Kentucky for analysis of BPA levels 
by LC-MS/MS. Significance was calculated using Mann-Whitney rank test comparing BPA exposure 
to control water group. Data show the mean ±SEM with 3 mice/ group. 5 µg BPA/kg BW was 





In this study we found that BPA exposure to adult female BL/6 mice housed in glass 
cages (and using soy-free bedding and food) had no significant effect on myocarditis at day 
10 pi. Using plaque assay and qRT-PCR to determine viral replication in the pancreas and 
and heart, respectively, virus was not altered by BPA exposure. BPA did not alter immune 
cell populations, body weight, cytokines, TLR4 pathway genes or complement genes in 
female BL/6 mice. ERα, ERβ, AR and ERRγ levels were unchanged according to qRT-PCR 
after BPA exposure compared to control water. Thus, BPA exposure in female BL/6 mice 
had no significant effect on acute myocarditis. Both our study and Yan et al found that the 
effect of BPA exposure on inflammation after infection was only observed in BALB/c mice 
(Yan 2008). Based on our finding that a central effect of BPA exposure in female BALB/c 
mice was to increase mast cell numbers and degranulation in Chapter 4 and 5, this suggests 
that the low numbers of mast cells present in BL/6 mice may prevent immune cell activation 
via this route. We have published previously that mast cells are the first antigen presenting 
cells to respond to CVB3 infection in our model in the spleen and peritoneum compared to 
dendritic cells, monocyte/macrophages, and B cells (Frisancho-Kiss 2006A). Thus, it is 
possible that BPA exposure does not affect BL/6 females due to their lack of or low numbers 
of mast cells. This idea will need to be verified in future studies. 
We assessed urine levels of free BPA by LC-MS/MS to determine if less active BPA 
was present in the urine of BL/6 mice. The average BPA concentration in BL/6 female mice 
was 0.0012 µg/L, and this level was similar to that found by LC-MS/MS in BALB/c female 
mice (0.0014 µg/L). Therefore, BPA concentration in the body does not appear to explain 






Bisphenol S, a replacement for bisphenol A in plastics, 













Myocarditis is an inflammatory heart disease that leads to DCM and heart failure. Sex 
hormones play a vital role in development of myocarditis with testosterone driving disease in 
males. Since myocarditis is influenced by sex hormones, it is highly probable that endocrine 
disruptors, which interfere with natural hormones, will play a part in the progression of the 
disease. The human population is exposed to the endocrine disruptor BPS from plastics such 
as water bottles and plastic food containers, for example. BPS is the plastic that has replaced 
BPA in many water and food containers. Very few studies have assessed the effect of BPS on 
disease states, and to our knowledge no one has examined the role of BPS on myocarditis. 
Glass cages and water bottles as well as soy-free food and bedding were used in these 
experiments in order to assess the effect of BPS exposure on female BALB/c mice without 
the confounding effect of leaching from plastic caging. The dose we used was equivalent to 
the BPA high human relevant dose of 25 µg BPA/L (5 µg BPA/kg BW) and was 27.5 µg 
BPS/L, which has an estimated intake exposure of 5.5 µg BPS/kg BW. We found that this 
dose of BPS significantly increased myocarditis in female BALB/c mice compared to control 
water. We also found that BPS had no effect on viral levels in the heart. We found that BPS 
exposure increased markers for CD4 and CD8 T cells and mast cells (cKit), which correlates 
with increased inflammation. BPS significantly increased ERα expression in the heart, which 
is known to be important in T cell proliferation. The increase in myocarditis was associated 
with an increase in M1 macrophage markers and TLR2, caspase-1, and IL-1R2 expression. 
Thus, BPS appears to increase CVB3 myocarditis in BALB/c females using very similar 
mechanisms as we found for BPA in plastic cages. However, in these studies with BPS we 




 Although BPA has been mandated to be removed from baby bottles and sippy cups 
and voluntarily removed by manufactures from other products such as plastic water bottles, it 
has been replaced with another endocrine disruptor- BPS. Therefore the study of BPS is 
extremely important because as BPA is removed from more and more plastic materials over 
time it is likely to be replaced with BPS. 
BPS can bind to ERα and ERβ, and is considered more estrogenic than BPA 
(Rochester 2015). When estradiol is bound to ERα, BPA can remove estradiol from the 
binding site whereas BPS only inhibited about 80% of the binding of estradiol (Molina-
Molina 2013). Additionally, BPA is able to activate both ERα and ERβ, whereas BPS 
activates ERβ more than ERα (Molina-Molina 2013). BPS is also thought to bind to the AR 
receptor as an agonist at a very low binding level of around 20% of that of testosterone 
(Molina-Molina 2013). However, BPA can also act as an antagonist to the AR, while BPS 
does not (Molina-Molina 2013). One study assessed the effect of BPS on CVD and found 
that BPS exposure was able to increase heart rate, arrhythmias, induced calcium handling 
changes via ERβ in females, but not males- similar to BPA (Gao 2015). No studies have 




BPS increases myocarditis in female BALB/c mice at high human relevant dose (5.5µg/kg) 
 Studies have found that BPA increases cardiac, autoimmune and inflammatory 
diseases such as cardiac arrhythmias (Orton 2004, Weinstock-Guttman 2003, Kendziorski 
2012, Melzer 2012, Shankar 2012, Gao 2014, O’Brien 2014, Jochmanova 2015, Ranciere 
2015, Han 2016, He 2016). However, few studies have assessed the effect of BPS exposure 
in animal models (Gao 2015), and there have been no studies on the effect of BPS exposure 
on inflammatory diseases including myocarditis. To assess the effect of BPS exposure on 
CVB3 myocarditis, 6-8 week old female BALB/c mice were given varying doses of BPS in 
their drinking water for two weeks prior to ip infection with CVB3 on day 0. BPS exposure 
was continued until day 10 harvest. Glass cages and water bottles with soy-free bedding and 
food were used for all experiments in this Chapter. Because we had found that a dose of 5 µg 
BPA/kg BW had significantly increased myocarditis in plastic cages (Chapter 4, Fig 2) (and 
we are not aware of any studies that estimate a low-dose or “safe” lifetime dose for BPS), we 
examined the effect of an equivalent dose of BPS on myocarditis in this Chapter. We 
determined that 27.5 µg BPS/L water was equivalent to an estimated intake of 5.5 µg BPS/kg 
BW based on an analytical calculation of Molarity. 
The effect of BPS exposure on CVB3 myocarditis was assessed histologically at day 
10 pi during acute myocarditis. BPS exposure in drinking water was continued from day 0 
until harvest at day 10 pi. We found that a 27.5 µg BPS/L exposure in drinking water 
significantly increased myocarditis in BALB/c female mice housed in glass cages compared 
to control water containing no BPS (p=0.03) (Fig 1). As expected, female BALB/c mice with 
control water developed a low level of myocarditis (i.e., 20%) at day 10 pi (Frisancho-Kiss 
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2007, Coronado 2012). Representative photos of the effect of BPS exposure on CVB3 
myocarditis in BALB/c females are shown in Figure 2. 
 
Figure 1. BPS exposure increases myocarditis in BALB/c female mice at high human relevant 
dose (5.5 µg BPS/kg BW). Female BALB/c mice were given 0 or 5.5 µg BPS/kg BW bisphenol S 
(BPS) in their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and 
inflammation examined at day 10 pi, during peak myocarditis. Myocarditis was assessed as the % 
inflammation in the heart compared to the overall size of the heart section by histology using an 
eyepiece grid. Data are shown as the mean +/-SEM from 10 mice/ group. Significance was 
determined using a two-tailed Student’s t test. 5.5 µg BPs/kg BW was obtained by dosing water with 






Figure 2. Representative inflammation after BPS exposure in BALB/c female mice during 
myocarditis. Female BALB/c mice were given A) 0 or B) 5.5 µg BPS/kg BW bisphenol S (BPS) in 
their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and 
inflammation examined at day 10 pi, during peak myocarditis. Representative H&E photos of 
myocardial inflammation. Pink represents cardiac tissue and purple is areas of myocardial 
inflammation. Bar is 2mm in length. 5.5 µg BPS/kg BW was obtained by dosing water with 27.5 µg 
BPS/L. 
 
BPS does not significantly alter viral gene expression in the heart during myocarditis 
We examined whether BPS exposure altered CVB3 levels in the heart during acute 
myocarditis. We used a primer/probe set directed to the CVB3 genome according to 
Antoniak et al (Antoniak 2013). We found that BPS had no significant effect on viral 
expression levels in the heart during acute myocarditis at day 10 pi by qRT-PCR (p=0.11) 
(Fig 3). Thus, increased myocardial inflammation following BPS exposure was not due to 





Figure 3. Viral gene expression in the heart was not effected by BPS treatment. Female BALB/c 
mice were given 0 (0 BPS) or 5.5 (5.5 BPS) µg BPS/kg BW in their drinking water for 2 weeks and 
then injected ip with 103 PFU of CVB3 ip on day 0 and inflammation examined at day 10 pi, during 
peak myocarditis. CVB3 levels in the heart were measured using qRT-PCR to determine relative gene 
expression (RGE) of CVB3 genomes compared to the housekeeping gene Hprt. Data are shown as the 
mean +/-SEM using a two-tailed Student’s t or Mann-Whitney rank test with 9-10 mice/ group. 5.5 
µg BPS/kg BW was obtained by dosing water with 27.5 µg BPS/L. 
 
BPS exposure does not affect body weight 
Recently BPA has been associated with an increased risk of type II diabetes (Bodin 
2014, Rezg 2014) no studies on BPS. We examined whether BPS altered the body weight of 
female BALB/c mice and found that BPS exposure had no significant effect on body weight 
during acute myocarditis at day 10 pi (p=0.59) (Fig 4). These data suggest that the role of 




Figure 4. Body weight was not altered due to exposure to BPS in female BALB/c mice in glass 
cages. Female BALB/c mice were given 0 (0 BPS) or 5.5 (5.5 BPS) µg BPS/kg BW in their drinking 
water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and body weight examined 
at day 10 pi, during peak myocarditis. Body weight was determined at day 10 pi. Data are shown as 
the mean +/-SEM using a two-tailed Student’s t test with 9-10 mice/ group. 5.5 µg BPS/kg BW was 
obtained by dosing water with 27.5 µg BPS/L. 
 
BPS exposure increases expression of immune cell markers including mast cells in female 
BALB/c mice in glass cages 
The effect of BPS exposure on markers of specific cardiac immune cells during acute 
myocarditis at day 10 pi was assessed using qRT-PCR. We found that 5.5µg BPS/ kg BW 
exposure to BALB/c female mice housed in glass cages significantly increased CD45 
(p=0.02) and cKit (mast cells, p=0.0005) in the heart compared to 0 BPS control water 
during CVB3 myocarditis (Fig 5). GR1 (p=0.05), CD11b (p=0.08), and F4/80 (p=0.05) were 
borderline significantly increased (Fig 5). CD14 expression was not significantly different 
between 5.5µg BPS and 0 BPS control water (p=0.15) (Fig 5E). The increase in cKit/ mast 
cells following BPS exposure in this Chapter was also observed in female BALB/c mice in 
plastic cages following BPA exposure (Chapter 4, Fig 10). The borderline increase in many 
of these immune cell populations indicates that the number of mice/ group needs to be 
increased in future experiments. Future experiments will also examine mast cell numbers and 
degranulation using histology and/or flow cytometry to confirm that the increase in cKit is 




Figure 5. CD45 and cKit are significantly increased by BPS exposure in BALB/c female mice in 
glass cages. Female BALB/c mice were given given 0 (0 BPS) or 5.5 (5.5 BPS) µg BPS /kg BW in 
their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts 
were harvested at day 10 pi. Immune cell populations from the heart were examined using qRT-PCR 
for relative gene expression (RGE) of the gene of interest vs. the housekeeping gene Hprt for A) 
CD45 (total immune cells), B) GR1 (neutrophils), C) CD11b (includes macrophages, neutrophils, 
mast cells and some dendritic cells), D) F4/80 (macrophages), E) CD14 (part of TLR4 signaling on 
mast cells and macrophages), and F) cKit (mast cells or stem cells). Data are shown as the mean +/-
SEM using a two-tailed Student’s t or Mann-Whitney rank test with 9-10 mice/ group. 5.5 µg BPS/kg 
BW was obtained by dosing water with 27.5 µg BPS/L. 
 
BPS exposure increases markers of T cells in female BALB/c mice in glass cages 
The effect of BPS exposure on markers for T cells during acute myocarditis at day 10 
pi was assessed using qRT-PCR. We found that 5.5µg BPS/ kg BW exposure to BALB/c 
female mice housed in glass cages significantly increased expression of CD4 (p=0.04) and 
CD8 (p=0.03) in the heart compared to 0 BPS control water during CVB3 myocarditis (Fig 
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6), indicating an increase in CD4+ and CD8+ T cells. CD3 expression was borderline 
significantly increased (p=0.06) (Fig 6A). We also examined Foxp3 expression (Treg cell 
marker), but found no significant difference between 5.5µg BPS and 0 BPS control water for 
this immune cell marker (p=0.10) (Fig 6D). The increase in T cell markers by qRT-PCR 
during acute myocarditis following BPS exposure is consistent with the increased 
inflammation observed with histology (Fig 1). The number of mice/ group also needs to be 
increased for the T cell analysis and cells analyzed using flow cytometry. 
          
Figure 6. T cells are significantly increased by BPS exposure in BALB/c female mice in glass 
cages. Female BALB/c mice were given 0 (0 BPS) or 5.5 (5.5 BPS) µg BPS /kg BW in their drinking 
water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts were harvested 
at day 10 pi. Immune cell populations from the heart were examined using qRT-PCR for relative gene 
expression (RGE) of the gene of interest vs. the housekeeping gene Hprt for A) CD3 (total T cells), 
B) CD4 (CD4+ T cells), C) CD8 (CD8+ T cells), and D) Foxp3 (Treg). Data are shown as the mean 
+/-SEM using a two-tailed Student’s t or Mann-Whitney rank test with 9-10 mice/ group. 5.5 µg 




BPS exposure increases markers of classically activated M1 macrophages 
Markers of M2 macrophages in mice include arginase-1 (Arg1) and Ym1 
(eosinophilic protein from chitinase family), while M1 markers include Cxcl9 and Cxcl10 
(Siracusa 2008, Fairweather 2009, Abston 2012A). Analysis of M1 vs. M2 macrophage 
markers using qRT-PCR revealed a borderline increase for the M1 marker Cxcl9 (p=0.05) 
and a significant increase in the M1 marker Cxcl10 (p=0.03), but no significant increase in 
M2 markers arginase-1 (p=0.38) and Ym1 (p=0.23) with BPS exposure compared to water 
controls (Fig 7). The data suggest that BPS increases a Th1-type immune response that is 
associated with elevated classically activated M1 macrophage responses. The data also 
suggest that we need to increase the number of mice/ group, which we will do in future 
experiments, and that we need to conduct ELISA to determine Th1 vs. Th2 cytokine profiles 
that are usually associated with M1 vs. M2 skewing. 
 
 
Figure 7. BPS exposure increases markers of classically activated M1 macrophages. Female 
BALB/c mice were given 0 (0 BPS) or 5.5 (5.5 BPS) µg BPS /kg BW in their drinking water for 2 
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weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts were harvested at day 10 pi. 
Relative gene expression (RGE) of A) M1 macrophage markers (Cxcl9, Cxcl10) and B) M2 
macrophage markers (Arg1, Ym1) vs. Hprt controls were assessed in whole hearts using qRT-PCR at 
day 10 pi comparing 0 and 5 µg BPS/kg BW groups. Data show the mean ±SEM using a two-tailed 
Student’s t or Mann-Whitney rank test with 9-10 mice/ group. 5.5 µg BPS/kg BW was obtained by 
dosing water with 27.5 µg BPS/L. 
 
BPS exposure does not alter expression of complement components in female BALB/c 
mice in glass cages 
Complement components play an important role in increasing myocarditis in male 
BALB/c mice housed in plastic cages (Fairweather 2006). In this study we found that BPS 
exposure had no significant effect on the expression of C3 (p=0.20), C4b (p=0.10), C3aR1 
(p=0.18), C5aR1 (p=0.45), CR1/2 (p=0.47), and CR3/CD11b (p=0.08) expression by qRT-
PCR (Fig 8). These data suggest that complement pathways are not responsible for the 
increase in myocarditis observed with BPS exposure. 
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Figure 8. BPS exposure does not alter complement components in female BALB/c mice in glass 
cages. Female BALB/c mice were given 0 (0 BPS) or 5.5 (5.5 BPS) µg BPS /kg BW in their drinking 
water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts were harvested 
at day 10 pi. Relative gene expression (RGE) of A) C3, B) C4b, C) C3aR1, D) C5aR1, E) CR1/2, and 
F) CR3/CD11b were compared to Hprt controls in the heart by qRT-PCR at day 10 pi comparing 0 to 
5.5 µg BPS/kg BW estimated intake groups. Data show the mean +/-SEM using a two-tailed 
Student’s t or Mann-Whitney rank test with 9-10 mice/ group. 5 µg BPA/kg BW was obtained by 
dosing water with 25 µg BPA/L. 
 
BPS exposure increases TLR2 and caspase-1 in the heart during myocarditis in BALB/c 
mice in glass cages 
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We showed previously that components associated with TLR4 signaling (i.e., IL-1R, 
caspase-1, IL-1β and IL-18) are upregulated in the heart during CVB3 myocarditis in male 
BALB/c mice in plastic cages (Coronado 2012, Fairweather 2015, Frisancho 2006, Frisancho 
2007, Frisancho 2009, Roberts 2013). TLR2 has been found to be associated with increased 
myocarditis and DCM in patients (Zhang 2009). In this study we found that BPS exposure 
significantly increased expression of TLR2 (p=0.02) and caspase-1 (p=0.009) in the heart 
during acute myocarditis (Fig 9). IL1R2 was borderline increased (p=0.07) (Fig 9C). TLR4 
was not significantly changed with BPS exposure compared to control water (p=0.43) (Fig 
9B). These data suggest that BPS increases myocarditis by elevating TLR2 and caspase-1 
expression in the heart. 
 
Figure 9. BPS exposure of female BALB/c mice activates TLR2 and caspase-1 during 
myocarditis. Female BALB/c mice were given 0 (0 BPS) or 5.5 (5.5 BPS) µg BPS /kg BW in their 
drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0 and hearts were 
harvested at day 10 pi. Relative gene expression (RGE) of inflammasome genes vs. the housekeeping 
control Hprt for A) TLR2, B) TLR4, C) IL-1R2, and D) caspase-1 (Casp-1) were examined in whole 
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hearts by qRT-PCR at day 10 pi comparing 0 to 5.5 µg BPS/kg BW groups. Data show the mean +/-
SEM using a two-tailed Student’s t or Mann-Whitney rank test with 9-10 mice/ group. 5.5 µg BPS/kg 
BW was obtained by dosing water with 27.5 µg BPS/L. 
 
BPS exposure does not alter genes associated with remodeling and fibrosis in female 
BALB/c mice in glass cages 
Because BPA affected genes associated with remodeling in female BALB/c mice in 
plastic cages (Chapter 4), we examined whether BPS promoted factors associated with 
cardiac remodeling during acute myocarditis- a timepoint when profibrotic genes/proteins are 
elevated but histologic fibrosis (i.e., collagen deposition) is not yet present (Coronado 2012). 
We found that BPS exposure did not significantly alter expression of Timp1, SerpinA3n, or 
TGFβ1 compared to control water by qRT-PCR (Fig 10). 
 
Figure 10. BPS exposure does not alter remodeling genes in the heart of female BALB/c mice 
during myocarditis in glass cages. Female BALB/c mice were given 0 (0 BPS) or 5.5 (5.5 BPS) µg 
BPS /kg BW in their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on 
day 0 and hearts were harvested at day 10 pi. Relative gene expression (RGE) of A) Timp1, B) Serpin 
A3n, and C) TGFβ1 vs. the housekeeping gene Hprt were analyzed in whole hearts by qRT-PCR at 
day 10 pi comparing 0 to 5.5 µg BPS/kg BW groups Data show the mean +/-SEM using a two-tailed 
Student’s t or Mann-Whitney rank test with 9-10 mice/ group. 5.5 µg BPS/kg BW was obtained by 




BPS exposure to female BALB/c mice in glass cages increases ERα expression during 
myocarditis 
 In Chapter 4 we found that BPA exposure decreased ERα and decreased ERβ in 
female BALB/c mice housed in plastic cages. In this Chapter, we found that BPS exposure 
increased the expression ERα (p=0.003) in the heart of female BALB/c mice during CVB3 
myocarditis housed in glass cages, but did not significantly affect the gene expression of the 
other sex hormone receptors (Fig 11). 
 
Figure 11. BPS exposure increases ERα levels in the heart of female BALB/c mice housed in 
glass cages. Female BALB/c mice were given 0 or 5.5 µg/kg BW bisphenol S (0 BPS vs. 5 BPS) in 
their drinking water for 2 weeks and then injected ip with 103 PFU of CVB3 ip on day 0. BPS 
exposure continued from day 0 to 10 pi. Relative gene expression (RGE) vs. Hprt controls of A) 
ERα, B) ERβ, C) ERRγ, and  D) AR mRNA by qRT-PCR at day 10 pi comparing 0 µg BPS/kg BW 
and 5.5 µg BPS/kg BW estimated intake groups. Data show the mean ±SEM using a two-tailed 
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Student’s t or Mann-Whitney rank test with 9-10 mice/ group. 5.5 µg BPS/kg BW was obtained by 
dosing water with 27.5 µg BPS/L. 
 
BPS exposure does not affect VDR or Vitamin D metabolism enzymes in the heart of 
female BALB/c mice with myocarditis housed in glass cages 
In Chapter 3 we showed that VDR deficient female mice had significantly increased 
acute myocarditis (Chapter 3, Fig 3), indicating that VDR signaling reduces CVB3 
myocarditis in female mice. Furthermore, we found that VDR deficient female mice had 
significantly increased expression of markers for T cells (Chapter 3, Fig 4), IFNγ and IL-
17A (Chapter 3, Fig 5), M1 macrophages (Chapter 3, Fig 6) and TLR4 activation 
(Chapter 3, Fig 7) in the heart during acute CVB3 myocarditis. These are the same findings 
we observed in WT female mice with CVB3 myocarditis exposed to BPA (Results of 
Chapter 4). For this reason we examined the expression of VDR and the cytochrome p450s 
that lead to active VitD in the heart during acute myocarditis in BPS exposed mice. We 
found that neither VDR nor the enzymes important in its metabolism were altered in the heart 
with BPS exposure (Fig 12). These data indicate that VDR signaling does not appear to be 





Figure 12. BPS exposure does not affect VDR or Vitamin D metabolism enzyme expression in 
the heart of female BALB/c mice with myocarditis housed in glass cages. Female BALB/c mice 
were given 0 or 5.5 µg/kg BW bisphenol S (0 BPS vs. 5 BPS) in their drinking water for 2 weeks and 
then injected ip with 103 PFU of CVB3 ip on day 0. BPS exposure continued from day 0 to 10 pi. 
Relative gene expression (RGE) of A) VDR, B) Cyp27B1, C) Cyp2R1 and D) Cyp24A1 vs. the 
housekeeping gene Hprt were analyzed in whole hearts by qRT-PCR at day 10 pi comparing 0 to 5.5 
µg BPS/kg BW groups. Data show the mean +/-SEM using a two-tailed Student’s t or Mann-Whitney 






In this study we found that BPS exposure to adult female BALB/c mice housed in 
glass cages significantly increased myocarditis at day 10 pi at a high human relevant dose 
(5.5 µg BPS/kg BW) compared to control water. Using qRT-PCR to determine viral 
expression in the heart, virus was not altered by BPS exposure suggesting that increased 
myocarditis was not due to BPS altering viral replication. Similar to our findings with BPA, 
BPS exposure increased myocarditis by increasing the immune cell infiltrate containing CD4 
and CD8 T cells and mast cells. In future studies we will examine mast cell numbers and 
degranulation using histology. ERα expression was significantly increased in the heart of 
female BALB/c mice during myocarditis, but the expression of other hormone receptors was 
unchanged according to qRT-PCR. TLR2 and caspase-1 expression was significantly 
increased in females after BPS exposure, similar to our findings in Chapter 4. Additionally, 
BPS was found to increase M1 proinflammatory macrophage markers, a cell type that is 
usually increased in male BALB/c mice. Thus, BPS exposure converted the cardioprotective 
female immune response to a proinflammatory immune response associated with increased 
myocarditis. 
BPS is thought to act primarily through ERβ rather than ERα (Molina-Molina 2013, 
Gao 2015). We found that BPS significantly increased ERα expression. This upregulation of 
ERα by BPS is likely to be important for increasing T cell-mediated inflammation during 
myocarditis in female BALB/c mice. It may also contribute to mast cell activation. We found 
that BPS exposure did not significantly alter ERβ mRNA gene expression in the heart, but 
significantly increased ERα. This is contradictory to the literature where BPS is thought to 
bind to and cause gene changes mainly through ERβ. In order to further investigate the effect 
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of BPS on ER activation we will need to repeat these experiments and examine ER 
phosphorylation using Western blot and flow cytometric analysis. 
With BPA being removed from plastic materials, the study of the effect of BPS on 
myocarditis will become increasingly important. We previously found that BPA exposure in 
the drinking water of female BALB/c mice housed in plastic cages increased myocarditis in a 
similar manner to BPS exposure. These findings were in contrast to our results for BPA 
exposure in glass cages, which had the opposite effect (Chapter 6). Because of the wide-
spread use of BPS in water bottles and other food products our results suggest that 
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 In this Thesis we have shown that BPA exposure effects CVB3 myocarditis based on 
sex, strain of mouse, and type of caging. The only apparent dose response we observed for 
BPA was its ability to activate pericardial mast cells in female BALB/c mice housed in 
plastic cages. An important next step will be to examine lower doses of BPA to determine the 
lowest dose that can significantly alter myocarditis. We obtained opposite results for BPA 
exposure in female BALB/c mice housed in plastic vs. glass cages. One possible explanation 
for this finding is that different doses of estrogen/estradiol can have opposite effects on 
inflammation; with low levels of estrogen being proinflammatory while high levels are anti-
inflammatory (Cutolo 1996, Accardo 1996, Hall 2001, Cutolo 2012, Jochmanova 2015, 
Jochmanova 2016). A similar dichotomy was observed with BPA exposures where a high 
dose was found to increase Th2-type immune responses (Lee 2010, Rogers 2013) and a low 
dose exposure found to increase Th1-type immune responses (Yoshino 2003, Yoshino 2004, 
Rogers 2013). Other studies found that BPA could either upregulate (Valentino 2013, 
Thompson 2015) or downregulate (Goto 2004, Yin 2007, Rogers 2013, Thompson 2015) 
proinflammatory cytokines (IL-6, IL-8, IL-17, and tumor necrosis factor-α) and immune cell 
proliferation depending on the study. Thus, many animal studies show conflicting 
information about the effect of BPA exposure on the immune response, with some studies 
finding that BPA upregulates Th1 responses and immune cell numbers while others find it 
decreases them. These differences in experimental results have been attributed to 
investigators using different doses, time points, and age at BPA exposure (i.e., prenatal, 
childhood, adult) (Kharrazian 2014). However, a major issue that is likely to confound dose 
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analysis that has been overlooked by most investigators is the type of cages and water bottles 
that are being used to conduct experiments on the role of endocrine disruptors. 
 
Future Directions 
 In the future we plan to examine the effect of VitD on acute myocarditis in male and 
female BALB/c and BL/6 mice by feeding them a VitD deficient diet to determine if it 
replicates the results we found with VDR-/- mice. We also plan to examine the effect of VitD 
supplementation on CVB3 myocarditis in male and female BALB/c and BL/6 mice using 
previously defined doses of VitD added to VitD deficient chow. Our current studies used 
VDR knockout mice, which is an extreme model of deficiency. Therefore, using a diet 
deficient in VitD paired with blocking UVB exposure through cages would be necessary to 
determine the true effect of VitD. Additionally, many physicians are now recommending/ 
prescribing VitD to their patients believing that it is generally protective. However, studies 
that have examined VitD supplementation have generally not taken into account that VitD is 
a sex steroid and not examined their data according to sex (or age). It is quite possible that 
VitD supplementation will have a different effect than what we observed for VDR-/- mice. 
 We have now developed a strong “descriptive” understanding of the effect of BPA on 
acute CVB3 myocarditis and the next step is to prove mechanisms that have been revealed by 
our initial analysis. We plan to use bead separation, FACS analysis, and Western blot as 
techniques to further determine the mechanism of how BPA is acting in our model. In order 
to determine if BPA is acting on immune cells specifically or cardiomyoctyes we plan to use 
magnetic bead isolation of immune cells and cardiomyocytes from digested hearts exposed to 
varying levels of BPA during myocarditis from both sexes to determine if the changes in 
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important genes (i.e., ERs, VDR, CRs, and TLR4) due to BPA exposure are present on 
CD45+ immune cells or cardiac resident cell types (cells that did not bind to CD45+ 
magnetic beads). Further, we will isolate live CD45+ immune cells from digested hearts 
during myocarditis for flow cytometric (FACS) analysis assessing the expression of the 
hormone receptors on/in specific immune cell types. In our current studies we found that 
BPA activated/phosphorylated the ERs using Western blot. Another possible mechanism that 
we will explore in the future will be the effect of BPA on non-genomic signaling from 
membrane ERs. It has been found that BPA can affect non-genomic pathways such as the 
ERK/MAPK and STAT pathways, both of which can lead to activation of the immune 
response (Alonso-Magdalena 2005, Watson 2005, Thomas 2006, Watson 2007, Alonso-
Magdalena 2008, Vandenberg 2009, Wildner 2013, Kharrazian 2014). 
After we confirm the effect of BPA exposure on genomic and non-genomic signaling 
pathways of ERs, we will identify which ER (i.e., ERα or ERβ) or non-genomic pathway 
(i.e., ERK, STAT, etc.) that BPA is acting through using antagonists against the specific 
receptor or pathway. This will allow us to determine how BPA signals cells leading to 
increased (or decreased) myocarditis. 
In future studies we will further assess BPA levels in water from water bottles, sera 
and urine using LC-MS/MS. We will also attempt to get a better understanding of the 
chemicals that are being released from the plastic cages and water bottles by sending samples 
collected from water left sitting in cages or water bottles to collaborators who will use mass 
spectrometry to determine the chemical composition. Once we determine what chemicals are 
leaching from the plastic cages and water bottles that are affecting our experiments, we 
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would like to design further exposure experiments to better understand their effect on sex 
differences in CVB3 myocarditis. 
There are several possible mechanisms for how BPA could alter myocardial 
inflammation that have not been the focus of this thesis. For example, studies by other 
investigators have found that BPA can directly bind to the arylhydrocarbon receptor and the 
thyroid hormone receptor (Kharrazian 2014,Vandenberg 2009), peroxisome proliferator-
activated receptors (Kharrazian 2014) and the G-protein coupled receptor for estrogen 
(GPR30) which has been found to be a nuclear ER (Acconcia 2015). Another possible 
mechanism for the action of BPA on myocarditis that could be increasing disease is through 
epigenetic modification. Studies have found that BPA increases cardiomyopathy and 
decreases cardiac function by DNA methylation (Jiang 2014). Studies looking at other 
disease endpoints have also found that BPA can affect DNA methylation (Cabaton 2013, 
Kundakovic 2013, O’Brien 2014, Jochmanova 2015) and cause DNA epigenetic 
reprograming (André 2009, Wildner 2013, Kharrazian 2014). It is known that epigenetics can 
regulate the immune response through shifting the Th1/Th2 response and thereby alter 
cytokine levels (Hirahara 2011). Both of these processes are involved in myocarditis disease 
pathogenesis and could be important in driving disease by potentially effecting immune cells 
(Ivashkiv 2016). BPA could also increase inflammation by elevating oxidative stress (Tiwari 
2012, Rezg 2014). These are just a few alternative mechanisms that could explain how BPA 
exposure alters inflammation leading to increased (or decreased) myocarditis in our mouse 
model. 
BPA has been found in some studies to have sex-specific effects on CVDs. For 
example, BPA was found to increase cardiac remodeling only in males, but in females BPA 
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affected cardiac function (Melzer 2010, Gao 2014). Others have found that BPA exposure 
increases cardiac remodeling, decreases cardiac function, activates TGFβ, and increases 
cardiac fibroblasts through the ERK1/2 pathway (Hu 2016). We found that BPA exposure 
upregulated genes associated with remodeling and fibrosis, suggesting that BPA exposure 
could increase the risk of progression to chronic myocarditis and DCM. To determine if BPA 
exposure alters the progression to DCM in males or females we will use the same exposure 
method as described for acute myocarditis and harvest at day 35 pi (rather than day 10 pi) 
with continued BPA exposure from day 0 to day 35 pi. At day 35 pi we will perform 
echocardiograms to assess cardiac function for mice exposed to BPA compared to control 
water exposure. We will use histological staining to quantify chronic myocarditis by H&E 
and remodeling using trichrome blue. 
Understanding whether prenatal exposure to BPA and/or other EDs increases adult 
myocarditis and DCM could have a large impact on our understanding of the pathogenesis of 
disease. Our finding that BPA exposure activated pericardial mast cells in the heart could be 
one possible reason why women in their 3rd trimester of pregnancy sometimes develop 
myocarditis and heart failure (called peripartum cardiomyopathy/ PPCM) (Blauwet 2011). 
The reason that PPCM develops is not well understood. Therefore, determining the effect of 
BPA on prenatal exposure in an animal model could help elucidate one possible cause and 
mechanism for a disease, PPCM, which does not have a good animal model. 
There are currently no human studies looking at the association of BPA levels with 
myocarditis, DCM or PPCM. Our laboratory is a member of the Peri/Myocarditis, DCM and 
PPCM Biobank at Mayo Clinic where we are collecting sera, peripheral blood mononuclear 
cells, and myocarditis biopsy tissues from patients to study mechanisms for sex differences in 
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disease comparing our mouse model to clinical samples. We are going to begin collecting 
urine as well in order to assess BPA levels in patients with myocarditis and DCM. 
 We have only just begun our analysis of the effect of BPS on CVB3 myocarditis. 
These studies will continue. BPF is another plastic being used to replace BPA in plastics. 
Meta-studies have found that BPF may be even more potent than BPA using estrogenic 
assays (Molina-Molina 2013, Rochester 2015). Other EDs that could increase the risk for 
myocarditis and DCM and could be studied in our model include genistein, which is in soy 
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